• Home

Oncology news - Sep 2010




2014: [Jan] [Feb] [Mar] [Apr] [May] [Jun] [Jul] [Aug] [Sep] [Oct] [Nov] [Dec]
2013: [Jan] [Feb] [Mar] [Apr] [May] [Jun] [Jul] [Aug] [Sep] [Oct] [Nov] [Dec]
2012: [Jan] [Feb] [Mar] [Apr] [May] [Jun] [Jul] [Aug] [Sep] [Oct] [Nov] [Dec]
2011: [Jan] [Feb] [Mar] [Apr] [May] [Jun] [Jul] [Aug] [Sep] [Oct] [Nov] [Dec]
2010: [Jan] [Feb] [Mar] [Apr] [May] [Jun] [Jul] [Aug] [Sep] [Oct] [Nov] [Dec]


Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnson's Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
... partner with Taxotere. After considering reimbursement hurdles in their countries, overall, French and Italian oncologists assign the greatest patient share to Sprycel and zibotentan. However, the greatest patient share ... Source: WRICTV8 »

Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnson's Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant
... Source: PR Newswire »

Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnson's Abiraterone Compared With Other Em
... and advisory firms for pharmaceutical and healthcare issues, finds that, according to surveyed European oncologists, Johnson & Johnson's abiraterone will capture greater patient share than Dendreon's Provenge, AstraZeneca's zibotentan ... Source: News Blaze »

Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnson's Abiraterone Compar
... Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnson's Abiraterone Compared With Other Emerging Therapies ... Source: Interest Alert »

UT MD Anderson Study Finds Women Treated for Breast Cancer While Pregnant Have Improved Survival
... the disease. Jennifer Litton, M.D., assistant professor in MD Anderson's Department of Breast Medical Oncology, presented the findings in a poster discussion session at the 2010 Breast Cancer Symposium. ... Source: Pharmalive.com/ »

IntelliDose Expert Moderates Oncology EMR Panel
... IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each ... Source: www.euroinvestor.co.uk »

Fresenius plans to turn India into cancer drug research hub
... New Delhi, to spearhead the effort. It runs its critical care and nutrition and oncology businesses in India through two separate Pune-based entities--Fresenius Kabi India Pvt. Ltd and Fresenius ... Source: Quote.com »

Chemical dependency centers will close
... recently expanded their services and treatment options for cancer patients. Capital Medical opened Capital Oncology, which includes a team of oncologists and associated radiation therapy and imaging facilities; St. ... Source: The Olympian »

Experimental Drug Aids Kids With Nervous System Tumor
... treatment were less likely to relapse with neuroblastoma," said Dr. Amal Abu-Ghosh, a pediatric hematologist/oncologist at Georgetown University's Lombardi Cancer Center, in Washington, D.C. And the improvement was seen ... Source: Health On the Net Foundation »

Mammograms Save Lives for Women in Their 40s, Study Says
... in the journal and is to be presented at the American Society of Clinical Oncology's annual Breast Cancer Symposium, which starts Friday in National Harbor, Md. The findings will ... Source: Health On the Net Foundation »

Mammograms still have a role, says oncologist
... Source: Asiaone »

Addition of Immunotherapy Boosts Pediatric Cancer Survival in Children With Neuroblastoma
... therapy," said Alice L. Yu, MD, PhD, study chair and Professor of Pediatric Hematology Oncology at Moores UCSD Cancer Center. "This is also the first time a mAb targeting ... Source: ScienceDaily Magazine »

Increases in 5-, 10-Year Survival at Every Stage of Breast Cancer
... every decade studied. Aman Buzdar, M.D., professor in MD Anderson's Department of Breast Medical Oncology presented the data in advance of the 2010 Breast Cancer Symposium. Similar to that ... Source: ScienceDaily Magazine »

Women With Triple Negative Breast Cancer and BRCA Mutations Have Lower Risk of Recurrence, Study Finds
... population. Ana M. Gonzalez-Angulo, M.D., associate professor in MD Anderson's Departments of Breast Medical Oncology and Systems Biology presented the findings in advance of the 2010 Breast Cancer Symposium. ... Source: ScienceDaily Magazine »

IUD proposed to treat uterine cancer
... published online Wednesday in , the monthly journal of the European Society for Medical Oncology. "The study was done to see if this was a viable option for younger ... Source: WRICTV8 »

Women Treated for Breast Cancer While Pregnant Have Improved Survival, Study Finds
... Jennifer Litton, M.D., assistant professor in MD Anderson's Department of Breast Medical Oncology, presented the findings in a poster discussion session at the 2010 Breast Cancer Symposium. ... Source: ScienceDaily Magazine »

Baby hope after womb cancer
... heavy periods. The study was carried out by researchers from the European Institute of Oncology in Milan and the Centro Integral Oncologico Clara Campal (CIOCC) in Madrid. No sources ... Source: Milton Keynes Today »

New mammogram study stirs debate
... will be presented Friday at a meeting sponsored by the American Society for Clinical Oncology and five other organizations. The study's conclusions contrast with those of a report last ... Source: The Seattle Times »

New Mammogram Study Stirs More Debate
... regular mammograms, said Dr. Jennifer Obel, a spokeswoman for the American Society of Clinical Oncology. Researchers estimate that 1,252 women in their 40s would have to be offered screening ... Source: The Ledger »

Mammogram Benefit Seen For Women in Their 40s
... be presented on Friday at a meeting sponsored by the American Society for Clinical Oncology and five other organizations. The study’s conclusions contrast with those of a report last ... Source: The New York Times »

Intrauterine Devices Can Be Used to Treat Endometrial Cancer
... 39 patients, aged between 20 and 40, were treated at the European Institute of Oncology in Milan, with results from a total of 34 being available for analysis in ... Source: Science Daily »

Drugs before surgery help women avoid mastectomies
... They will be presented Saturday at a meeting of the American Society of Clinical Oncology and several other groups in Washington. Results also have been sent to a scientific ... Source: www.whec.com »

Neogenix Oncology to Commence Phase I Trial for Therapeutic Antibody for Pancreatic and Colorectal Cancer
... Neogenix Oncology to Commence Phase I Trial for Therapeutic Antibody for Pancreatic and Colorectal Cancer . ... Source: Business Wire »

Cancer society renews call for more coverage of catastrophic drugs
... my financial burden aside, he explained. But it was still difficult to go into oncology every week and see the people suffering who couldnt afford their medication and some ... Source: TheSpec.com »

Swedish mammography study sows more confusion about screening for breast cancer
... on Wednesday and is to be presented Friday at the American Society of Clinical Oncology's Breast Cancer Symposium in Alexandria, Va. Epidemiologist Hakan Jonsson of Umea University in Sweden ... Source: Los Angeles Times »

Study demonstrates plunge in breast cancer deaths
... meeting in Washington of breast cancer specialists sponsored by the American Society of Clinical Oncology later this week. His team pulled the records of thousands of women treated at ... Source: The Malaysian Star »

Medford's Nancy Hayes stays healthy biking
... some breathtaking locales. She recently biked through France, along with friend and Mount Auburn oncologist Dr. Lisa Weissman, as part of a Tour de France route last year. It ... Source: Medford Transcript »

New Mammogram Study Stirs Debate For Women In 40s
... regular mammograms, said Dr. Jennifer Obel, a spokeswoman for the American Society of Clinical Oncology. The Swedish researchers estimate that 1,252 women in their 40s would have to be ... Source: Fox 11 Reno »

With Over 3,000 Robotic Prostatectomy Surgeries to His Credit, Dr. David Samadi, MD Discusses SMART Surgery and How it Improves Sexual and Urinary Function
... invented the SMART Surgery Technique (Samadi Modified Advanced Robotic Technique) by using the oncologic principles for he has learned in his long career and combining them with his ... Source: WTHR »

John Hartson believes Neil Lennon has the O'Neill factor
... going to plan and he is now at the stage where he sees his oncologist every three months. But his life has changed irrevocably since his scare. "I appreciate ... Source: The Scotsman »

Neogenix Oncology to Commence Phase I Trial for Therapeutic Antibody for Pancreatic and Colorectal Cancer (BIZ)
... said Michael A. Morse, M.D., associate professor of medicine at Additional information regarding Neogenix Oncology can be found at . Physicians and patients may request information on the clinical ... Source: AlphaTrade Finance »

Neogenix Oncology to Commence Phase I Trial for Therapeutic Antibody for Pancreatic and Colorectal Cancer
... Neogenix Oncology to Commence Phase I Trial for Therapeutic Antibody for Pancreatic and Colorectal Cancer researchers ... Source: www.euroinvestor.co.uk »

140 Lilly Scientists Have New Base For Designing Cancer Drugs
... Eli Lilly and Co. is taking that approach by setting up shop for its oncology-discovery operations near a major medical school in New York City. The Indianapolis drug maker ... Source: Pharmaceutical News »

Healthcare: A Global Mission for WellTek, Inc.
... ADDitude Magazine, Adoptive Families Magazine, ADRInstitute.org, Advamed, ADVANCE for Administrators in Radiology and Radiation Oncology, ADVANCE for Administrators of the Laboratory, ADVANCE for Health Information Executives, ADVANCE for Imaging ... Source: M2 »

Oncology practice opens in South San Antonio
... has unveiled a state-of-the-art cancer clinic on the city’s South Side. Oncology San Antonio — SOUTH is working to better serve cancer patients in South San ... Source: Bizjournals »

Mesothelioma Tests And Diagnosis Information Snappily Discussed
... that the mesothelioma diagnosis is malignant, they will likely refer the patient to an oncologist (cancer doctor) for further tests and treatment. The second more common way that doctors ... Source: American Chronicle »

IUD Proposed to Treat Uterine Cancer
... published online Wednesday in , the monthly journal of the European Society for Medical Oncology. "The study was done to see if this was a viable option for younger ... Source: HealthDay »

ZIOPHARM Oncology to Present at the 9th Annual BIO Investor Forum
... NEW YORK--(BUSINESS WIRE)-- ZIOPHARM Oncology, Inc. (Nasdaq: ) announced today that Jonathan Lewis, MD, PhD, Chief Executive Officer, will ... Source: Street Insider »

ZIOPHARM Oncology to Present at the 9th Annual BIO Investor Forum (BIZ)
is a biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of cancer drugs. The Company is currently focused on three clinical ... Source: AlphaTrade Finance »

HCG Bags Frost and Sullivan Oncology Healthcare Provider Company of the Year 2010' Award
... patients across the globe. About HealthCare Global Enterprises Ltd (HCG) HealthCare Global Enterprises Ltd. (hcgoncology.com), South Asias largest cancer care network, currently owns & manages a network of 18 ... Source: Newswire Today »

Provectus Reports Encouraging Data On Visceral Metastases Presented At ASCO
... Provectus Pharmaceuticals, Inc. (OTC BB: PVCT) , a development-stage oncology and dermatology biopharmaceutical company, has announced additional positive data from its Phase 2 clinical ... Source: Medical News Today »

arGEN-X AWARDED '¬1.5 MILLION IWT GRANT TO ACCELERATE PRE-CLINICAL ANTIBODY DEVELOPMENT
... proprietary SIMPLE Antibody™ platform and are being developed by the Company to target the inflammation/oncology space. Today’s award is the second grant that arGEN-X has received from the IWT. ... Source: PharmiWeb.com »

Eli Lilly powers up its NYC cancer research center
... Eli Lilly and Co. is taking that approach by setting up shop for its oncology-discovery operations near a major medical school in New York City. The Indianapolis drug maker ... Source: IndyStar.com »

MethylGene Issued Key Patents for Lead Oncology Program
... United States Patent and Trademark Office for the Company's multi-targeted (Met) kinase inhibitor for oncology, MGCD265, which is currently in clinical development. U.S. Patent Number 7,772,247 titled "Substituted Thieno ... Source: PR-USA.net »

ASTRO announces 2010 Annual Meeting awards
... will be honored this year, Anthony L. Zietman, M.D., ASTRO president and a radiation oncologist at Massachusetts General Hospital in Boston, said. The high quality of the research submitted ... Source: Web NewsWire »

IUD device shows promise to treat womb cancer
... accounting, for 4.8 percent of all female cancers. Dr Lucas Minig of the gynaecologic oncology unit at the Hospital Universitario Madrid Sanchinarro, Madrid and one of the authors of ... Source: The Money Times »

How breast cancer drug causes arthritis in some women
... aromatase inhibitors due to the accompanying joint pain," said Dr. James Ingle, Mayo Clinic oncologist and senior author of the study. "We used the latest genetic technology in a ... Source: Expressindia.com »

A place for kids: New children's medical center makes tough times easier
... areas including neonatology, cardiology, nephrology, emergency medicine and trauma, infectious diseases, neurology, hematology and oncology, orthopedics, general surgery and adolescent medicine. The Diamond Children’s Medical Center is named for ... Source: Green Valley News & Sun »

Aeterna Zentaris: Poster on Diagnostic Use of Oral Synthetic Growth Hormone Secretagogue/Ghrelin Receptor Agonist, AEZS-130 (Macimorelin, Solorel(TM)) to be Presented at Upcoming 5th International Congress of the GRS-IGF Society i
... Inc. (NASDAQ: AEZS, TSX: AEZ), ("the Company") a late-stage drug development company specialized in oncology and endocrinology, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin ... Source: Therapeutics Daily »

[$] Salem hospital to hold oncology seminar
To read this article, please subscribe now. Paid subscribers have full access to all online news content as part of their subscription. If you are ... Source: The Review »

Doctor Finders Introduces New Traffic Overview on Personal Doctor Pages Including Specialists from Oncologists to Allergic Dyspnea Allergists
... Doctor Finders introduces new traffic overview on personal doctor pages including specialists from oncologists to allergic dyspnea allergists. Phoenix, AZ (Vocus) September 28, 2010 -- introduces new traffic ... Source: Yahoo Italia »

Depression: Researchers' work from Regenstrief Institute, Inc. focuses on depression
... depression. In this article, data on patients enrolled from 16 urban or rural community-based oncology practices are analyzed to test the associations of pain and depression with HRQL, disability, ... Source: NewsRx »

Dr. Ramin Mirhashemi, MD of Gynecological Oncology Associates Discusses Uterine Fibroid Treatment with da Vinci Robotic Hysterectomy Surgery
... robotic surgery for gynecologic conditions in western . He and his staff at Gynecological Oncology Associates provide comprehensive care, professional expertise, and individualized attention to each patient seeking optimal ... Source: WRICTV8 »

Eli Lilly and Company Researchers Begin Working at New State-of-the-Art Lab Located in the Heart of New York City
... in 2008, along with certain rights to already marketed Erbitux and ImClone's pipeline of oncology biologics. At the site, ImClone scientists will conduct the preclinical discovery efforts for ... Source: WRICTV8 »

How to widen the hunt for targeted cancer therapy
... NCI's director, will begin quizzing top researchers from around the country about which of oncology's underlying mysteries should be part of his "Big Questions Initiative," a new focus of ... Source: Post-Bulletin »

Questions to Ask Before Radiation Therapy for the Treatment of Cervical Cancer
... cervical cancer. Doctors who specialize in treating cancers with radiation are known as radiation oncologists. During radiation therapy, high-energy x-rays are used to kill cancer cells. Radiation therapy can ... Source: CancerConsultants.com »

Coil could help delay womb cancer
... Minig, one of the authors of the study conducted at the European Institute of Oncology in Milan, said the findings gave encouragement for starting a larger international trial of ... Source: BBC »

Duke researchers get $1.5M windfall
... women with HER2+ breast cancer, according to Linda Sutton, M.D., director of the Duke Oncology Network, who will work with the Duke CME office in implementing a regionalized, collaborative ... Source: Durham Herald-Sun »

Managing Partnerships with CROs
... UCB Celltech The rough guide to outsourcing of genomics activities Pearl Huang, Vice President, Oncology Franchise Integrator, Merck ... Source: PharmiWeb.com »

Intrauterine devices can be used to treat endometrial cancer
... 39 patients, aged between 20 and 40, were treated at the European Institute of Oncology in Milan, with results from a total of 34 being available for analysis in ... Source: Eurek Alert »

Vail Valley Medical Center names new VP
... St. Charles Health System in Bend, Oregon as the cancer program director and then oncology service line director, where she was responsible for all aspects of cancer care for ... Source: Vail Daily News »

Clifton R. Sparkman
... like to give special thanks to Hospice Compassus, the Doctors and Staff of Tennessee Oncology, Sarah Cannon Cancer Center, Dr. Paul Perryman and staff and the staff of Maury ... Source: The Daily Herald »

SNPs Lead to Painful Aromatase Inhibitor Side Effects
... aromatase inhibitors due to the accompanying joint pain," says James Ingle, M.D., Mayo Clinic oncologist and senior author of the study. "We used the latest genetic technology in a ... Source: Drug Discovery »

Books for your cocktail-party quiver
... grandson has fallen in with ecoterrorists. And his other daughter may be a famous oncologist, but she's also a workaholic. Multiple plots lingers and interweave. Proofiness: The Dark Arts ... Source: The Pacific Northwest Inlander »

Merrimack Pharmaceuticals to Present at the Jefferies 2010 Global...
... advancing a robust pipeline of engineered therapeutics paired with molecular diagnostics. Merrimack has three oncology candidates in clinical development: MM-121, partnered with sanofi-aventis, in Phase 2 clinical testing, MM-111 ... Source: PR Web »

First radiation oncologist here
... in northern B.C. has happened with the hiring and arrival of the first radiation oncologist for the BC Cancer Agency Centre for the North. Dr. Robert Olson is the ... Source: Prince George Citizen »

Dr. Ramin Mirhashemi, MD of Gynecological Oncology Associates Discusses Uterine Fibroid Treatment wi
... Dr. Ramin Mirhashemi, MD of Gynecological Oncology Associates Discusses Uterine Fibroid Treatment with da Vinci Robotic Hysterectomy Surgery Dr. Ramin Mirhashemi, ... Source: Interest Alert »

Dr. Ramin Mirhashemi, MD of Gynecological Oncology Associates Discusses Uterine Fibroid Treatment with da Vinci Robotic
... removal, with fewer complications and a faster recovery," says Dr. Ramin Mirhashemi of Gynecological Oncology Associates. "And with , the technology only improves the procedure." With the use of ... Source: News Blaze »

Dr. Ramin Mirhashemi, MD of Gynecological Oncology Associates Discusses Uterine Fibroid Treatment with da Vinci Robotic Hysterectomy Surgery
... robotic surgery for gynecologic conditions in western . He and his staff at Gynecological Oncology Associates provide comprehensive care, professional expertise, and individualized attention to each patient seeking optimal ... Source: PR Newswire »

ZIOPHARM Oncology Inc awarded Japanese patent for various organic arsenic compounds
... ZIOPHARM Oncology Inc awarded Japanese patent for various organic arsenic compounds Sep 28, 2010 (M2 EQUITYBITES ... Source: Quote.com »

Oncologists Will Be More Aggressive In Adopting Biosimilars Compared With Other Specialties
... Primary research reveals U.S oncologists in particular will more rapidly adopt biosimilars compared to their European counterparts. Compared with ... Source: PR Newswire »

ITA Partners Receives URAC Health Utilization Management Accreditation
... an independent company with nearly a decade of experience in transforming the quality of oncology care by aligning the interests of patients, physicians and payers to improve clinical outcomes ... Source: www.euroinvestor.co.uk »

MethylGene Issued Key Patents for Lead Oncology Program
... United States Patent and Trademark Office for the Company's multi-targeted (Met) kinase inhibitor for oncology, MGCD265, which is currently in clinical development. U.S. Patent Number 7,772,247 titled "Substituted Thieno ... Source: Street Insider »

MethylGene Issued Key Patents for Lead Oncology Program (CCN)
The second patent "Inhibitors of VEGF Receptor and HGF Receptor Signaling" (U.S. Patent Number 7,790,729), covers composition of matter, including the compound ... Source: AlphaTrade Finance »

Doctors work to reduce ordeal of cancer treatment
... treatment on the back of the throat. Dr. Melissa Dinolfo, who is board-certified in oncology pharmacy, says there are ways to neutralize a patient's reaction to chemotherapy, including different ... Source: The Review-Appeal »

AVEO Pharmaceuticals, Inc. to Present at Upcoming Oncology Medical Meetings and Investment Conference (BIZ)
... Symposium (IKCS), October 1-2, 2010 at the Swisstel in Chicago. European Society for Medical Oncology (ESMO) Congress , October 8-12, 2010 in Milan, Italy. In addition, William Slichenmyer, M.D., ... Source: AlphaTrade Finance »

AVEO Pharmaceuticals, Inc. to Present at Upcoming Oncology Medical Meetings and Investment Conference
... cancer therapeutics, today announced that the company will have a presence at two upcoming oncology medical meetings and Citi's 5 Data from AVEO's tivozanib clinical development program will be ... Source: News Blaze »

How breast cancer drug causes arthritis in some women
... aromatase inhibitors due to the accompanying joint pain, said Dr. James Ingle, Mayo Clinic oncologist and senior author of the study. We used the latest genetic technology in a ... Source: Thaindian News »

Addi and Cassi Hempel, Reno twins with rare disorder, receive experimental treatment
... Niemann Pick Type C disease," said Dr. Caroline Hastings, the Children's Hospital Oakland pediatric hematologist/oncologist who diagnosed the twins. Hastings also manages the satellite hematology/oncology clinic at Renown Regional ... Source: Rgj.com »

Integrative Oncology Research Center for Breast Cancer Funded by...
... valuable information and direction to improve quality of life and save lives. The Integrative Oncology Research Center at Bastyr University of Kenmore, WA and the Fred Hutchinson Cancer Research ... Source: PR Web »

Women & Infants Receives $2 Million Grant from NIH to Continue Work on Perinatal Biology
... for women and newborns, Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic ... Source: Newswire Today »

Bayer HealthCare Pharmaceuticals' Beyaz receives FDA approval
... of Medicine (IOM) call for women who are overweight or obese... Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (... Social isolation and ... Source: News-Medical.net »

Japanese Patent Office issues patent for ZIOPHARM Oncology's darinaparsin
Data presented at the 15th European Hematology Association (EHA) congress in Barcelona, highlights t... Allos Therapeutics, Inc. today reported new analyses of data from the ... Source: News-Medical.net »

Quantum Immunologics Announces Clinical Study Collaboration With Florida Cancer Institute-New Hope
... it has completed a Clinical Study Agreement with Florida Cancer Institute-New Hope, a large oncology group with six clinical sites in the Tampa region. Under the Agreement, FCI-NH has ... Source: PR-CANADA.net »

Premier Purchasing Partners announces new agreements for radiation oncology portfolio
Premier Purchasing Partners, LP, today announced new agreements for integrated platforms have been a... Merck Serono, a division of Merck KGaA, and its U.S. ... Source: News-Medical.net »

Young Cancer Patient Taking Steps To Preserve Fertility
... But Fisseha said that often doesn't happen. A 2009 study found 70 percent of oncologists were aware of guidelines recommending counseling about fertility preservation, but only 25 percent ended ... Source: Clickondetroit »

Plans for building progress
... clinical space for a variety of specialties, ranging from primary care to allergies to oncology. It is intended to address crowding at the current home for most of the ... Source: The Minnesota Daily »

Colitis: New findings in colitis described from Harvard University
... Carcinoma, Colonic Diseases, Colorectal, Digestive System Diseases, Gastroenteritis, Gastroenterology, Gastrointestinal Diseases, Inflammation, Intestinal Diseases, Oncology, Ulcerative Colitis. This article was prepared by NewsRx editors from staff and other reports. ... Source: NewsRx »

Butterflies larger than life
... Zarzecki recalled. "We actually stopped with Wings. It was well past 18 months." An oncologist at St. Louis Children's Hospital told the Zarzeckis if Caleb's brain tumor did not ... Source: The Telegraph »

Licensing Executives Society (USA & Canada) Reveals Results of Groundbreaking Royalty Rates and Deal Terms Surveys
... preclinical stage of development and close to 40% were related to small molecule. Anticancer (Oncology), CNS, and infectious disease deals were the most prevalent therapeutic area types submitted and ... Source: Business Wire »

Evalúan la terapia focalizada contra el cáncer
... interrogar a los principales investigadores de todo el pas sobre cules misterios de la oncologa deberan ser parte de su "Iniciativa Grandes Preguntas", un nuevo enfoque de la investigacin ... Source: Houston Chronicle »

How to widen the hunt for targeted cancer therapy
... NCI's director, will begin quizzing top researchers from around the country about which of oncology's underlying mysteries should be part of his "Big Questions Initiative," a new focus of ... Source: bnd.com »

"The Widower's Tale" has a protagonist you'll want to know
... daughter Trudy is the opposite of her sister in terms of direction. A respected oncologist in Boston, she has a healthy marriage and a son, Robert, at Harvard. When ... Source: The Denver Post Online »

Nurse solves mysterious ailment that puzzled orthopedists, oncologist
... her husband's leg would be amputated. The doctor referred John Gordon to an orthopedic oncologist and an infectious-disease specialist, and the couple waited several agonizing days for results of ... Source: The Washington Post »

Pfizer Discontinues Late-Stage Trial Of Cancer Drug Sutent - Update
... "We have a strong pipeline with programs in development across important therapeutic areas including oncology, neuroscience and inflammation." PFE closed Monday's regular trading at $17.17, down $0.23 or 1.32%, ... Source: Stock Markets Review »

Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need
... "We have a strong pipeline with programs in development across important therapeutic areas including oncology, neuroscience and inflammation. We remain committed to growing our biologics and vaccines development ... Source: WRICTV8 »

How to widen hunt for targeted cancer therapy
... NCI's director, will begin quizzing top researchers from around the country about which of oncology's underlying mysteries should be part of his "Big Questions Initiative," a new focus of ... Source: Metro Toronto »

Quantum Immunologics Announces Clinical Study Collaboration With Florida Cancer Institute-New Hope
... it has completed a Clinical Study Agreement with Florida Cancer Institute-New Hope, a large oncology group with six clinical sites in the Tampa region. Under the Agreement, FCI-NH has ... Source: News Blaze »

Hospitals, Healthcare Providers to Benefit from New Premier Healthcare Alliance Radiation Oncology Portfolio Agreements
... Hospitals, Healthcare Providers to Benefit from New Premier Healthcare Alliance Radiation Oncology Portfolio Agreements awarded to suppliers in its new radiation oncology portfolio. The portfolio is ... Source: www.euroinvestor.co.uk »

Fairfax Northern Virginia Hematology Oncology Changes its Name to Virginia Cancer Specialists
... and accommodating for their patients both clinically and administratively. In line with the US Oncology Practice Quality and Efficiency ( ) model, VCS is enhancing the patient experience. The ... Source: PR Newswire »

WellTek, Inc. is the Healthy Place to Be
... ADDitude Magazine, Adoptive Families Magazine, ADRInstitute.org, Advamed, ADVANCE for Administrators in Radiology and Radiation Oncology, ADVANCE for Administrators of the Laboratory, ADVANCE for Health Information Executives, ADVANCE for Imaging ... Source: M2 »

IntelliDose Expert Moderates Oncology EMR Panel
... Regency St. Louis, St. Louis, Missouri IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each ... Source: News Blaze »

Novartis drug Tasigna recommended...
... follow-up data presented at the 2010 annual meeting of the American Society of Clinical Oncology held in June[2]. "We are glad that the development of Tasigna may result in ... Source: BoiValley CH »

Integrative Oncology Research Center for Breast Cancer Funded by Cleavage Creek Winery Receives $3.1 Million Research Grant
... The Integrative Oncology Research Center at Bastyr University, established by funding from Cleavage Creek Winery, will conduct ... Source: Yahoo Italia »

Integrative Oncology Research Center for Breast Cancer Funded by...
... valuable information and direction to improve quality of life and save lives. The Integrative Oncology Research Center at Bastyr University of Kenmore, WA and the Fred Hutchinson Cancer Research ... Source: PR Web »

Spectrum Pharmaceuticals to Ring the NASDAQ Stock Market Opening Bell on Tuesday, September 28, 2010
... company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that Rajesh C. Shrotriya, MD, Chairman of the Board, Chief Executive Officer, ... Source: Street Insider »

Seattle Genetics and Millennium Announce Positive Top-Line Brentuximab Vedotin (SGN-35) Data from Pivotal Trial in Relap
... Mass. - (BUSINESS WIRE) - Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced positive ... Source: News Blaze »

Seattle Genetics and Millennium Announce Positive Top-Line Brentuximab Vedotin (SGN-35) Data from Pivotal Trial in Relapsed and Refractory Hodgkin Lymphoma
... Wash. & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Seattle Genetics, Inc. (Nasdaq: ) and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE: ), today announced ... Source: Street Insider »

OncoGenex Pharmaceuticals Announces Initiation of a Phase 2 Trial Evaluating OGX-427 Treatment in Men with Advanced Prostate Cancer
... Such funds were awarded by an independent granting agency to Dr. , a medical oncologist at the BC Cancer Agency and Research Scientist at the Vancouver Prostate Centre. OGX-427 ... Source: Street Insider »

OncoGenex Pharmaceuticals Announces Initiation of a Phase 2 Trial Evaluating OGX-427 Treatment in Men with Advanced Prostate Cancer (CNW)
... funds were awarded by an independent granting agency to Dr. Kim Chi, a medical oncologist at the and Research Scientist at the Vancouver Prostate Centre. OGX-427 is a second-generation ... Source: AlphaTrade Finance »

Exercise bad before cancer treatment?
... very differently than what happens in real life," said Dr. Anil Sood, a gynecologic oncologist and researcher at the M.D. Anderson Cancer Center in Texas. Many phases of clinical ... Source: Columbus Dispatch »

Siemens Now Offers Complete Oncology Menu On Dimension Vista(R) Intelligent Lab Systems
... on the Dimension Vista Intelligent Lab Systems, which now offer a complete panel of oncology assays outside the U.S. The Dimension Vista systems are the only integrated chemistry instruments ... Source: Medical News Today »

European shares advance on M&A news; Unilever up
... improve survival in a late-stage clinical trial, dealing a fresh blow to the company's oncology pipeline. 'This news extends a period of poor results for AstraZeneca's oncology franchise with ... Source: London South East »

Chemotherapy-induced Nausea and Vomiting (CINV): No Longer an Inevitable Side Effect of Chemotherapy for Liver Cancer
... side effect can drastically interfere with treatment. At a recent annual meeting of the Oncology Nursing Society, more than half of oncology nurses surveyed reported that they had interrupted ... Source: CancerConsultants.com »

Instrumentation Laboratory To Host 2nd Asia Pacific Hemostasis Forum
... to attend. Professor Karmel Tambunan, MD, PhD, from the Division of Hematology and Medical Oncology at the University of Indonesia, Jakarta will serve as Scientific Chairman of the Forum. ... Source: Laboratory Network »

Cancer Drug Trials
... (“Target: Cancer” series, front page, Sept. 19): Many interventions have become standard pieces of oncology practice without being tested in a randomized controlled trial. The Pap smear has never ... Source: The New York Times »

Actor's battle highlights oral cancer risk factors
... your risk,' said Dr. Tapan Padhya, director of the Division of Head and Neck Oncology at Moffitt Cancer Center in Tampa, Fla. Put smoking and alcohol use together and ... Source: The Daily Item »

CHKD throws party for kids
... them in that, you can't measure that. That's what's fun," said Sheila McElmurry, an oncology social worker. The challenge now will be getting the contestants to bed. September is ... Source: WAVY TV 10 »

Children fighting cancer celebrate their survival
... There's physical discomfort, long periods in the hospital," said Dr. Eric Werner, a pediatric oncologist at CHKD. "To see that other families have come through it... I think it ... Source: PilotOnline.com »

Cactus Hotel fixes up space
... to raise awareness and money for its Cancer Empowerment Center outside its newly renovated oncology department. Michelle Snuggs, lead radiologist at Shannons Women Imaging and MRI Center, said breast ... Source: San Angelo Standard Times »

Genetics and Gastric Cancer: Report summarizes genetics and gastric cancer study findings from Gifu University
... Keywords: City:Gifu, Country:Japan, Carcinogenesis, DNA, Gastric Cancer, Gastric Carcinoma, Gastroenterology, Genetics and Gastric Cancer, Oncology. This article was prepared by NewsRx editors from staff and other reports. Copyright 2010, ... Source: NewsRx »

Breast Cancer: Research on breast cancer discussed by scientists at University Medical Center, Department of Molecular Cell Biology
... of Molecular Cell Biology, Leiden, Netherlands. Keywords: City:Leiden, Country:Netherlands, Biotechnology, Breast Cancer, Breast Carcinoma, Oncology, Proteomics, Transcription Factors, Women's Health. This article was prepared by NewsRx editors from staff ... Source: NewsRx »

Angiogenesis: New angiogenesis data have been reported by T. Benameur and co-authors
... CNRS, UMR 6214, Angers, France. Keywords: City:Angers, Country:France, Angiogenesis, Bone Marrow, Immune System, Neovascularization, Oncology, Tumor Vascularization. This article was prepared by NewsRx editors from staff and other reports. ... Source: NewsRx »

3SBio Inc. to Hold 2010 Annual General Meeting on October 29, 2010 (PRN)
... Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP certified manufacturing facilities ... Source: AlphaTrade Finance »

HBA Boston - Healthcare Business in Europe - What opportunities are you missing?
... What Opportunities Are You Missing? The event will be hosted by Millennium -The Takeda Oncology Company in Cambridge. Stefan Borgas, CEO of Lonza, a multi-billion dollar global company will ... Source: WebWire »

Walkers make strides against breast cancer in inaugural Corning event
... middle of chemotherapy. It is in my lymph nodes. I will have surgery. "My oncologist says I am doing quite well. I feel blessed. I'm just delighted to try ... Source: stargazette.com »

Metamark Genetics, Inc. Announces Three New Board Members
... Metamark Genetics, Inc., a privately held, oncology-focused molecular diagnostics company, announced today the appointment of three new Board Members. As a ... Source: PR-USA.net »

Beardsworth® Selects OmniComm Systems® AE Reporting System
... trial management. With a command of the complex trial, Beardsworth's niche expertise focuses on oncology/supportive care and vaccine/anti-infective therapeutics. In business since 1986, Beardsworth brings 20+ years of experience, ... Source: PR-USA.net »

Deirdre Imus Keynotes at Princeton Public Library
... Imus is the Founder and President of The Deirdre Imus Environmental Center for Pediatric Oncology at Hackensack University Medical Center and Co-Founder and Co-Director of the Imus Cattle Ranch ... Source: ParamusPost.com »

Radiotherapy centre to bulk-bill
... month. It will complement existing chemotherapy facilities at Nambour Hospital, but at the Oceania Oncology Facility in Wises Road, bulk-billing of radiotherapy will now be available for Coast residents ... Source: Sunshine Coast Daily »

One Woman's Story: Saying No to Conventional Cancer Treatment
... to chemotherapy, radiation and hormones, the standard care of the day in the best oncology centers nationwide. They said YES to an evidence based and are living well to ... Source: The Huffington Post »

Free Breast Cancer Book Details Top Ten Foods to Reduce Risk
... Caring; National Circle of Life Award; Pharmacia & Upjohns "Unsung Hero" for breast cancer; Oncology Nursing Societys Award for Excellence in Breast Cancer Education; National Consortium of Breast Centers ... Source: PR Web »

Stellarton prospect chose med school over NHL
... He is currently the Mayo Clinics orthopedic surgery consultant and chair of its orthopedic oncology department. He is also professor of orthopedic surgery at Mayo Medical School. And he ... Source: The Chronicle Herald »

National Patient Advocate Foundation Delivers Letter Urging Congress to Oppose Cuts to Cancer Care i
... of care due to reimbursement, financial risk and patient out-of-pocket exposure. In particular, small oncology practices are losing money on the most commonly used drugs for cancer care and ... Source: PR-USA.net »

Kenyan Teenage Opera Singer Successfully Treated for Rare Brain Tumor by HCG
... the nature of disorder and treatment provided to Seraphine, Dr P S Sridhar, Radiation Oncologist, HCG, said, “Detailed examination revealed that the patient was suffering from one of the ... Source: PR-USA.net »

Merck Significantly Expands Its Patient Assistance Program Offerings To Provide Access To More Medicines For People In Need
... Merck Patient Assistance Program, the Merck Vaccine Patient Assistance Program, the ACT Program for Oncology and Hepatitis C medicines, and the SUPPORT® Program for HIV/AIDS medicines. The Merck Helps ... Source: Medical News Today »

Sanofi-aventis And The Belfer Institute Of Applied Cancer Science At The Dana-Farber Cancer Institute Establish Powerful Alliance In Oncology
... announced that they have entered into a collaboration and licence agreement to identify novel oncology targets for the development of new therapeutic agents directed at such targets and related ... Source: Medical News Today »

Pine Tree student stays on track in school, life despite cancer
... started coming. His ear, nose and throat doctor saw them and called in an oncologist friend of his." Knox said the oncologist biopsied the lumps and discovered Cory had ... Source: Longlew News-Journal »

Teal ' the new pink
... After the ultrasound confirmed that something was amiss, she was sent to a gynecological oncologist in Winston-Salem. He told Norris that he did not know what the mass was ... Source: Asheboro Courier-Tribune »

BUSINESS NOTES: Southside Makes Fortune List Of Fast-Growing Companies
... at Tyler. Dr. Hyman, an assistant professor of medicine, is board certified in medical oncology and internal medicine. He has been a cancer specialist in Tyler since 1990. He ... Source: Tyler Morning Telegraph »

Genetics and Colon Cancer: Data on genetics and colon cancer detailed by researchers at Pomeranian Medical University, International Hereditary Cancer Center
... Colon Carcinoma, Colorectal Cancer, Colorectal Carcinoma, Enzymes and Coenzymes, Gastroenterology, Genetics and Colon Cancer, Oncology. This article was prepared by NewsRx editors from staff and other reports. Copyright 2010, ... Source: NewsRx »

Cancer: Researchers from Kaiser Permanente report details of new studies and findings in the area of cancer
... Kaiser Permanente, Downey, CA USA. Keywords: City:Downey, State:CA, Country:United States, Cancer, Gastroenterology, Kidney, Nephrology, Oncology, Renal Function. This article was prepared by NewsRx editors from staff and other reports. ... Source: NewsRx »

Pancreatic Cancer: Research from Zeria Pharmaceutical Co., Ltd. broadens understanding of pancreatic cancer
... Endothelial Growth Factors, Gastroenterology, Gastrointestinal Hormones, Gemcitabine, Immunosuppressant, Intercellular Signaling Peptides and Proteins, Neuropeptides, Oncology, Pancreas, Pancreatic Cancer, Pancreatic Neoplasms, Radiation Sensitizing Agent. This article was prepared by NewsRx ... Source: NewsRx »

Rain doesn't put damper on book fest
... be a part of the festival. Reno County authors included Dr. Mark Fesen, an oncologist and internist in Hutchinson; Robert Hannigan, former warden of the Hutchinson Correctional Facility; Steven ... Source: The Hutchinson News »

ANGIOTECH PHARMACEUTICALS AND PARTNER ATHERSYS ANNOUNCE UPDATED RESULTS FROM PHASE I STUDY OF MULTIS
... for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation and oncology treatment support, ischemic stroke, and inflammatory bowel disease. The Company is also developing a ... Source: PR-USA.net »

Megan Hafner, John Bacigalupi
... Dr. Samuel Hafner, and a stepdaughter of Paul Francoeur. The bride’s father was an oncologist in private practice in Pomona, Calif., and the medical director of the oncology program ... Source: The New York Times »

Spectral Molecular Imaging's Chairman and CEO Presented at an Invited Talk at the International Microscopy Congress in Rio de Janeiro
... division of Medtronic Corporation and in the University of Southern California Physical Sciences in Oncology Center Seminar Series. These talks, and the invitations to present them, reflect the diversity ... Source: Street Insider »

Spectral Molecular Imaging¿s Chairman and CEO Presented at an Invited Talk at the International Microscopy Congress in Rio de Janeiro (BIZ)
... Minimally Invasive Spine Surgery in Las Vegas; at the Surgical Navigation division of in Oncology Center Seminar Series. These talks, and the invitations to present them, reflect the diversity ... Source: AlphaTrade Finance »

Gut cheer
... the experience and knowledge of a team which consists of colorectal surgeons, gastroenterologists, radiologists, oncologists, pathologists, and liver surgeons, an individualised decision can be made collectively for each patient. ... Source: The Star Online »

How to Manage Pain with Intercourse and Vaginal Dryness After Breast Cancer Treatment
... stimulating blood flow to the area. Through their fundraising project, Steppin Out, the Gynecologic Oncology Group (GOG) supports research in gynecologic cancer and gynecologic complications of cancer treatment. Steppin ... Source: CancerConsultants.com »

Randall F. Holcombe, MD, Named Director of Clinical Cancer Affairs at...
... for Clinical Affairs in The Tisch Cancer Institute, and Director of Gastrointestinal (GI) Medical Oncology for the Division of Hematology/Oncology. His appointment became effective on September 1. Dr. Holcombe ... Source: PR Web »

Aeterna Zentaris to Present at Upcoming Sachs 10th Annual Biotech Europe Investment Forum on Septemb
... Zentaris Inc. (NASDAQ: AEZS,TSX: AEZ), ("the Company") a late-stage drug development company specialized in oncology and endocrinology, today announced that its President and CEO, , Ph.D., will be part ... Source: PR-USA.net »

Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum
... Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that , M.D., the company's president and CEO, will present at ... Source: PR-CANADA.net »

Amgen Initiates Voluntary Nationwide Recall of Certain Lots Of Epogen
... these risks, prescribers and hospitals must enroll in and comply with the ESA APPRISE Oncology Program to prescribe and/or dispense PROCRIT to patients with cancer. To enroll in the ... Source: Therapeutics Daily »

Seattle Genetics to Host Conference Call and Webcast on September 27, 2010 Regarding Top-line Data from Brentuximab Vedotin (SGN-35) Pivotal Hodgkin Lymphoma Clinical Trial
... and Drug Administration. Brentuximab vedotin is being developed in collaboration with Millennium: The Takeda Oncology Company. In addition, Seattle Genetics has four other clinical-stage programs: SGN-75, ASG-5ME, dacetuzumab (SGN-40) ... Source: Pharmalive.com/ »

James Cook Hospital leads way with tumour treatment
... opened the machine which treated his prostate cancer. Victor Chivers, 65, joined staff from oncology and radiotherapy at the James Cook University Hospital, in Middlesbrough, after becoming the first ... Source: Gazette Live »

Three Moors Tour will test hospital team to limit
... two days. Money raised through the event will go to the Bristol Haematology and Oncology Centre, which treats patients from across the South West. The team of cyclists is ... Source: SouthWestBusiness »

Gene therapy could be here soon
... confirm or deny the tie-up. Intas is consolidating its presence in the Rs 1,400-crore oncology segment in India growing every year at 21%. The company has over 26 drugs ... Source: FinancialExpress.com »

Physical Therapy Continuing Education Courses in New York State
... Advanced Management of Lower Extremity Injuries in the Athlete Advanced Management of Lymphedema Advanced Oncology Rehabilitation for Successful Outcomes Advancements in the Management and Treatment of Spinal Cord Injury ... Source: PR.com »

Kenyan Teenage Opera Singer Successfully Treated for Rare Brain Tumor by HCG
... the nature of disorder and treatment provided to Seraphine, Dr P S Sridhar, Radiation Oncologist, HCG, said, “Detailed examination revealed that the patient was suffering from one of the ... Source: PR.com »

Baskets of Care helps women get through breast cancer diagnosis
... next critical steps, like getting a team in place: your gynecologist, your surgeon, your oncologist, your radiologist. Both women admit it's a lot to tackle while walking through the ... Source: WTOL.com »

Oncology Philadelphia - Get The Best Treatment Possible
... Oncology Philadelphia - Get The Best Treatment Possible When it comes to our health, we ... Source: American Chronicle »

Renaissance Surgical Arts at Newport Harbor Awarded Accreditation from The Joint Commission
... Ear Nose and Throat, Gastroenterology, Neurosurgery, Orthopedics, Spinal, Ophthalmology, Plastic and Reconstructive Surgery, Podiatry, Oncology, Interventional Radiology, GYN and General Surgery. More information: Send2Press® is the originating wire service ... Source: Send2Press »

Home/Garden Notes: 09/25/10 (Today)
... are presented by the Pennsylvania Resources Council in partnership with UPCI Center for Environmental Oncology. The Oct. 5 event is at CCI Center, 64 S. 14th St., South Side. ... Source: Post-Gazette »

Govern? Cool app!
... their lives will be forever richer for the experience. 'How much longer, doctor?' An oncologist reflects on euthanasia. Celebrity actors and rock stars will be out in force at ... Source: The Sydney Morning Herald »

Iraqi woman gets new life with bone marrow transplant in India
... that,' said Rakesh Ojha, head of department of bone marrow transplant at Fortis International Oncology Centre. Maha had undergone four cycles of chemotherapy in Iraq before she came to ... Source: MyNews.in »

Why Kashmir is Burning Again
... have won the respect of a broad spectrum of Kashmiris. Shad Salim is an oncologist in his 50s who returned to Kashmir in 2007 after 20 years abroad. He ... Source: TIME.com »

Editorial: How effective are mammograms in beating breast cancer?
... longer the key to surviving breast cancer is actually good news, according to some oncologists. When treatment improves, detection plays less of a role in outcomes. The new study ... Source: Los Angeles Times »

"The Cancer Market Outlook to 2015" Published
... products in the global cancer market accounted for majority of the revenue in 2009. Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies because ... Source: PR Inside »

U.S. FDA Approves New Oral Contraceptive That Also Raises Folate Levels
... pharmaceutical company, Bayer HealthCare Pharmaceuticals provides products for Diagnostic Imaging, General Medicine, Hematology, Neurology, Oncology and Women's Healthcare. The company's aim is to discover and manufacture products that will ... Source: Interest Alert »

Randall F. Holcombe, MD, Named Director of Clinical Cancer Affairs at The Mount Sinai Medical Center
... for Clinical Affairs in The Tisch Cancer Institute, and Director of Gastrointestinal (GI) Medical Oncology for the Division of Hematology/Oncology. New York (Vocus) September 24, 2010 -- Renowned colon ... Source: Yahoo Italia »

Effectively Educating the Marketplace to Support a Successful New Oncology Product Launch
... As the bio-pharmaceutical marketplace continues to evolve, launch leaders in the high-growth area of Oncology are tailoring their market education strategies and tactics to better reflect the unique characteristics ... Source: Kait »

The Japanese Cancer Association and Debiopharm Group Present the JCA-Mauvernay Award to Dr Ogawa and Prof. Maeda for Their Outstanding Oncology Research
... Group Present the JCA-Mauvernay Award to Dr Ogawa and Prof. Maeda for Their Outstanding Oncology Research From the PharmaLive.com News Archive - Sep. 24, 2010 LAUSANNE, Switzerland, September 24, ... Source: Therapeutics Daily »

Publication of Phase I/II trial of NGR-hTNF in combination therapy for the treatment of colorectal cancer by the Annals of Oncology
... NGR-hTNF in combination therapy for the treatment of colorectal cancer by the Annals of Oncology From the PharmaLive.com News Archive - Sep. 24, 2010 Milan (Italy), September 22, 2010 ... Source: Therapeutics Daily »

Metamark Genetics, Inc. Announces Three New Board Members
... or representations in connection therewith. - Company leadership strengthened with prominent advisors in diagnostics, oncology, and international business affairs - /PRNewswire/ -- Metamark Genetics, Inc., a privately held, oncology-focused ... Source: WRICTV8 »

New orthopedic clinic coming
... recently expanded their services and treatment options for cancer patients. Capital Medical opened Capital Oncology, which includes a team of oncologists and associated radiation therapy and imaging facilities; St. ... Source: The Olympian »

The Japanese Cancer Association and Debiopharm Group(TM) Present the JCA-Mauvernay Award to Dr Ogawa and Prof. Maeda for Their Outstanding Oncology Research (PRN)
(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, ... Source: AlphaTrade Finance »

The Japanese Cancer Association and Debiopharm Group(TM) Present the JCA-Mauvernay Award to Dr Ogawa and Prof. Maeda for Their Outstanding Oncology Research
/PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target ... Source: Street Insider »

Hall hands oncologist Dexter's blood box
... Thursday, September 23, 2010 2:41 PM CDT The actor's oncologist helped Hall with his battle against Hodgkin's lymphoma and he was rewarded with a ... Source: Lake Wales News »

Cancer - Step Outside The Box.
... natural cancer cure pancreatic cancer treatment breast cancer radiation treatment lung cancer survivors radiation oncology radiation therapy for lung cancer breast cancer facts breast cancer treatment options cancer treatment ... Source: IdeaMarketers »

Kenyan Teenage Opera Singer Successfully Treated for Rare Brain Tumor By HCG
... the nature of disorder and treatment provided to Seraphine, Dr P S Sridhar, Radiation Oncologist, HCG, said, Detailed examination revealed that the patient was suffering from one of the ... Source: Open Press »

Sanofi-aventis enters research collaboration with Belfer Institute to identify novel oncology targets
... Source: Pharmabiz.com »

Clatterbridge to implement Kainos EDRMS
... Clatterbridge Centre for Oncology NHS Foundation Trust has signed a deal with Kainos to implement its electronic document ... Source: E-Health Insider »

Lance Armstrong Applauds Efforts to Ensure Affordable Health Care for Children Armstrong Joined by American
... and chairman, cancer survivor and champion cyclist, made a surprise visit to the pediatric oncology unit at Children's National Medical Center. He was joined by John R. Seffrin, PhD, ... Source: PR Inside »

Lucas backs patient travel subsidy efforts
... is a better option than increasing the allowance. "The investment that we're making in oncology in Cairns means about 300 people in Cairns each year will no longer have ... Source: ABC.net.au »

Marshall Edwards CEO to present at JMP Securities Healthcare Conference
... following announcement: San Diego – 22 September, 2010 – Marshall Edwards, Inc.(Nasdaq: MSHL), an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today that Daniel ... Source: Novogen »

Biology CRO: Crown Biosciences Announces Deal With Takeda Pharmaceuticals
... As leaders in the Pharmaceutical and Biotech industry, Crown Bioscience and Takeda Pharmaceuticals combine oncology drug discovery expertise to further enhance the ever-growing cancer drug pipeline. Through combined efforts ... Source: News Blaze »

Huskies' Udeze has learned to appreciate every day
... time around, he said this week, there were two other people, and they were oncologists. What they told Udeze was that his white-cell blood count, which had previously been ... Source: The Herald »

That's What Friends Are For
... band called NED short for 'No Evidence of Disease.' NED is six gynecologic oncologists who use their music to raise awareness of women's cancer." McGihon, who this week ... Source: The Connection Newspapers »

Patients with cancer who stop hospice care boost health-care costs
... The results are published in the October 1 issue of the Journal of Clinical Oncology. Led by Melissa D.A. Carlson, PhD, Assistant Professor of Geriatrics and Palliative Medicine, and ... Source: Eurek Alert »

NCCN Announces New Treatment Guidelines for Patients
... Comprehensive Cancer Network ( , consumer-friendly translations of the NCCN Clinical Practice Guidelines in Oncology ( Rather than having to consult numerous sources, patients now have straightforward access to ... Source: Business Wire »

Bladder cancer support offered
... than 170 participants, featured UNC Lineberger members Matthew Nielsen and Raj Pruthi, UNC Urologic Oncology faculty and BCAN National Scientific Advisory Board members. The two physicians led a panel ... Source: Durham Herald-Sun »

Hall Gives His Oncologist Dexter's Blood Box Dexter star Michael C. Hall has handed over a special keepsake to the doctor who helped save his life earlier this year (10) - his serial killer character's blood box. The actor's oncol
... life earlier this year (10) - his serial killer character's blood box. The actor's oncologist helped Hall with his battle against Hodgkin's lymphoma and he was rewarded with a ... Source: Cinema Blend »

Early breast cancer detection may not help
... teams are similar to those at many U.S. medical centers that involve surgeons, pathologists, oncologists, radiologists and nurses to coordinate breast cancer care. The study, published in The New ... Source: United Press International (UPI) »

Instrumentation Laboratory to Host 2nd Asia Pacific Hemostasis Forum
... Dr. Tambunan is a Professor of Clinical Medicine, Division Hematology-Medical Oncology, at the University of Indonesia, Cipto Mangunkusumo Hospital. He is a board-certified Internist, and ... Source: Interest Alert »

New oncology unit for Mayo General Hospital
... New oncology unit for Mayo General Hospital A new €700,000 oncology unit will be opened at ... Source: Advertiser.ie »

Oncology day a roaring success
... ONCE again our Oncology Day was a roaring success, it never ceases to amaze us the generosity of ... Source: Myall Coast Nota »

Reportlinker Adds Oncology Adjuvants: Technologies and Global Markets
... Reportlinker Adds Oncology Adjuvants: Technologies and Global Markets /PRNewswire/ -- Reportlinker.com announces that a new market research ... Source: PR Newswire »

OncoGenex Pharmaceuticals, Inc. - Journal of Clinical Oncology Publishes Data from Randomized Phase 2 Custirsen Trial
... publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in ... Source: Pharmalive.com/ »

Sanofi-aventis and the Belfer Institute of Applied Cancer Science at the Dana-Farber Cancer Institute Establish Powerful Alliance in Oncology
... Institute of Applied Cancer Science at the Dana-Farber Cancer Institute Establish Powerful Alliance in Oncology - Research Collaboration gives access to Belfer Institute’s Cancer Platform and Translational Medicine Capabilities ... Source: Pharmalive.com/ »

Zalicus Presents Data on Oncology Programs at Targeted Cancer Therapies World Europe 2010
... Zalicus Presents Data on Oncology Programs at Targeted Cancer Therapies World Europe 2010 - Systematic Discovery of Novel Combination ... Source: Business Wire »

From the Pacific to the Atlantic, 42 cyclists Arrive in Halifax for Grand Finale of the Sears National Kids Cancer Ride
... survival rate in the future. Sears is fully committed to the cause of pediatric oncology. Through the involvement of our associates and the vast network of Sears locations across ... Source: Canadian Business Magazine »

From the Pacific to the Atlantic, 42 cyclists Arrive in Halifax for Grand Finale of the Sears National Kids Cancer Ride (CNW)
... the survival rate in the future. is fully committed to the cause of pediatric oncology. Through the involvement of our associates and the vast network of locations across the ... Source: AlphaTrade Finance »

Five Prime Therapeutics receives US and European patent for its lead oncology drug
... Source: Pharmabiz.com »

Joining forces
... the treatment and services they need under one roof, said Marge Baker, director of oncology services for HMHP. The center is equipped with the latest technology in radiation oncology. ... Source: www.vindy.com »

HALL HANDS ONCOLOGIST DEXTER'S BLOOD BOX=20
... earlier this year (10) - his serial killer c haracter's blood box. The actor's oncologist helped Hall with his battle against Hodgkin's ly mphoma and he was rewarded with ... Source: PR Inside »

Sanofi-Aventis: Signs Cancer Partnership With Belfer Institute
... best in the field, declared Debasish Roychowdhury, M.D. Senior Vice President, Head of Global Oncology Division, sanofi-aventis. We have an obligation to discover new medicines. This innovative collaboration structure ... Source: The FINANCIAL »

HALL HANDS ONCOLOGIST DEXTER'S BLOOD BOX
... life earlier this year (10) - his serial killer character's blood box. The actor's oncologist helped Hall with his battle against Hodgkin's lymphoma and he was rewarded with a ... Source: Contactmusic.com »

US and EU Regulatory Submissions for Vandetanib in Advanced Medullary Thyroid Cancer Accepted for Review
... or placebo. The study results were presented on at the American Society of Clinical Oncology annual meeting in Chicago. Results from ZETA showed that treatment with vandetanib significantly extended ... Source: PR Newswire »

Cancer family fear clinic cuts
... to permanently share services. The changes will start on October 15, when Wellington's paediatric oncologist Sarah Strandjord returns to the United States and a specialist from Christchurch replaces her ... Source: Wairarapa Times-Age »

In the Pink: CISD athletes help breast cancer patients recover from surgery
... with a Velcro-like opening and internal pockets to hold the drain tubes. Carol Lewis, oncology nurse navigator, sees breast cancer patients from diagnosis through the process. I love it ... Source: Houston Community Newspapers Online »

Lance Armstrong Weighs In on a Silent Killer: Cancer in the Developing World
... shockingly few resources with which to combat the illness. Said Farmer: "There are no oncologists in Rwanda, Burundi, or Lesotho. There is in Haiti." Almazor, a doctor based in ... Source: Politics Daily »

War on cancer causes 'collateral damage'
... directly confronting the enemy, but in the role of support and supply, providing the oncologist the ability to keep the warrior strong enough to defeat the enemy. In fighting ... Source: United Press International (UPI) »

Mammograms' Value in Cancer Fight at Issue in Study
... the program of mammograms and optimal new treatment with coordinated teams of surgeons, pathologists, oncologists, radiologists and nurses lower the breast cancer death rate? The investigators found that women ... Source: The New York Times »

Patient navigator to assist cancer survivors
... a patient navigator is to help cancer patients navigate through their cancer journey. While oncologists and medical experts suggest a treatment regimen to help the patient, the patient navigator ... Source: The Times-Reporter »

Driscoll children's drawings inspire hope and faith for holiday joy
... Scholarship Foundation. Last year $18,000 in $1,000 scholarships were awarded to former and present oncology patients, said Jan Cuellar, holiday gifts committee co-chair. Lucas required urologic surgery as a ... Source: Caller Times »

Fun run in Taylah Hopwood's honour
... organisers hope to raise $300,000 this year. The revamped ward will include a state-of-the-art oncology room, new high-dependency rooms that allow 24-hour-a-day one-on-one with a nurse and a new ... Source: The Geelong Advertiser »

Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test
... and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, ... Source: salesandmarketingnetwork.com »

Stanford opens entrepreneur course to public
... model of their prototype. In July, their work earned praise at a radiation and oncology conference in Philadelphia. "It feels great to earn validation from doctors and researchers like ... Source: SF Gate »

Mammograms found to be less crucial in preventing deaths
... a 10% decrease in mortality in the screening group. Dr. Joanne Mortimer, a medical oncologist and director of women's cancer programs at the City of Hope medical center in ... Source: WDBJ7 »

Kidney Cancer Association Expands Outreach to North Africa
... Presents information at Africa and Middle East Oncology Forum (PRWEB) September 22, 2010 -- Kidney Cancer Association (KCA) Vice President of Development ... Source: Yahoo Italia »

Celsion Announces ThermoDox Abstract Accepted at the 2010 Breast Cancer Symposium
... Chest Wall Breast Cancer study This is third DIGNITY abstract accepted at a major oncology meeting this year ) announced today that an abstract on its Phase I/II DIGNITY ... Source: Pharmalive.com/ »

Texas Oncology Acquires Hyperthermia System from BSD Medical
... - BSD Medical Corporation (NASDAQ:BSDM) (the "Company" or "BSD" ) announced today that Texas Oncology has acquired the BSD-500 Hyperthermia System (BSD-500). Texas Oncology is an affiliate of the ... Source: News Blaze »

California group chooses Via Oncology treatment protocols
... treatment protocols developed in Pittsburgh as part of a contract reached with Shadyside-based Via Oncology. The San Rafael-based association represents about 400 hematologists/oncologists in northern California and Oregon, and ... Source: Bizjournals »

Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum
... Sachs Biotech in Europe Investor Forum /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that , M.D., the company's president and CEO, will present at ... Source: PR Newswire »

Celsion Announces ThermoDox
... other abstracts have been published at the June 2010 ASCO (American Society of Clinical Oncology) meeting in Chicago and the upcoming ASTRO (American Society for Radiation Oncology) meeting in ... Source: Medical News Today »

Results of custirsen Phase 2 trial for advanced prostate cancer published in Journal of Clinical Oncology
When combined with standard chemotherapy, an international Phase III trial has shown that the oral t... Drug discovery and development company Esperance Pharmaceuticals today presented ... Source: News-Medical.net »

OncoGenex Pharmaceuticals, Inc. - Journal of Clinical Oncology Publishes Data from Randomized Phase 2 Custirsen Trial (PRN)
... the rate of death favoring custirsen treatment," said Dr. , Principal Investigator and medical oncologist at . "These data provide the foundation and rationale for the upcoming SYNERGY Phase ... Source: AlphaTrade Finance »

OncoGenex Pharmaceuticals, Inc. - Journal of Clinical Oncology Publishes Data from Randomized Phase 2 Custirsen Trial
... publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in ... Source: Street Insider »

Oncology unit to open in Castlebar
... > Oncology unit to open in Castlebar A NEW dedicated oncology unit at Mayo General is ... Source: Westernpeople.ie »

Boehringer Ingelheim Initiates Phase III Clinical Trial with Novel Oral Agent in Advanced Breast Cancer
... initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib ... Source: PharmiWeb.com »

Positive Prognosis for Genoptix
... May. The lowered outlook given Tuesday was attributed to softer patient volumes at community oncologists as macroeconomic stresses are causing people to delay visits to their general doctor, which ... Source: Seeking Alpha »

Synthetic lethality boosts effectiveness of molecularly targeted therapies against tumors
... mortality in postmenopausal women, according to a... Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Tak... Exelixis, Inc. today reported long-term results in ... Source: News-Medical.net »

TroVax® Selected as one of Top 10 Oncology Projects to Watch
... Selected as one of Top 10 Oncology Projects to Watch - 9/22/2010 -- Development plan on track, recruitment underway for Phase ... Source: Oxford BioMedica »

On his bike for sick kids
... general maintenance assistant at Barnier Public School, Quakers Hill said he was inspired by Oncology Childrens' Foundation founder Col Reynolds. He said he and his mother met him while ... Source: Blacktown Sun »

Chemotherapy-induced Nausea and Vomiting (CINV): No Longer an Inevitable Side Effect of Chemotherapy for Leukemia
... side effect can drastically interfere with treatment. At a recent annual meeting of the Oncology Nursing Society, more than half of oncology nurses surveyed reported that they had interrupted ... Source: CancerConsultants.com »

Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing's Disease, a Debilitating
... physically and emotionally debilitating symptoms associated with Cushing's disease," said Herve Hoppenot, President, Novartis Oncology. These data will form the basis for the first regulatory filing of SOM230 planned ... Source: News Blaze »

Novartis International AG: Novartis drug SOM230 is first medical therapy to show efficacy in a Phase III trial in Cushing's disease, a debilitating hormonal disorder
... Chief of the Neuroendocrine Unit at the Department of Molecular and Clinical Endocrinology and Oncology, Federico II University of Naples and one of the study investigators. "The study findings ... Source: FinanzNachrichten »

Speech By Mesoblast Limited (ASX:MSB) Chairman Brian Jamieson To Extraordinary General Meeting
... shared stem cell technology platform for a range of non-orthopaedic applications, including heart diseases, oncology, diabetes, and eye diseases. For example, two of Angioblast's products are in late stage ... Source: Stockwatch »

A love stronger than cancer
... Farmington Hills to get a second opinion regarding her treatment. She met with medical oncologist Ulka Vaishampayan, M.D., team leader for the Genitourinary Oncology Multidisciplinary Team at Karmanos. After ... Source: The Oakland Press »

Vitamin D Protects Against Obesity-Induced Endometrial Cancer, Study Suggests
... due to obesity," says the study's lead investigator, Leena Hilakivi-Clarke, PhD, a Professor of Oncology. "Still, if these results are confirmed in women, use of vitamin D may be ... Source: ScienceDaily Magazine »

B.C. politician Sindi Hawkins leaves legacy of cancer advocacy
... before she was diagnosed with the disease. Ms. Hawkins began her career as an oncology nurse before turning to politics. “She would have understood the progression with alarming clarity,” ... Source: The Globe and Mail »

Norway-China Translational Oncology Alliance Formed
... Oslo Cancer Cluster (OCC), the leading Norwegian research- and industry oncology cluster and the prestigious Shanghai Institute of Materia Medica (SIMM), part of the Chinese ... Source: Scandinavian news portal for S.E.A. »

Enzo Biochem Streamlines Operations; Expects Positive Operating Cash Flow in 2011
... tests include, in addition to routine tests, capabilities for detecting molecular infection disease, molecular oncology, autoimmune disorders and genetics. Enzo Clinical Labs also provides clinical diagnostic services that allow ... Source: Pharmalive.com/ »

Roche Launches New Initiative - 'Roche Goes to Town'
... and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, ... Source: Pharmalive.com/ »

Fire breaks out in hospital, patients evacuated
... One of the 10 electrical boxes at the Ali Osman Snmez Oncology Hospital caught on fire at about 6 a.m. The patients were taken out of ... Source: Today's Zaman »

Targeted Therapy Triggers Complex Mechanism of Resistance
... Weiner is a member of the Scientific Advisory Board of Merrimack Pharmaceuticals and the Oncology Advisory Boards for Abbott and Johnson & Johnson. ... Source: ScienceDaily Magazine »

Steroids Do the Impossible: They Shut Up Chael Sonnen
... to cancer, by the way, Chael might want to make an appointment with an oncologist.) The self-proclaimed poet laureate of mixed martial arts blustered away for month after month, ... Source: The Faster Times »

Robotic Prostatectomy Expert Dr. David Samadi, MD Introduces His SMART Surgery Website for Prostate Cancer Treatment Education
... make no warranties or representations in connection therewith. /PRNewswire/ -- A board-certified urologist and oncologist specializing in the diagnosis and treatment of urologic diseases, is proud to announce the ... Source: KTEN Online »

Robotic Prostatectomy Expert Dr. David Samadi, MD Introduces His SMART Surgery Website for Prostate
... Prostate Cancer Treatment Education NEW YORK, Sept. 21 /PRNewswire/ -- A board-certified urologist and oncologist specializing in the diagnosis and treatment of urologic diseases, , Dr. David B. Samadi ... Source: Interest Alert »

Q&A Interview with BioSante Pharmaceuticals (NASDAQ: BPAX), A Company Focused on Female Sexual Health and Oncology
... Interview with BioSante Pharmaceuticals (NASDAQ: BPAX), A Company Focused on Female Sexual Health and Oncology Stephen M. Simes, President and Chief Executive Officer, Discusses Potential of Leading Product, LibiGel ... Source: prminds.com »

Via Oncology Pathways helps support outcomes, payer strategy
... SAN RAFAEL, CA – The Association of Northern California Oncologists (ANCO) recently selected Via Oncology Pathways as a preferred pathways option for its nearly ... Source: Healthcare IT News »

Five Prime Therapeutics receives patent for lead oncology product
Five Prime Therapeutics, Inc. today announced it has been issued two patents, U.S. Patent No. 7,678,890 and European Patent No.1910542B1, with ... Source: News-Medical.net »

Five Prime receives patent for lead oncology product
Five Prime Therapeutics, Inc. today announced it has been issued two patents, U.S. Patent No. 7,678,890 and European Patent No.1910542B1, with ... Source: News-Medical.net »

Celsion Announces ThermoDox® Abstract Accepted at the 2010 Breast Cancer Symposium
... Chest Wall Breast Cancer study This is third DIGNITY abstract accepted at a major oncology meeting this year ) announced today that an abstract on its Phase I/II DIGNITY ... Source: PR Newswire »

Five Prime Therapeutics, Inc. Announces Issuance of Key Patents in the U.S. and Europe Covering Its
... Inc. Announces Issuance of Key Patents in the U.S. and Europe Covering Its Lead Oncology Drug Five Prime Therapeutics, Inc. Announces Issuance of Key Patents in the U.S. and ... Source: Interest Alert »

Five Prime Therapeutics, Inc. Announces Issuance of Key Patents in the U.S. and Europe Covering Its Lead Oncology Drug
... Inc. Announces Issuance of Key Patents in the U.S. and Europe Covering Its Lead Oncology Drug SAN FRANCISCO, Sept. 21, 2010 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. today ... Source: PrimeZone.com »

Elekta: Three-month interim report May - July 2010/11 (BIZ)
... Our world leading solutions in image-guided radiation therapy, stereotactic radiosurgery as well as in oncology software, make it possible for oncologists and neurosurgeons to effectively treat tumors, blood vessel ... Source: AlphaTrade Finance »

Wilshire Oncology Medical Group and US Oncology enter Comprehensive Strategic Alliance relationship
... to more "We are excited to join a nationwide network of more than 1,000 oncologists who share the same vision as we do about high-quality care based on evidence-based ... Source: News-Medical.net »

Clatterbridge Centre for Oncology Becomes Latest NHS Trust to Standardise on Kainos Evolve'
... Clatterbridge Centre for Oncology Becomes Latest NHS Trust to Standardise on Kainos Evolve Evolve is the final piece ... Source: Source Wire »

University Hospital Florence presented at the ESTRO meeting the first international study supporting the clinical benefits of th
... are all active in the field of radiation therapy. The company attended the European oncology and physics meeting ESTRO in Barcelona, Spain, 12-16 September 2010. The GEMini ED and ... Source: www.euroinvestor.co.uk »

Study shows capecitabine with concurrent radiation effective for gastric cancer
... clinical trial of ... Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinolo... In a clinical trial known as PROVE 3 published in this week's ... Source: News-Medical.net »

Crack The Cancer Code.
... patients liver cancer cure terminal lung cancer alternative colon cancer treatments natural cancer treatment oncology hematology alternative cancer therapies new cancer treatments alternative treatment for lung cancer cancer t ... Source: IdeaMarketers »

Hollywood stylist's a big hit at salon
... she offered to work in the salon doing makeovers to raise money for Bristol Oncology Unit. Dozens of customers flocked to the busy salon over the weekend to be ... Source: SouthWestBusiness »

Lance Armstrong and San Francisco Mayor Gavin Newsom Celebrate Progress in Hispanic/Latino Cancer Care Visit
... toured the infusion center, where patients were receiving treatment, and a portion of the oncology center. They also met with hospital doctors to discuss the Hispanic/Latino cancer burden and ... Source: PR Inside »

ZIOPHARM Oncology to Present at the JMP Healthcare Conference
... ZIOPHARM Oncology to Present at the JMP Healthcare Conference NEW YORK, Sep 20, 2010 (BUSINESS WIRE) ... Source: Quote.com »

Less invasive cancer surgery gets boost
... no difference in the patients' survival rates. The study was published today in Lancet Oncology. ... Source: The Boston Globe Online »

Target Cancer: New Drugs Stir Debate on Rules of Clinical Trials
... not be allowed to switch, lest it muddy the trial’s results. , the U.C.L.A. oncologist treating both cousins, told Mr. Ryan’s mother, Jan. He sounded so miserable that afternoon ... Source: The New York Times »

24-Week Phase 3 Study Found Investigational Drug Dapagliflozin Improved Glycosylated Hemoglobin (HbA1c) When Added to Glimepiride in Adults With Type 2 Diabetes Mellitus
... commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US in 2009. For more ... Source: Rt Magazine »

Study: Less Invasive Surgery OK for Breast Cancer
... Department of Health and Human Services. It was published today in the journal Lancet Oncology. "This is good for patients because this is a less aggressive technique which could ... Source: The Ledger »

Targeted Therapy Decreases Progression Rate In Thyroid Cancer
... Clinic who are publishing findings of a phase II clinical trial in The Lancet Oncology. VIDEO ALERT: Additional audio and video resources, including excerpts from an interview with Dr. ... Source: RedOrbit »

2 Studies Find New Genetic Links To Ovarian Cancer Risk
... form of disease, known as serous ovarian cancer. Andrew Berchuck, MD, professor of gynecologic oncology at Duke University Medical Center and head of the steering committee of the international ... Source: RedOrbit »

Michele Finch, Dominican Hospital's nurse navigator, will assist cancer patients
... figure out the complexities of the health care system," said Gail Bailey, director of oncology services at Dominican Hospital. The nurse navigator will work with cancer patients during the ... Source: Santa Cruz Sentinel »

Breast cancer treatment questioned
... of Health and Human Services. It was published on Tuesday in the journal Lancet Oncology. "This is good for patients because this is a less aggressive technique which could ... Source: SBS Television »

Study: Early breast cancer patients survive just as long with less invasive lymph node surgery
... Department of Health and Human Services. It was published Tuesday in the journal Lancet Oncology. "This is good for patients because this is a less aggressive technique which could ... Source: FOX 4 »

Less surgery OK for early breast cancer
... Department of Health and Human Services. It was published Tuesday in the journal Lancet Oncology. "This is good for patients because this is a less aggressive technique, which could ... Source: CBC »

Duel-energy mammography: Visualizing victory over breast cancer
... imaging technique pioneered by UCI researchers to battle the deadly disease. As UC Irvine oncologists with the Chao Family Comprehensive Cancer Center continue to make strides in the fight ... Source: PhysOrg »

Alternative Cancer Treatment Guide.
... herbs cancer treatment side effects alternative treatments for breast cancer natural cures for cancer oncology hematology alternative colon cancer treatments natural cancer treatment homeopathic cancer treatment new cancer treatments ... Source: IdeaMarketers »

Wilshire Oncology Medical Group and US Oncology Unite to Expand and Enhance Cancer Patient Services
... Wilshire Oncology Medical Group and US Oncology Unite to Expand and Enhance Cancer Patient Services in ... Source: Interest Alert »

Wilshire Oncology Medical Group and US Oncology Unite to Expand and Enhance Cancer Patient Services in SoCal (PRN)
... The group's physicians and staff offer extensive patient care and services including medical oncology and hematology, radiation, psycho-oncology, nuclear oncology and clinical research. Under this new relationship with ... Source: AlphaTrade Finance »

Wilshire Oncology Medical Group and US Oncology Unite to Expand and Enhance Cancer Patient Services in SoCal
... . The group's physicians and staff offer extensive patient care and services including medical oncology and hematology, radiation, psycho-oncology, nuclear oncology and clinical research. Under this new relationship with ... Source: PR Newswire »

Sears National Kids Cancer Ride cyclists arrive at Sears Place Laurier Store
... to the Centre mere-enfant du Centre hospitalier universitaire de Qubec and three other paediatric oncology centres," explains Simon Bourque, Regional Vice-President, Corporate Stores, Sears Canada Inc. "Through the Sears ... Source: Canadian Business Magazine »

ZIOPHARM Oncology to Present at the JMP Healthcare Conference (BIZ)
is a biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of cancer drugs. The Company is currently focused on three clinical ... Source: AlphaTrade Finance »

ZIOPHARM Oncology to Present at the JMP Healthcare Conference
... NEW YORK--(BUSINESS WIRE)-- ZIOPHARM Oncology, Inc. (Nasdaq: ) announced today that Richard Bagley, President and Chief Operating Officer, will ... Source: Street Insider »

Kite Pharma Appoints Dr. Gloria Lee Chief Medical Officer
... M.D., Ph.D., as Chief Medical Officer. Dr. Lee, who brings over 18 years of oncology clinical development experience, will be responsible for the development of Kites portfolio of product ... Source: Street Insider »

Potsdam cancer center hires radiation oncologist
... POTSDAM — Canton-Potsdam Hospital has hired a radiation oncology specialist for the Warner Cancer Treatment Center at 145 Market St. Dr. David A. ... Source: Watertown Daily Times »

New Drugs Stir Debate on Rules of Clinical Trials
... lest it muddy the trials results. Im very sorry, Dr. Bartosz Chmielowski, the U.C.L.A. oncologist treating both cousins, told Mr. Ryans mother, Jan. He sounded so miserable that afternoon ... Source: Occala Star-Banner »

New treatment kills prostate cancer
... patients usually end up resistant to therapy," said Dr. Oscar B. Goodman, Jr., Medical Oncologist at Nevada Cancer Institute. George found Dr. Goodman and a new drug that starves ... Source: KING5 »

Boehringer Ingelheim Initiates Phase III Clinical Trial With Novel Oral Agent In Advanced Breast Cancer
... initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) . Afatinib is ... Source: Medical News Today »

ARIAD Announces Initiation Of Ponatinib (AP24534) Pivotal Trial In Drug-Resistant Or Intolerant Chronic Myeloid Leukemia
... CML field, including: -- Michele Baccarani, M.D., Professor and Head, Institute of Hematology and Oncology, Universita di Bologna, Bologna, Italy -- Jorge Cortes, M.D., Professor and Deputy Chair, Department ... Source: Medical News Today »

First Australian Study Into Diagnosis Of Ovarian Cancer
... Overall, 6% were given a diagnosis, and 37% were referred to a gynaecologist, gynaecological oncologist or oncologist as a result of their first medical consultation." "However, for 12% of ... Source: Medical News Today »

Oncology center gives hope in dark hour
... Dr. Madhu Jodhani and his Yuba Sutter Oncology Clinic staff are caring people and the first caring person met when entering the ... Source: Appeal Democrat »

University Hospital of North Staffordshire Redesign Document Creation with SRC's Digital Dictation Solution
... an evaluation of alternative providers and completed a pilot deployment with SRC within the Oncology & Haematology department. The way the solution enables work to flow was extremely straight-forward ... Source: Street Insider »

Young women do get breast cancer | PHOTOS
... of all women diagnosed with breast cancer, said Michelle Walker of Haubstadt, Ind., an oncology nurse whose cancer was detected in 2008 when she was 35 years old. Young ... Source: Evansville Courier & Press »

LRMC Seeks Millions In Loans
... machines at Lakeland Regional because our program has blossomed," said Dr. Mark Bandyk, surgical oncologist at the cancer center. Its doctors and some Watson Clinic surgeons use the da ... Source: The Ledger »

25 years and counting: Collin College still bringing innovation to the community
... Allen, RadioVision director of Internet Marketing; Dr. Niclas C. Tan, Millennium Pharmaceuticals: the Takeda Oncology Company scientist; Marcela Guerrero Casas, policy and advocacy manager for Africa Fairtrade Network in ... Source: Star Community Newspapers »

CrystalGenomics Up for Scrip Award in the Category of Best Company in an Emerging Market
... this year as it had reached few notable clinical milestones with its antibiotic and oncology programs. President & CEO of CrystalGenomics, Joong Myung Cho said, "Even with a record ... Source: Quote.com »

Myeloid Leukemia: Studies from Seattle Genetics, Inc. have provided new information about myeloid leukemia
... State:WA, Country:United States, Acute Myeloid Leukemia, Antibodies, Blood Proteins, Clinical Trials, Globulins, Hematology, Immunoglobulins, Oncology, Pre Trials Research, Therapy, Treatment. This article was prepared by NewsRx editors from staff ... Source: NewsRx »

Leukemia: New research on leukemia from University of Munich summarized
... Country:Germany, Acute Myeloid Leukemia, Antigen Presenting Cells, Dendritic Cells, Hematology, Immunotherapy, Mononuclear Phagocyte System, Oncology, Treatment. This article was prepared by NewsRx editors from staff and other reports. Copyright ... Source: NewsRx »

Studies zero in on breast, ovarian cancer risk
... ovarian cancer when it is most treatable," said Andrew Berchuck, a professor of gynaecologic oncology at Duke University Medical Center, who worked on the study. "It also suggests that ... Source: Emirates24|7 »

Ovarian Cancer: Research in the area of ovarian cancer reported from University Medical Center
... Durham, NC 27705 USA. Keywords: City:Durham, State:NC, Country:United States, Contraception, Female Contraceptive Agents, Gynecology, Oncology, Oral Contraceptives, Ovarian Cancer, Ovarian Carcinoma, Pharmacologic Actions, Reproductive Control Agents, Therapeutic Uses, Women's ... Source: NewsRx »

Targeted Therapy Decreases Progression Rate in Thyroid Cancer
... a year in response to pazopanib therapy," says Keith Bible, M.D., Ph.D., a medical oncologist and researcher who led the multicenter clinical trial, funded by the National Cancer Institute. ... Source: Science Daily »

Novel Target for Existing Drug May Improve Success of Radiation Therapy
... S. McDonnell III Distinguished Professor in Medicine and chair of the Department of Radiation Oncology at the School of Medicine and senior author of the study. "There are hundreds ... Source: Science Daily »

Two Studies Find New Genetic Links to Ovarian Cancer Risk
... form of disease, known as serous ovarian cancer. Andrew Berchuck, MD, professor of gynecologic oncology at Duke University Medical Center and head of the steering committee of the international ... Source: Science Daily »

Target Cancer: New Drugs Stir Debate on Rules of Clinical Trials
... not be allowed to switch, lest it muddy the trial’s results. , the U.C.L.A. oncologist treating both cousins, told Mr. Ryan’s mother, Jan. He sounded so miserable that afternoon ... Source: The New York Times »

Gene sweeps nets female cancer clues
... use the information in any kind of genetic test. Associate Professor Jennifer Byrne, an oncology researcher at the Medical School, says the research is interesting "because it's leading us ... Source: ABC »

Gene studies zero in on women's cancer risk
... ovarian cancer when it is most treatable," said Andrew Berchuck, a professor of gynaecologic oncology at Duke University Medical Centre, who worked on the study. "It also suggests that ... Source: IOL.co.za »

Texas Children's Cancer Center Deputy Director Helps Congressmen Put the Spotlight on Pediatric Canc
... Washington D.C. The event brought together the top minds in the field of pediatric oncology and was hosted by Congressman Joe Sestak and Congressman Michael McCaul. Timed to Childhood ... Source: PR-USA.net »

''Simple change in lifestyle can bring down cancer deaths''
... like avoiding fatty, junk foods and doing regular exercise," Dr A K Vaid, medical oncologist, said while speaking at a seminar 'Preventive Oncology' organised by the Indian Cancer Society ... Source: in.news.yahoo.com »

Sears National Kids Cancer Ride cyclists arrive at Sears Carrefour Angrignon Store
... event has allowed us to fund projects worth $245,000 in the field of paediatric oncology. These projects provide insight into the evolution of childhood cancer, reduce the side effects ... Source: Canadian Business Magazine »

Prevention is best medicine for cancer: Experts
... would prove to be the best medicine for cancer in India, experts believe. 'Preventive oncology is the treatment India needs for curbing cancer because over 55 percent of cancers ... Source: in.news.yahoo.com »

J&J on the Hunt for China M&A
... her discussion of J&J’s plans, she told Reuters reporters, "We are especially interested in oncology, infectious diseases and metabolic areas, so M&As in these areas will be high on ... Source: Seeking Alpha »

China Biotech Week in Review: East / West Biopharma Alliances
... Pharmaceutical R&D Asia, at a recent Shanghai biopharma meeting. "We are especially interested in oncology, infectious diseases and metabolic areas, so M&As in these areas will be high on ... Source: Seeking Alpha »

ImmunoCellular Therapeutics Selects Averion International Corp. To Conduct Phase II Glioblastoma Study
... supporting global clinical trials for pharmaceutical, biotechnology and medical device companies. Averion has significant oncology experience across varied treatment modalities, including approved and investigational agents in brain cancer. Averion ... Source: Medical News Today »

Partnership On National Database Addresses Cancer In NJ
... chief of the Division of Cancer Bioinformatics and Surveillance in the Department of Radiation Oncology at UMDNJ-Robert Wood Johnson Medical School. Dr. Graff joined CINJ this past July. He ... Source: Medical News Today »

Missing diamond story is a gem of a tale
... got her medium regular at Coffee Central and rode up to the 21st floor oncology ward. She put her things in her locker, and took her coffee and banana ... Source: Boston Globe »

Menopause: Investigators at University of California target menopause
... Breast Cancer, Breast Carcinoma, Breast Ductal Carcinoma, Chemical Actions and Uses, Estrogens, Hormones, Menopause, Oncology, Pharmacologic Actions, Physiological Effects of Drugs, Progestins, Women's Health. This article was prepared by ... Source: NewsRx »

Gastric Cancer: Findings from Seoul National University, Department of Internal Medicine broaden understanding of gastric cancer
... median (OS) were 21.1 weeks and 68.3 weeks, respectively. Patients with good Eastern Cooperative Oncology Group (ECOG) (PS) of 0-1 had prolonged PFS and OS compared with patients with ... Source: NewsRx »

Summit Medical Group Physicians Listed As Top Doctors
... internal medicine; Brian Beyerl, M.D., neurosurgery; Edward Zampella, M.D., neurosurgery; Michael B. Wax, M.D., oncology/hematology; John Hurley, M.D., orthopedics; Avrim. R. Eden, M.D., otology/neurotology; Jed A. Kwartler, M.D., otology/neurotology; ... Source: Yahoo Italia »

Brain Research: Scientists at Tokyo Medical and Dental University publish research in brain research
... Japan. Keywords: Country:Japan, Amines, Amphetamines, Brain Research, Central Nervous System, Ethylamines, Hematology, Methamphetamine, Neuroblastoma, Oncology, Organic Chemicals. This article was prepared by NewsRx editors from staff and other reports. ... Source: NewsRx »

Cancer Research: Data on cancer research described by S. Schnittger et al
... Schnittger, MLL Munich Leukemia Laboratory GmbH, Munich, Germany. Keywords: City:Munich, Country:Germany, Cancer, Cancer Research, Oncology. This article was prepared by NewsRx editors from staff and other reports. Copyright 2010, ... Source: NewsRx »

As he nears 100, work continues for medical icon
... their fields. The oldest son, Dr. Howard Jones III, 67, is director of gynecological oncology at Vanderbilt-Ingram Cancer Center in Tennessee. His daughter, Dr. Georgeanna Jones Klingensmith, 66, is ... Source: PilotOnline.com »

Debate over controlled drug trials escalates
... mutated gene in his cancer cells made him eligible for the experimental drug PLX4032. Oncologist Paul Chapman leads the controlled trial of the melanoma drug PLX4032. Growing up in ... Source: The Seattle Times »

New Drugs Stir Debate on Basic Rules of Clinical Trials
... not be allowed to switch, lest it muddy the trial’s results. , the U.C.L.A. oncologist treating both cousins, told Mr. Ryan’s mother, Jan. He sounded so miserable that afternoon ... Source: The New York Times »

Victoria Klarfeld, John Capehart
... Capehart and Dr. John E. Capehart of Dallas. The bridegroom’s mother is a surgical oncologist at Doctors Hospital in Dallas. His father is a cardiothoracic surgeon at A version ... Source: The New York Times »

Five area doctors bring help to 1,900 villagers
... and Peter Emanuel, interventional radiologist, both from Fort Sanders Parkwest; and Leo Hamilton, pediatric oncologist at East Tennessee Children's Hospital. Robbins, Daigle and Bunick participated in the first medical ... Source: Oak Ridger Online »

Targeted Therapy Decreases Progression Rate in Thyroid Cancer
... a year in response to pazopanib therapy," says Keith Bible, M.D., Ph.D., a medical oncologist and researcher who led the multicenter clinical trial, funded by the National Cancer Institute. ... Source: ScienceDaily Magazine »

Cyclists Riding Across the Country for Kids with Cancer Arrive in Toronto Today
... Leaf and Team Canada great Ron Ellis, Dr. Victor Blanchette, Staff physician, haematology and oncology at The Hospital for Sick Children, Dene Rogers, President and CEO, Sears Canada, as ... Source: Canadian Business Magazine »

Cyclists Riding Across the Country for Kids with Cancer Arrive in Toronto Today (CNW)
... the riders include former great Ron Ellis, Dr. Victor Blanchette, Staff physician, haematology and oncology at , as well as some parents of children who have had cancer and ... Source: AlphaTrade Finance »

Welcome to Bayhealth Oncology Services:
... Source: Delmarva`s News Leader »

John B. Amos cancer center achieves two accreditations
... comprehensive cancer program a Three-Year Accreditation with Commendation, while the American College of Radiation Oncology awarded full accreditation to John B. Amos Cancer Center's Radiation Oncology Practice. "We are ... Source: WTVM.com »

New drug shows promise in fighting aggressive thyroid cancer
... vital role in cancer development. Lead author of the study, Dr. Julian Molina, an oncologist at the Mayo Clinic in Rochester, Minn. stated, "Thyroid cancers, when they grow, they ... Source: The Money Times »

Archbold unveils state-of-the-art oncology center
... Source: WALB-TV »

Benefits Of CyberKnife
... at ESTRO 29; the Annual Congress of the European Society for Therapeutic Radiology and Oncology in Barcelona, Spain. Also featured at this meeting were multiple presentations demonstrating this system's ... Source: Medical News Today »

Medco buys United BioSource for $730 million
... a statement. "There is a large pipeline of new, complex biotechnology products including oncology drugs that will require an ongoing collection of evidence in the commercial market ... Source: North Jersey Media Group »

Bus seat belts could depend on funding
... starts at 8 a.m. on Oct. 16 at Heritage Plaza in downtown Longview. Texas Oncology-Longview Cancer Center and the Life Beyond Cancer Foundation are sponsoring this first-time event. Proceeds ... Source: Longlew News-Journal »

FDA decides to review information on Avastin for advanced HER2-negative breast cancer
... medicines to treat diabetes, one of the fastest-growing diseases in America, are be... ZIOPHARM Oncology, Inc. announced today that Dr. Claire Verschraegen of the University of New Mexico... Fresenius ... Source: News-Medical.net »

Oncology: Scientists at Merck & Company, Inc. describe research in oncology
... Laboratories, Dept. of Imaging, West Point, PA USA. Keywords: City:West Point, State:PA, Country:United States, Oncology. This article was prepared by NewsRx editors from staff and other reports. Copyright 2010, ... Source: NewsRx »

Nektar Therapeutics To Present at the UBS 2010 Global Life Sciences Conference
... conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. In the area of pain, Nektar has an exclusive worldwide ... Source: Interest Alert »

Benefits of CyberKnife® Lung Radiosurgery Treatments Emphasized During Europe's Largest Congress in Radiation Oncology
... Benefits of CyberKnife Lung Radiosurgery Treatments Emphasized During Europe's Largest Congress in Radiation Oncology Information contained on this page is provided by companies via press release distributed through ... Source: KGUN TV-9 (ABC - Tucson) »

Common Diabetes Medication Shown to Fight Cancer
... represent an unexpected and exciting lead", says Dr. Michael Pollak, a Canadian professor of oncology at Montreal's McGill University, "Here we have an old drug, a safe drug, that ... Source: Associated Content »

Teikoku Pharma USA Announces FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA for Review (BIZ)
... new indications and formulations. focuses its efforts on three therapeutic areas: integrative neuroscience, integrative oncology, and vascular and immunology reaction. Through a global network of research facilities, manufacturing sites ... Source: AlphaTrade Finance »

Luncheon and style show benefit oncology patients
... the Lima Mall. All proceeds are to go toward the monthly Tranquili-Teas served to oncology and medical inpatients at St. Ritas Medical Center. Doors open for the benefit at ... Source: Catholic Chronicle »

Benefits of CyberKnife(R) Lung Radiosurgery Treatments Emphasized During Europe's Largest Congress in Radiation Oncology
... Benefits of CyberKnife(R) Lung Radiosurgery Treatments Emphasized During Europe's Largest Congress in Radiation Oncology SUNNYVALE, California, Sep 17, 2010 (PR Newswire Europe via COMTEX News Network) -- Conference ... Source: Quote.com »

New Drug Promising for Advanced Thyroid Cancer
... a lot of blood vessels," explained researcher Dr. Julian Molina, an assistant professor of oncology at the Mayo Clinic and co-author of the study. "For blood vessels to grow, ... Source: Pharmaceutical News »

Teikoku Pharma USA Announces FDA Accepts Aricept(R) Patch (Donepezil Transdermal System) NDA for Review
... indications and formulations. Eisai focuses its efforts on three therapeutic areas: integrative neuroscience, integrative oncology, and vascular and immunology reaction. Through a global network of research facilities, manufacturing sites ... Source: Quote.com »

Targeted Therapy Substantially Decreases Progression Rate in Patients with an Aggressive Form of Thyroid Cancer, Mayo Clinic Reports Given potential side effects, patients with slow-growing thyroid cancer should not use pazopanib
... Clinic who are publishing findings of a phase II clinical trial in The Lancet Oncology. VIDEO ALERT: Additional audio and video resources, including excerpts from an interview with Dr. ... Source: Quote.com »

Targeted Therapy Substantially Decreases Progression Rate in Patients with an Aggressive Form of Thyroid Cancer, Mayo Cl
... almost a year in response to pazopanib therapy," says , M.D., Ph.D., a medical oncologist and researcher who led the multicenter . Most of the patients treated were enrolled ... Source: News Blaze »

Chino restaurant puts emphasis on healthy eating
... power source and immune system are not as strong as they were, according to oncologist Julie Gralow, professor of medicine at the University of Washington and spokeswoman for the ... Source: Champion »

F.D.A. Postpones Rule on Avastin
... what patients it would work, said Dr. Daniel Hayes, clinical director of the breast oncology program at the University of Michigan. Research is under way to find genetic variations ... Source: The New York Times »

Targeted Therapy Substantially Decreases Progression Rate in Patients with an Aggressive Form of Thyroid Cancer, Mayo Clinic Reports
... almost a year in response to pazopanib therapy, says , M.D., Ph.D., a medical oncologist and researcher who led the multicenter . Most of the patients treated were enrolled ... Source: Business Wire »

Provectus Pharmaceuticals Completes Initial Enrollment in Phase 1 Trial of PV-10 for Liver Cancer
... KNOXVILLE, Tenn.--(BUSINESS WIRE)--Sep 14, 2010 - Provectus Pharmaceuticals, Inc. (OTC BB: ), a development-stage oncology and dermatology biopharmaceutical company, announced today that it has completed enrollment in the first ... Source: Pharmalive.com/ »

Benefits of CyberKnife® Lung Radiosurgery Treatments Emphasized During Europe's Largest Congress in Radiation Oncology / Conference Presentations Highlight CyberKnife Motion Management Capabilities in Treatment of Lung Cancer
... at ESTRO 29; the Annual Congress of the European Society for Therapeutic Radiology and Oncology in Barcelona, Spain. Also featured at this meeting were multiple presentations demonstrating this system's ... Source: FinanzNachrichten »

Benefits of CyberKnife® Lung Radiosurgery Treatments Emphasized During Europe's Largest Congress in Radiation Oncology (PRN)
... at ESTRO 29; the Annual Congress of the European Society for Therapeutic Radiology and Oncology . Also featured at this meeting were multiple presentations demonstrating this system's best-in-class motion ... Source: AlphaTrade Finance »

Benefits of CyberKnife® Lung Radiosurgery Treatments Emphasized During Europe's Largest Congress in Radiation Oncology
... at ESTRO 29; the Annual Congress of the European Society for Therapeutic Radiology and Oncology in . Also featured at this meeting were multiple presentations demonstrating this system's best-in-class ... Source: Stockwatch »

Cyclists Riding Across the Country for Kids with Cancer Arrive in Toronto Tomorrow
... Leaf and Team Canada great Ron Ellis, Dr. Victor Blanchette, Staff physician, haematology and oncology at The Hospital for Sick Children, Dene Rogers, President and CEO, Sears Canada, as ... Source: Canadian Business Magazine »

Cyclists Riding Across the Country for Kids with Cancer Arrive in Toronto Tomorrow (CNW)
... the riders include former great Ron Ellis, Dr. Victor Blanchette, Staff physician, haematology and oncology at , as well as some parents of children who have had cancer and ... Source: AlphaTrade Finance »

Has Roche got the right medicine?
... had even seen. Today, Roche is the world's top supplier of cancer medicines, with oncology accounting for 53 percent of its drug sales. It is also a major manufacturer ... Source: Reuters »

Access Pharmaceuticals Receives Initial Purchase Order for MuGard in North America
... distribution capability and diversified payor network. Access and its partners continue working with large oncology networks and key clinical sites to educate oncologists and radiation oncologists on MuGard and ... Source: PR-USA.net »

Boehringer Ingelheim Initiates Phase III Clinical Trial with Novel Oral Agent in Advanced Breast Cancer
... initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib ... Source: www.euroinvestor.co.uk »

ImmunoCellular Therapeutics selec...
... supporting global clinical trials for pharmaceutical, biotechnology and medical device companies. Averion has significant oncology experience across varied treatment modalities, including approved and investigational agents in brain cancer. Averion ... Source: BoiValley CH »

Dying at home better for cancer patients
... heightened risk for developing PTSD," said the authors, led by Alexi Wright, a medical oncologist and outcomes researcher at Dana-Farber. Patients and caregivers were interviewed at the beginning of ... Source: Zee News »

Cerulean Pharma Inc. CEO to Present at BioPharm AmericaTM 2010
... candidate, CRLX288, a novel docetaxel nanopharmaceutical. Docetaxel is one of the most widely prescribed oncology drugs and is efficacious in many solid tumors. CRLX288 has been designed to further ... Source: PharmiWeb.com »

Rexahn Pharmaceuticals to Attend 18th Annual BioPartnering Europe Conference
... Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that the Company will be attending the 18th Annual ... Source: PharmiWeb.com »

Chemotherapy-induced Nausea and Vomiting (CINV): No Longer an Inevitable Side Effect of Chemotherapy for Hodgkin's Lymphoma
... side effect can drastically interfere with treatment. At a recent annual meeting of the Oncology Nursing Society, more than half of oncology nurses surveyed reported that they had interrupted ... Source: CancerConsultants.com »

Breast cancer drug Avastin in jeopardy of losing FDA approval
... cancer insurers may no longer cover the cost for those women who do benefit. Oncologists say it comes down to what's most cost effective for most patients. "The biggest ... Source: KING5 »

Aushon BioSystems Forms Scientific Advisory Board
... includes. Johann de Bono, M.D., FRCP, MSc, Ph.D.Senior Lecturer and Honorary Consultant in Medical Oncology at the Royal Marsden Hospital and Institute of Cancer ResearchDr. de Bono is the ... Source: PR Inside »

Antigens: New antigens research reported from University Hospital, Oncology Department
... thus play a role in immunologic surveillance," wrote E. Fischer and colleagues, University Hospital, Oncology Department. The researchers concluded: "Due to the high of immune responses against some of ... Source: NewsRx »

US Food and Drug Administration Extends Review Timeline For Brilinta (Ticagrelor) New Drug Application
... commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. ... Source: Pharmaceutical News »

Cell Therapeutics to Appeal FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma
... Officer for the University of Pittsburgh Cancer Centers and Chief of the Division of Hematology/Oncology at UPMC. "After discussions with a number of leading U.S. and international lymphoma experts ... Source: Pharmaceutical News »

Bionovo Regains Compliance With NASDAQ Minimum Closing Bid Price Requirement
... a drug discovery and development company focused on unmet needs in women's health and oncology, today announced that it has received notification from the NASDAQ Listing Qualifications department that ... Source: WRICTV8 »

Prometheus and Tarrot Laboratories Collaborate to Identify Markers Associated With Response to Anti-TNF Therapies in Crohn's Disease
... to the diagnosis and treatment of gastrointestinal diseases and is applying these principles to oncology. Its strategy includes the marketing and delivery of pharmaceutical products complemented by proprietary diagnostic ... Source: WRICTV8 »

Cell Therapeutics, Inc. Reports Outcome of Annual Meeting of Shareholders
... ending , CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit Sign up ... Source: WRICTV8 »

Metamark Genetics, Inc. Announces New Chief Scientific Officer
... WorldNow and this Station make no warranties or representations in connection therewith. - Experienced oncology leader to rapidly expand R&D efforts to pinpoint the mechanisms governing tumor aggression and ... Source: WRICTV8 »

Memorial Health Care Presents "Prostate Cancer: Long Term And Late Effects Of Treatment"
... Late Effects of Treatment will be presented by Dr. Fischel Liberman, director of radiation oncology at Good Samaritan Hospital in Kearney, NE. Dr. Libermans career has focused on radiation ... Source: The Chattanoogan »

MEDIA ADVISORY - Radiation Therapy Saves Lives Everyday in Canada
... Canada's leading radiation therapy clinicians and scientists gather in at Canadian Association of Radiation Oncology (CARO-ACRO) national Annual Scientific Meeting. Stories developed to improve public, cancer patients' and their ... Source: CNW Group »

Alere to Attend the Fifth Annual JMP Securities Healthcare Conference on September 28, 2010 (PRN)
... products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Alere is headquartered in ... Source: AlphaTrade Finance »

Shelby selling hope at Share Medical Center
... This community needs this hospital! Source: Alva Review Courier »

Alere to Attend the Fifth Annual JMP Securities Healthcare Conference on September 28, 2010
... products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Alere is headquartered in Waltham, Massachusetts. Copyright © ... Source: Interest Alert »

New Oncology Series
... to offer a 'Buy One, Get One Free' special with the purchase of an 'Oncology Series' tutorial by Ashley Davidoff, M.D. Purchase one of the below oncology courses using ... Source: rt-image.com »

Research and Markets: Pediatric Hematology and Oncology: Scientific Principles and Clinical Practice
... is a practical, up-to-date resource for clinicians responsible for the care of children with oncologic and malignant hematologic disease. It is specifically designed for practicing oncologists and hematologists, pediatricians ... Source: News Blaze »

Metamark Genetics, Inc. Announces New Chief Scientific Officer (PRN)
... Dr. Blume-Jensen joins Metamark with over 20 years of experience in cancer research and oncology drug discovery. From 2001 to 2008 Dr. Blume-Jensen was department head at Merck Research ... Source: AlphaTrade Finance »

Metamark Genetics, Inc. Announces New Chief Scientific Officer
... - Experienced oncology leader to rapidly expand R&D efforts to pinpoint the mechanisms governing tumor aggression and ... Source: Street Insider »

Association of Northern California Oncologists Taps Via Oncology to Support its Payer-Provider Partnership Strategy
... Via Oncology" Pathways Provide a Way Forward for Community Oncologists in Northern California to Forge Partnerships ... Source: Yahoo Italia »

The Cancer Support Community, With Support From Cephalon, Launches New Patient Education Campaign - Framing Life With Lymphoma - Aimed at Enhancing Communication Between Lymphoma Patients and Physicians
... an expert Steering Committee, and a national survey fielded by Harris Interactive of 150 hematologists/oncologists and 133 indolent lymphoma patients, which found that almost all physicians (96 percent) and ... Source: Pharmalive.com/ »

Association of Northern California Oncologists Taps Via Oncology to...
... Via Oncology: The Path to Better Care Pathways enable oncology groups to bring a proactive, physician-directed ... Source: PR Web »

Top Cancer Specialists Receive ESMO Awards
... The European Society for Medical Oncology (ESMO) honors three eminent specialists for their contribution to the advancement of medical research. ... Source: Medical News Today »

3rd Annual Oncology Market & Patient Access Conference, December 13th-14th 2010, Barcelona
... Implementing Innovative Pricing & Reimbursement Schemes for High-Value Oncology Treatments This conference and networking event will present a fresh and original perspective on ... Source: Medical News Today »

Intas Pharma in oncology drug supply pact with Astrazeneca
Novartis Phase I/II study of the Janus kinase (JAK) inhibitor with the investigational name INC424 (also known as INCB018424 and INCB18424) has shown clinical ... Source: Pharmaceutical Business Review »

Cancer strikes, educates third-year med student
... Lilienstein lined up for treatment this summer at Los Angeles County-USC Medical Center's general oncology clinic. Lilienstein, a medical student who had been battling cancer for four years, had ... Source: monterey Herald »

Compendia Usage and Off-Label Indications Focus of NCCN Oncology Summit
... Compendia Usage and Off-Label Indications Focus of NCCN Oncology Summit Submitted by editor on September 16, 2010 - 11:36 The use of drugs ... Source: Web NewsWire »

Study Finds Where Patients Die Affects Quality of Life and Mental Health of Caregivers
... and decision-making, including whether patients fully understand their prognosis, and what is involved when oncologists and cancer patients are considering stopping therapy, including chemotherapy. Approximately 70 percent of advanced ... Source: Web NewsWire »

Heat Biologics Announces Scientific Advisory Board
... the treatment of melanoma, renal cell carcinoma, prostate cancer and ovarian cancer. is an oncologist and executive medical director of the Mary Crowley Cancer Research Centers (MCCRC) in Dallas ... Source: PR-CANADA.net »

ExonHit Therapeutics ' Strong Growth of Half-Year 2010 Results
... Oncology: promising advances in internal programs and exclusive agreement with Genmab The focus on oncology ... Source: Business Wire »

Oslo Cancer Cluster and Shanghai Institute of Materia Medica Sign Groundbreaking MoU to Form Third Pillar of Global Bios
... - (BUSINESS WIRE) - Oslo Cancer Cluster (OCC), the leading Norwegian research and industry oncology cluster and the prestigious Shanghai Institute of Materia Medica (SIMM), part of the Chinese ... Source: News Blaze »

Ortho Biotech Oncology Research and Development Reports Study on Investigational Agent Abiraterone Acetate for Metastatic Advanced Prostate Cancer
... Ortho Biotech Oncology Research and Development Reports Study on Investigational Agent Abiraterone Acetate for Metastatic Advanced Prostate ... Source: Quote.com »

ExonHit Therapeutics ¿ Strong Growth of Half-Year 2010 Results (BIZ)
... Oncology: promising advances in internal programs and exclusive agreement with The focus on oncology activities ... Source: AlphaTrade Finance »

Oslo Cancer Cluster and Shanghai Institute of Materia Medica Sign Groundbreaking MoU to Form Third Pillar of Global Biosciences Gateway (BIZ)
... The first step is a mutual exchange of students and researchers in oncology between the two organizations. This program is starting immediately with the first Chinese PhD-student ... Source: AlphaTrade Finance »

Oslo Cancer Cluster and Shanghai Institute of Materia Medica Sign Groundbreaking MoU to Form Third Pillar of Global Biosciences
... Pillar of Global Biosciences Oslo Cancer Cluster (OCC), the leading Norwegian research and industry oncology cluster and the prestigious Shanghai Institute of Materia Medica (SIMM), part of the Chinese ... Source: www.euroinvestor.co.uk »

New model may simplify high-dose radiosurgery planning
... brain and lung cancer, or for high-dose brachytherapy for prostate and other cancers. Radiation oncologists at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard ... Source: Eurek Alert »

Oslo Cancer Cluster and Shanghai Institute of Materia Medica Sign Groundbreaking MoU to Form Third Pillar of Global Biosciences Gateway
... OSLO & SHANGHAI--(BUSINESS WIRE)-- Oslo Cancer Cluster (OCC), the leading Norwegian research and industry oncology cluster and the prestigious Shanghai Institute of Materia Medica (SIMM), part of the Chinese ... Source: Street Insider »

Shoulder to cry on helps
... with the result, she sought other opinions from a pathologist in Malaysia and an oncologist in Singapore. "That period was really a nightmare for me. Every night, I couldn't ... Source: Malay Mail Online »

Bioengineering: Research from Genentech, Inc., Department of Structural Biology reveals new findings on bioengineering
... Keywords: City:South San Francisco, State:CA, Country:United States, Bioengineering, Biotechnology, Cancer, Medical Device, Monoclonal Antibodies, Oncology, Protein Engineering, Therapeutics, Trastuzumab. This article was prepared by NewsRx editors from staff and ... Source: NewsRx »

Fort Lee ' Kyongah Hwang of Fort Lee has been named manager of South Nassau Communities Hospital's Center for Comprehensive Radiation Services and Long Island Gamma Knife Center.Prior to working at the hospital, located in Oc
... Hwang served as senior radiation therapist at Hackensack University Medical Center. "South Nassaus radiation oncology program continues to grow rapidly to meet the needs of the patients and the ... Source: North Jersey Media Group »

MicroRNA Enhances Stomach Cancer Survival
... of the Pharmacogenomics Laboratory at the Applied Medical Research Centre (CIMA) and Director of Oncology at the University Hospital of Navarra. This was one of the results presented at ... Source: Drug Discovery »

Solace for the terminally-ill
... "Palliative care begins when cancer is diagnosed. The palliative care team works with the oncology team," said Law. "If nothing more can be done medically, the oncology team releases ... Source: New Straits Times »

UK Body Rejects Novartis' Gleevec For Higher GIST Dosing
... )- Britain's cost watchdog NICE Thursday said it will not recommend Novartis AG's (NOVN.VX) oncology medicine Gleevec at doses of 600 or 800 milligrams per day for people with ... Source: FOX Business »

Paul Allen says test for lymphoma is 'clean'
... have rights to develop and commercialize the compounds carfilzomib and ONX 0912 for all oncology indications in Japan. Onyx retains rights in other countries in Asia as well as ... Source: San Luis Obispo Telegram »

THE CANDIDATES JEFFERSON PARISH SCHOOL BOARD, 1ST DISTRICT
... Registered nurse at Touro Infirmary and East Jefferson General Hospital in Metairie. Member of Oncology Nursing Society and Louisiana State Bar Association. ... Source: Everything New Orleans »

Phase I/II Data Published in New England Journal of Medicine Demonstrate that Incyte JAK Inhibitor, INCB18424, Provides Marked and Durable Clinical Benefits in Patients with Myelofibrosis, a Rare, Life-Threatening Blood Cancer
... November 2009, Incyte and Novartis announced a major collaboration and license agreement for two hematology-oncology programs in which Incyte retained exclusive rights to develop and commercialize INCB18424 in the ... Source: Business Wire »

EpiCept Corporation to Present at the Rodman & Renshaw 12th Annual Global Investment Conference
... adult patients with Acute Myeloid Leukemia (AML) in first remission. The Company has two oncology drug candidates currently in clinical development that were discovered using in-house technology and have ... Source: PR Inside »

What to Wear When You Have Breast Cancer
... skin or interfere with medical treatments. Barbara Zarrell, RN, BSN, has a background in oncology nursing and had a strong desire to create her own business when she developed ... Source: CancerConsultants.com »

Arno Therapeutics, Inc. Raises $15 Million in Private Placement To Advance Clinical Development of Oncology Compounds
... Arno Therapeutics, Inc. Raises $15 Million in Private Placement To Advance Clinical Development of Oncology Compounds PARSIPPANY, N.J.--(BUSINESS WIRE)--Sep 13, 2010 - Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company ... Source: Pharmalive.com/ »

Compendia Usage and Off-Label Indications Focus of NCCN Oncology Summit
... of Policy Summits, Issues in Off-Label Use and the Applications of Compendia. This NCCN Oncology Policy Summit will explore a broad range of issue areas that impact the availability ... Source: Pharmalive.com/ »

MCG pediatric hematologist/oncologist appointed to national committee
... Dr. Theodore S. Johnson, a physician-scientist in the Section of Pediatric Hematology/Oncology in the Medical College of Georgia Department of Pediatrics, has been appointed to the ... Source: MCG »

Med BioGene's LungExpress Dx Technology the Focus of a Publication in the Journal of Clinical Oncology (CCN)
MBI is a life science company focused on the development and commercialization of genomic-based personalized clinical laboratory diagnostic tests. MBI is committed to advancing ... Source: AlphaTrade Finance »

Med BioGene's LungExpress Dx Technology the Focus of a Publication in the Journal of Clinical Oncology
... The study was published online ahead of print in the prominent Journal of Clinical Oncology with an accompanying editorial. LungExpess Dx is a genomic test under development to improve ... Source: Street Insider »

BioCryst Pharma Announces Preliminary Results From Two Forodesine Oncology Studies - Quick Facts
(RTTNews) - BioCryst Pharmaceuticals Inc. (BCRX) announced preliminary top-line results from its multinational, open-label, single-arm trial evaluating 200 mg once-daily oral forodesine ... Source: Stock Markets Review »

BioCryst Reports Results from Two Forodesine Oncology Studies Top-line results from pivotal study in patients with relapsed or refractory cutaneous T-cell lymphoma
... BioCryst Reports Results from Two Forodesine Oncology Studies Top-line results from pivotal study in patients with relapsed or refractory cutaneous T-cell ... Source: Quote.com »

BioCryst Reports Results from Two Forodesine Oncology Studies (BIZ)
These data expand our understanding of the potential role for forodesine and other purine nucleoside phosphorylase inhibitors in the treatment of patients with hematological malignancies, ... Source: AlphaTrade Finance »

Hopkins Prostate Cancer Experts Available
... in the detection and staging of prostate cancer. Dr. Carter, professor of urology and oncology at the Johns Hopkins University School of Medicine and director of the Division of ... Source: Medical News Today »

New Anti-Cancer Drug, Levact(R) (Bendamustine), Approved In The UK For Low Grade Non-Hodgkin's Lymphoma
... been available to patients as part of a Compassionate Use Programme initiated by Napp Oncology to address the huge unmet need in this area. Since November 2008 over 450 ... Source: Medical News Today »

Dendritic Cell Therapy for Oncology Roundtable Conference
... conference in Brussels, where major experts in the field of dendritic cell therapy for oncology were invited. Dendritic cell therapy is based on the isolation of the patient’s own ... Source: PharmiWeb.com »

Cancer center in Bloomington regains financial health
... caseload at some for-profit proton centers, according to Dr. Jay Loeffler, chief of radiation oncology at Massachusetts General Hospital. But at the proton center at Massachusetts General, prostate patients ... Source: IndyStar.com »

News From The Journal Of Clinical Investigation: Sept. 13, 2010
... peripheral olfactory structures. Title: Defective migration of neuroendocrine GnRH cells in human arrhinencephalic conditions ONCOLOGY What's SMAD-da u? The TGF-beta signaling pathway can be tumor suppressing or promoting depending ... Source: Medical News Today »

Marshall Edwards Reaches Ag...
... Principle to Acquire IP Portfolio from Novogen SAN DIEGO - Marshall Edwards Inc., an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced in a press ... Source: ag-ip-news.com »

IBt - International Brachytherapy s.a. IBt Bebig Introduces New SmartSeed® Permanent Brachytherapy Solution for Radiation Oncolo
... Solution for Radiation Oncolo IBt Bebig Introduces New SmartSeed Permanent Brachytherapy Solution for Radiation Oncologists and Urologists Seneffe - Belgium, September 15, 2010, IBt Bebig (Reuters: IBTH.BR - Bloomberg: ... Source: www.euroinvestor.co.uk »

Millennium Sales Force Ranked #1 by Independent Survey of Leading Oncologists
... Millennium Sales Force Ranked #1 by Independent Survey of Leading Oncologists today announced its sales force ranked first in an independent assessment of hematology/oncology sales ... Source: Business Wire »

Ultrasonic Therapy: Scientists at European Institute of Oncology target ultrasonic therapy
... median follow-up period of 12 months," wrote F. Orsi and colleagues, European Institute of Oncology. The researchers concluded: "According to our short-and long-term follow-up results, ultrasound-guided high-intensity focused ultrasound ... Source: NewsRx »

Cancer Research: Research on cancer research published by scientists at McMaster University, Department of Oncology
... H0 but less than HA)," wrote S. Allegro and colleagues, McMaster University, Department of Oncology. The researchers concluded: "This may make the development strategies difficult and better understanding of ... Source: NewsRx »

Lung Cancer Culprit Could Offer Target for Therapy, Researchers Report
... disease. To find out, lead study author Dr. Mark Hatley, an instructor of pediatric hematology/oncology, and UT Southwestern colleagues used mice that had been altered specifically to harbor non-small-cell ... Source: Science Daily »

Market Report, "UCB Group (UCB) - Financial and Strategic Analysis Review", published
... of central nervous system (CNS) disorders, allergy, respiratory diseases, immune and inflammatory disorders and oncology. Its product portfolio consists of small, chemically derived molecules and large, antibody-based molecules called ... Source: PR Inside »

CrystalGenomics Nominated for the Scrip Award in the Category of Best Company in an Emerging Market
... this year as it had reached few notable clinical milestones with its antibiotic and oncology programs. said, "Even with a record number of entries this year for the Scrip ... Source: KGUN TV-9 (ABC - Tucson) »

Access Pharmaceuticals Receives Initial Purchase Order for MuGard in North America
... capability and diversified payor network. Access and its partners continue working with large oncology networks and key clinical sites to educate oncologists and radiation oncologists on MuGard and ... Source: KGUN TV-9 (ABC - Tucson) »

Assured Pharmacy Receives $500,000 in Debt Financing
... Our business model targets physicians specializing in pain management anesthesiology, orthopedics, neurology, oncology, psychiatry, physical rehabilitation and industrial medicine. The focus is on treating patients with long-term, ... Source: KGUN TV-9 (ABC - Tucson) »

Resident Physician is Latest Winner of New Product Development Firm's...
... cancer research. The Pittsburgh-based design firm chose CureSearch because of its support for Childrens Oncology Group, the largest cooperative pediatric cancer research organization in the world, made up of ... Source: PR Web »

A fond farewell to comedian Robert Schimmel
... I was in the oncologists office with my parents and my wife, and he said, Theres Hodgkins disease and ... Source: The Jewish Journal »

3SBio Announces Partial Conversion of Isotechnika Debenture (PRN)
... Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP certified manufacturing facilities ... Source: AlphaTrade Finance »

Provectus Pharmaceuticals Completes Initial Enrollment in Phase 1 Trial of PV-10 for Liver Cancer
... in Progress -- Rodman & Renshaw Annual Global Investment Conference NYC ), a development-stage oncology and dermatology biopharmaceutical company, announced today that it has completed enrollment in the first ... Source: Business Wire »

Amerinet Announces New Leadership for Energy Solutions, Quality Programs
... regulatory and patient safety program development for 14 clinical off-site specialty practices and 18 oncology units being transitioned to the hospitals license. She was also project manager for the ... Source: Business Wire »

Adelson Medical Research Foundation-Sponsored Research Identifies Two Genes Newly Implicated in Aggressive Form of Ovarian
... cancer drug discovery," Fasman said. Victor E. Velculescu, M.D., Ph.D., is Associate Professor of Oncology and Director of Cancer Genetics at the Ludwig Center for Cancer Genetics and Therapeutics ... Source: PR Inside »

Millennium Sales Force Ranked #1 by Independent Survey of Leading Oncologists
... today announced its sales force ranked first in an independent assessment of hematology/oncology sales teams in the pharmaceutical industry. The survey was conducted by Health Strategies Group, ... Source: Street Insider »

Millennium Sales Force Ranked #1 by Independent Survey of Leading Oncologists (BIZ)
... , asked oncologists who treat hematologic cancers to rank their sales representatives based on the behaviors, knowledge ... Source: AlphaTrade Finance »

Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010,
... fast, powerful and efficient cancer treatments at the European Society for Therapeutic Radiology and Oncology exhibition in Barcelona next week. A fully-featured TrueBeam system will be the centerpiece of ... Source: PR-USA.net »

Ziopharm Oncology to Present at the Rodman & Renshaw Annual Global Investment Conference NYC
... ZIOPHARM Oncology, Inc. is a biopharmaceutical company that is seeking to develop and commercialize a diverse, ... Source: Pharmalive.com/ »

Heat Biologics Announces Scientific Advisory Board
... the treatment of melanoma, renal cell carcinoma, prostate cancer and ovarian cancer. is an oncologist and executive medical director of the Mary Crowley Cancer Research Centers (MCCRC) in Dallas ... Source: Interest Alert »

Heat Biologics Announces Scientific Advisory Board Panel of Internationally Renowned Investigators and Clinicians Will Guide
... melanoma, renal cell carcinoma, prostate cancer and ovarian cancer. John Nemunaitis, M.D., is an oncologist and executive medical director of the Mary Crowley Cancer Research Centers (MCCRC) in Dallas ... Source: PR Inside »

IntrinsiQ Summit: Top Oncology Market Experts Examine Clinical and Economic Bellwethers
... 5 , the company improving the quality and understanding of cancer care, today brings oncology experts and practitioners together to discuss the sweeping trends and forces that will impact ... Source: Street Insider »

IntrinsiQ Summit: Top Oncology Market Experts Examine Clinical and Economic Bellwethers Emergence of Oral Chemotherapy a Central Theme at 5th Annual Pharmaceutical Client Meeting
... IntrinsiQ Summit: Top Oncology Market Experts Examine Clinical and Economic Bellwethers Emergence of Oral Chemotherapy a Central Theme ... Source: Quote.com »

New collaboration seeks to improve the lives of children living with cancer
... TORONTO, Sept. 14 /CNW/ - The Canadian Cancer Society and the Pediatric Oncology Group of Ontario (POGO) today announced that they have joined forces to improve the ... Source: Canadian Business Magazine »

The Cancer Support Community, With Support From Cephalon, Launches New Patient Education Campaign - Framing Life With Ly
... an expert Steering Committee, and a national survey fielded by Harris Interactive of 150 hematologists/oncologists and 133 indolent lymphoma patients, which found that almost all physicians (96 percent) and ... Source: News Blaze »

: Reports Critical NEWS ALERTS -- Cryo-Cell International, Inc. (OTCBB: CCEL), Adino Energy Corporation (OTCBB: ADNY), Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), Vical Incorporated (NASDAQ: VICL): Sign-Up for our FREE Stock Al
... KNOXVILLE, Tenn. aEUR" 09/13/2010 aEUR" Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma ... Source: Tradingcharts.com »

Lippincott Williams & Wilkins Journals Garner Six 2010 APEX Awards
... & Wilkins Journals Garner Six 2010 APEX Awards Emergency Medicine News, Nephrology Times, and Oncology Times Honored For Excellence in Editorial Content, Graphic Design, and Overall Communication Effectiveness , ... Source: Wolters Kluwer »

NCCN Oncology Policy Summit focuses on off-label use of drugs and biologics
Network (NCCN) announced today that key policy organizations and thought leaders will convene to discuss the critically important subject of the use of drugs and ... Source: News-Medical.net »

StockProfiler.US: Medical News You Can Use: WellTek, Inc., AGA Medical Holdings, Inc., Spring Creek Capital Corporation, Angeion Corporation, VCA Animal Hospitals and Human Genome Sciences, Inc.
... ADDitude Magazine, Adoptive Families Magazine, ADRInstitute.org, Advamed, ADVANCE for Administrators in Radiology and Radiation Oncology, ADVANCE for Administrators of the Laboratory, ADVANCE for Health Information Executives, ADVANCE for Imaging ... Source: M2 »

Compendia Usage and Off-Label Indications Focus of NCCN Oncology Summit
... care is off-label. The introduction and utilization of many innovative drugs and biologics in oncology practice, combined with their significant expense, has focused the attention of payors and other ... Source: PharmiWeb.com »

Leading Dutch Cancer Center Commences Treatments Using New TrueBeam From Varian Medical Systems
... in combination with Varian's RapidArc® technology. Professor Ben Slotman, the hospital's head of radiation oncology, says, "The treatment has proceeded very well. Thanks to the higher dose rate delivery ... Source: Medical News Today »

Xoft Introduces Electronic Brachytherapy Cancer Treatment Platform At ESTRO Meeting
... here at the 29th Annual Meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO), where Xoft is exhibiting for the first time. Xoft recently received CE Mark ... Source: Medical News Today »

Ovarian Cancer Researchers Request Practice Changes To Protect Against Ovarian Cancer (Deaths Could Be Reduced 50 Percent Over 20 Years)
... Gynecologic oncologists with the Ovarian Cancer Research Program at Vancouver General Hospital (VGH) and the BC ... Source: Medical News Today »

Debiopharm Group™ And Aurigene Nominate Development Candidate - A Novel Inhibitor Of An Undisclosed Oncology Pathway
... successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway. Debio 0617 has started IND enabling studies and is expected to enter clinical ... Source: Medical News Today »

Chemotherapy-induced Nausea and Vomiting (CINV): No Longer an Inevitable Side Effect of Chemotherapy for HIV- Related Cancers
... side effect can drastically interfere with treatment. At a recent annual meeting of the Oncology Nursing Society, more than half of oncology nurses surveyed reported that they had interrupted ... Source: CancerConsultants.com »

The Top 10 Eastern European Pharmaceutical Companies: Growth strategies, performance and SWOT analys
... Marketed products Therapeutic focus Research and development Growth strategies Focus on biosimilars Strengthening its oncology portfolio Strengthening presence in Romania Growing business by forging alliances and partnerships Acquisitions and ... Source: PR-USA.net »

Patients should take reins in cancer treatment
... treatment on the back of the throat. Dr. Melissa Dinolfo, who is board-certified in oncology pharmacy, says there are ways to neutralize a patient's reaction to chemotherapy, including different ... Source: Miami Herald »

ADHD medication improves childhood cancer survivors: Research
... new drugs that reduce the severity of... CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the grantin... NanoViricides, Inc., announced today that it has raised $5,000,000, drawing ... Source: News-Medical.net »

Cell Therapeutics to Appeal FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma / Pixantrone NDA transferred to newly created Division of Hematologic Produc
... Officer for the University of Pittsburgh Cancer Centers and Chief of the Division of Hematology/Oncology at UPMC. "After discussions with a number of leading U.S. and international lymphoma experts ... Source: FinanzNachrichten »

Cell Therapeutics to Appeal FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma
... and Chief Medical Officer for the Cancer Centers and Chief of the Division of Hematology/Oncology at UPMC. "After discussions with a number of leading U.S. and international lymphoma ... Source: Street Insider »

New Product Development Firm Supports CureSearch for Children's Cancer...
... to donate $10 to the organization, which funds the lifesaving research of the Childrens Oncology Group, the largest cooperative pediatric cancer research organization in the world. CureSearch does truly ... Source: PR Web »

Paraguayan president health condition causes unrest among lawmakers
... at the Syrian-Lebanese hospital of Sao Paulo which hosts what is considered the best oncology clinic of South America. A second session was done in Asunción and the third ... Source: MercoPress »

Ways to neutralize reaction to chemotherapy
... treatment on the back of the throat. Dr. Melissa Dinolfo, who is board-certified in oncology pharmacy, says there are ways to neutralize a patient's reaction to chemotherapy, including different ... Source: The Seattle Times »

Dying at home better for cancer patients - study
... saves physical and emotional pain as well, they reported in the Journal of Clinical Oncology. "Patients with cancer who died in an intensive care unit or hospital experienced more ... Source: The Malaysian Star »

Study: Men With Low Prostate Cancer Scores Benefit Least From Test
... Center in Rotterdam, the Netherlands, in an e-mail. Anthony D'Amico, chief of Genitourinary Radiation Oncology at Brigham and Women's Hospital in Boston, said the average of nine years of ... Source: The Ledger »

Options For Colon Cancer Screening
... 2004 to 80% last year, which Michael Kelley, the V.A.'s national program director for oncology, attributes to electronic patient-tracking and the administration's efforts to clear a backlog of colonoscopies. ... Source: Wall Street Journal »

Research and Markets: Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer Book Covers the Whole Field of Targeted Radionuclide Therapy
... issues that need to be appreciated to ultimately see their widespread use in clinical oncology. New and emerging areas such as molecular imaging in evaluating the response and resistance ... Source: Business Wire »

Progress in prostate canter
... the patients that we've treated, a majority have done very well," said and Radiation Oncology at Stamford Hospital. "Wer'e very pleased with the treatment and optimistic about continued usage." ... Source: NewsTimes »

FDA Approves New Dosing for Faslodex (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
... commercialization of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of $32.8 billion in 2009. In ... Source: Pharmaceutical News »

BMI's £8m prescription for growth
... at the Alex last year, with the refurbishment of the physiotherapy unit. A new oncology centre was officially opened by Coronation Street actress Betty Driver in July, and work ... Source: Manchester Evening News »

Arno Therapeutics, Inc. Raises $15 Million in Private Placement To Advance Clinical Development of Oncology Compounds (BIZ)
"We are extremely pleased to have the continued support of the investment community as we work to advance our promising technologies for the treatment of ... Source: AlphaTrade Finance »

Arno Therapeutics, Inc. Raises $15 Million in Private Placement To Advance Clinical Development of Oncology Compounds
... PARSIPPANY, N.J.--(BUSINESS WIRE)-- Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced that it has closed a private placement of its securities resulting ... Source: Street Insider »

New location for Young Oncology unit from today
... New location for Young Oncology unit from today New location for Young Oncology unit from today Young Oncology Service ... Source: Young Witness »

Mayo Clinic to Open Radiation Oncology Treatment Center in Northfield
... paste this block of HTML code onto your webpage. Mayo Clinic to Open Radiation Oncology Treatment Center in Northfield Groundbreaking ceremony for a new radiation oncology treatment center. The ... Source: Mayo Clinic »

Oncologists Play Key Role in Fight Against Smoking
... Source: HealthNewsDigest »

Compendia Usage and Off-Label Indications Focus of NCCN Oncology Summit
... of Policy Summits, Issues in Off-Label Use and the Applications of Compendia. This NCCN Oncology Policy Summit will explore a broad range of issue areas that impact the availability ... Source: Street Insider »

Phase 2 Safety and Efficacy Data To Be Presented on Provectus' PV-10 at 7th International Melanoma Research Congress on November 4, 2010
... ), a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma ... Source: Business Wire »

Leading Dutch Cancer Center Commences Treatments Using New TrueBeam from Varian Medical Systems
... using TrueBeam in combination with Varian's RapidArc technology. , the hospital's head of radiation oncology, says, "The treatment has proceeded very well. Thanks to the higher dose rate delivery ... Source: KGUN TV-9 (ABC - Tucson) »

Xoft Introduces Electronic Brachytherapy Cancer Treatment Platform at ESTRO Meeting
... here at the 29th Annual Meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO), where Xoft is exhibiting for the first time. Xoft recently received CE Mark ... Source: KGUN TV-9 (ABC - Tucson) »

Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results
... Preclinical eValuation services; and Began to offer genome sequencing as part of its Personalized Oncology services. , M.D., Chairman of the Board of Champions Biotechnology, Inc., noted, "The 2011 ... Source: WRICTV8 »

Phase 2 Safety and Efficacy Data To Be Presented on Provectus' PV-10 at 7th International Melanoma Research Congress on
... KNOXVILLE, Tenn. - (BUSINESS WIRE) - Provectus Pharmaceuticals, Inc. (OTC BB: ), a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma ... Source: News Blaze »

Xoft Introduces Electronic Brachytherapy Cancer Treatment Platform at ESTRO Meeting
... here at the 29th Annual Meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO), where Xoft is exhibiting for the first time. Xoft recently received CE Mark ... Source: Kait »

Leading Dutch Cancer Center Commences Treatments Using New TrueBeam from Varian Medical Systems
... using TrueBeam in combination with Varian's RapidArc technology. , the hospital's head of radiation oncology, says, "The treatment has proceeded very well. Thanks to the higher dose rate delivery ... Source: Kait »

ARIAD Announces Initiation of Ponatinib (AP24534) Pivotal Trial in Drug-Resistant or Intolerant Chronic Myeloid Leukemia
... the CML field, including: Michele Baccarani, M.D., Professor and Head, Institute of Hematology and Oncology, Universita di Bologna, Bologna, Italy Jorge Cortes, M.D., Professor and Deputy Chair, Department of ... Source: Street Insider »

Local Sears National Kids Cancer Rider, Matthew Thiessen, Arrives in Winnipeg Today - Crossing the Country Raising Money for Kids, Families
... survival rate in the future. Sears is fully committed to the cause of pediatric oncology. Through the involvement of our associates and the vast network of Sears locations across ... Source: Canadian Business Magazine »

Varian Medical Systems Spotlights TrueBeam Treatment System For First Time In Europe At ESTRO 2010, September 12-16, Barcelona
... for fast, powerful and efficient treatments at the European Society for Therapeutic Radiology and Oncology exhibition in Barcelona next week. A fully-featured TrueBeam system will be the centerpiece of ... Source: Medical News Today »

AVEO Pharmaceuticals, Inc. Appoints Michael P. Bailey to the Newly Created Position of Chief Commercial Officer (BIZ)
... experiences in building commercial organizations and leading the global launch of Erbitux across multiple oncology indications, as well as Donnas experience with CMC and supply chain matters, will be ... Source: AlphaTrade Finance »

Abiraterone Strong in Phase III, but No Worries for Provenge Yet
... as study COU-AA-301, will be presented soon at the upcoming European Society for Medical Oncology Congress in Milan, Italy. The study of 1,195 patients included those with metastatic advanced ... Source: Therapeutics Daily »

Anti-Angiogenic Anti-Cancer Agent Avastin
... of the drug. 1) The 46th Annual Meeting of the Japan Society of Clinical Oncology (October 30-November 1, 2008, Nagoya) #S6-8 2) 2009 Gastrointestinal Cancers Symposium (ASCO GI, January ... Source: Medical News Today »

Debiopharm, Aurigene nominates Debio 0617 candidate for inhibiting oncology pathway
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical ... Source: News-Medical.net »

Kylie's cancer woes
... in 2005, said "Trust me, I have been in floods of tears at my oncologist, saying, 'I can't stand it, get me off this stuff,' and he will become ... Source: The Times of India »

Debiopharm Group¿ and Aurigene Nominate Development Candidate (PRN)
... successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway. Debio 0617 has started IND enabling studies and is expected to enter clinical ... Source: AlphaTrade Finance »

Marshall Edwards Reaches Agreement in Principle to Acquire IP Portfolio from Novogen
... Principle to Acquire IP Portfolio from Novogen SAN DIEGO - Marshall Edwards Inc., an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced in a press ... Source: ag-ip-news.com »

Debiopharm Group'
... warranties or representations in connection therewith. Debio 0617, a novel inhibitor of an undisclosed oncology pathway /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with ... Source: Kait »

DGAP-News: 4SC to Present at the UBS Global Life Sciences Con...
... arthritis and a Phase IIa exploratory study in inflammatory bowel disease. The company's lead oncology compound, resminostat (4SC-201), a pan histone deacetylase (HDAC) inhibitor, is in Phase II trials ... Source: equitystory.com »

Cancer support group welcomes Coalition hospital pledge
... the state election in November. It says the centre would include radiotherapy facilities and oncology wards, as well as four radiotherapy bunkers. The support group's Bob Harwood says it ... Source: ABC »

Biomolecular Screening: New findings reported from Eli Lilly and Company describe advances in biomolecular screening
... 91320, USA. Keywords: City:Indianapolis, State:IN, Country:United States, Antigens, Biological Factors, Biomolecular Screening, Cancer, Glioblastoma, Oncology, Stem Cell Research, Stem Cells. This article was prepared by NewsRx editors from staff ... Source: NewsRx »

12-year old completes race for charity
... the test by running a half-marathon, 13.1 miles, to raise money for the Pediatric Oncology Unit of Joe DiMaggio Children’s Hospital. Working with a website his father set up ... Source: Miami Herald »

Darcee D. Dunkle
... during her 25 years of employment there, Darcee became one of the first certified oncology nurses in the area, earned a Bachelor's Nursing degree from Kennedy Western University, and ... Source: Kane Republican Online »

Killing cancer, without killing healthy cells
... late for the patient's recovery. Every individual responds differently to treatment, and it's the oncologist's challenge to find the optimal combination for each patient. This challenge is exacerbated by ... Source: Israel21C »

Kylie Minogue's cancer tears
... 2005 - said: "Trust me, 'I have been in floods of tears at my oncologist, saying, 'I can't stand it, get me off this stuff,' and he will become ... Source: The Chronicle »

Recent Study: Nycomed International Management GmbH - Strategic Analysis Review
... for the treatment of respiratory, gastroenterology, pain management, osteoporosis, tissue management, neurology, insomnia, cardiology, oncology, and inflammatory diseases. Operating as a subsidiary of Nycomed SICAR S.C.A., the company is ... Source: PR Inside »

Now Available: SuperGen, Inc. (SUPG) - Financial and Strategic Analysis Review
... for the treatment of cancer. It is focused on the development of hematology and oncology drugs for use by oncologists, hematologists for the treatment of solid tumors, blood disorders ... Source: PR Inside »

Kylie on cancer drugs for five years
... life without medication. "Trust me, I have been in floods of tears at my oncologist, saying, 'I can't stand it, get me off this stuff' And then he will ... Source: news.com.au »

Mayo Clinic Turning Viruses Into Cancer Killers
... made amazing progress turning various viruses into cancer killers. Mayo's Director of Molecular Medicine, Oncologist Eva Galanis, M.D., points to the proof captured in highly magnified photographs. "These are ... Source: WCCO »

An ode to healing
... Snohomish County physicians will perform: Chung, a cardiologist at The Everett Clinic; Walker, an oncologist at Providence Regional Cancer Partnership; Dr. Cristina Santiago, who works at Providence Regional Medical ... Source: The Herald »

Bridgeport Hospital to offer Cancer College on Sept. 25; Free to the public
... to 11:30 a.m. Recent Developments: Medical Management of Breast Cancer, Dr. Neal Fischbach, medical oncologist; 1:15 to 2 p.m. Is Colon Cancer Hereditary? Dr. Darlene Negbenebor, gastroenterologist; 9:45 to ... Source: Hewrsam Acorn Newspaper »

Brain tumor causes
... cancers in the country. "We are working on ways to be able to support oncology services," he said. "The new Cyto-toxic unit at CWM hospital was built at a ... Source: Fiji Times »

21st Century Oncology Offers Complimentary Screenings for Prostate Cancer
... common, it’s also very treatable if it is caught early. That’s why 21st Century Oncology along with participating Prostate Cancer Institute urologists in Lee and Collier Counties are offering ... Source: PR-USA.net »

Complex Lung Cancer Treatments Delivered Successfully at Leading Varian-Equipped Proton Therapy Cent
... energy characteristic to destroy tumors. The proton energy has a predictable drop-off which enables oncologists to deposit the peak of the energy within the tumor and reduce the exposure ... Source: PR-CANADA.net »

Elekta Customers See Their Ideas Brought to Life at ESTRO 29
... Elekta will demonstrate its continued leadership role in the technological advancement of radiation oncology at the 2010 meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO) ... Source: PR-USA.net »

Clarient Presentation Time Change at the Baird 2010 Health Care Conference
... Clarient, Inc. , a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the biopharmaceutical industry, today announced that the Company's presentation time at the Baird ... Source: PR-CANADA.net »

Elekta Among Major Sponsors of Rocks Against Cancer Fundraiser
... only freestanding cancer center of its kind in Manhattan, The Farber Center for Radiation Oncology, is hosting the event, as well as serving as a major sponsor. "Rocks Against ... Source: PR-CANADA.net »

Doctors will show their musical side at benefit concert
... Snohomish County physicians will perform: Chung, a cardiologist at The Everett Clinic; Walker, an oncologist at Providence Regional Cancer Partnership; Dr. Cristina Santiago, who works at Providence Regional Medical ... Source: The Herald »

Tragara Pharmaceuticals Initiates Phase I Clinical Program for TG02
... modulation of the ERK5 pathway in solid tumors," added Francis Burrows, Ph.D., head of oncology biology, Tragara Pharmaceuticals. "Our testing in solid tumor preclinical models, particularly in triple-negative breast ... Source: PR-USA.net »

GlaxoSmithKline And Genmab Announce Start Of Ofatumumab Phase III Combination Study In Non-Hodgkin's Lymphoma
... (SEER) Cancer Statistics Review 1975-2006 , National Cancer Institute. (2) McLaughlin, Peter. Mayo Clinic Hematology/Oncology Review: Part 1 Progress and Promise in the Treatment of Indolent Lymphomas. The Oncologist, ... Source: Medical News Today »

Immunoglobulins: New immunoglobulins study findings reported from AstraZeneca
... Globulins, Hematology, Immunoglobulins, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Medical Device, Monoclonal Antibodies, Oncology This article was prepared by NewsRx editors from staff and other reports. Copyright 2010, ... Source: NewsRx »

Cancer Therapy: New findings from Genentech, Inc. in the area of cancer therapy published
... a predictive biomarker in anticancer therapy. For additional information, contact L.C. Amler, Genentech, Inc., Oncology Biomarker Development, 1 Keywords: City:South San Francisco, State:94080-4990, Country:United States, Anticancer Therapy, Treatment. This ... Source: NewsRx »

Bone Marrow: Studies from Sunesis Pharmaceuticals Inc. describe new findings in bone marrow
... San Francisco, State:94080, Country:United States, Anticancer Therapy, Bone Marrow, Cancer, Hematology, Immune System, Leukemia, Oncology, Treatment. This article was prepared by NewsRx editors from staff and other reports. Copyright ... Source: NewsRx »

Teen Fighting Cancer With Cord Blood Transplant
... she decided to help other cancer patients by donating her hair to . Her oncologist, Dr. Andrew Koh, decided her best chance at beating cancer would be a transplant ... Source: CBS 11 »

Book Review | 'The Widower's Tale': Perfect Children
... home crumble around him as Matlock goes upscale. His younger daughter, Trudy, a prominent oncologist in Boston with a trouble-free only child and a staid husband who works as ... Source: The New York Times »

Junk food binging ups cancer risk
... also saw a spurt in the number of these forms of cancer," said senior oncologist Gautam Mukhopadhyay, who led a study of carcinogen-induced cancer in the city. According to ... Source: The Times of India »

Teen Fighting Cancer After Cord Blood Transplant
... she decided to help other cancer patients by donating her hair to . Her oncologist, Dr. Andrew Koh, decided her best chance at beating cancer would be a transplant ... Source: CBS 11 »

AHS goes pink to fight cancer Pink socks at Friday's football game
... are working to develop better treatment options and OUCI is one of the largest oncology physician groups in the state. A new clinic will open in Oklahoma City next ... Source: Alva Review Courier »

GOOD HEALTH: Sept. 12 Health briefs
... Hospital’s nurse navigator. Widmaier’s responsibilities include helping breast cancer patients navigate through mammograms, medical oncology, radiation oncology, surgery and other testing. This role will allow Widmaier to be an ... Source: The Oakland Press »

Survivor Supporting Others In Cancer Fight
... years of being carefully watched by doctors," she said. Dr. Claude Denham is her oncologist. "We email each other, and she calls me by my first name," Dr. Denham ... Source: CBS 11 »

Son Is Bright Spot From Darkest Medical Moment
... of his family's life. And, it all happened at the unexpected suggestion of his oncologist. Cute little Gage Hubka will one day know how unique his path into this ... Source: CBS 11 »

Blood pressure pills could raise cancer risk
... those not on them. The study was published Monday in the medical journal, Lancet Oncology. No funding was provided for the study, but Dr. Ilke Sipahi, the study's lead ... Source: Today's Zaman »

A Good Prognosis Gets Better: Advances in the Treatment of Early-stage Breast Cancer
... to results presented at the 2006 annual meeting of the American Society of Clinical Oncology, women treated with one year of Herceptin had a lower risk of death, a ... Source: CancerConsultants.com »

Syndax Pharmaceuticals to Present at R.W. Baird 2010 Healthcare Conference and BioPharm America 2010
... Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that Joanna Horobin, M.D., the company's president and CEO, will present ... Source: PR-CANADA.net »

Dr. Robert Shorr, Leading Scientist in Cancer Metabolism, to Speak at Two Upcoming Pharmaceutical Co
... D.I.C., will be speaking and Co-Chairing The Center for Business Intelligence's (CBI's) 4th Annual Oncology Clinical Trials Summit and chairing a panel on cancer metabolism at the Life Sciences ... Source: PR-CANADA.net »

Study of Investigational Agent Abiraterone Acetate for Metastatic Advanced Prostate Cancer Unblinded
... Ortho Biotech Oncology Research & Development, a unit of Cougar Biotechnology, Inc., today announced that it has ... Source: PR-USA.net »

Tower Cancer Research Foundation to Host Breast Cancer Symposium
... the first in a series of free symposiums on October 19. The 2010 Tower Oncology Fall Cancer Symposium - Advances in Breast Cancer Research and Treatment: A Multidisciplinary Panel ... Source: PR-CANADA.net »

Ovarian cancer researchers request practice changes to protect against ovarian cancer: deaths could
... Gynecologic oncologists with the Ovarian Cancer Research Program at Vancouver General Hospital (VGH) and the BC ... Source: PR-USA.net »

British Columbian Researchers uncover new ovarian cancer gene: a connection between cancer and endom
... cancers represents a major scientific breakthrough," says Dr. Andrew Berchuck, director, Division of Gynecologic Oncology, Duke University Medical Center. "This discovery also sheds light on how endometriosis predisposes to ... Source: PR-USA.net »

21st Century Oncology Offers Complimentary Screenings for Prostate Cancer
... 21st Century Oncology Offers Complimentary Screenings for Prostate Cancer 21st Century Oncology along with participating Prostate Cancer ... Source: PR.com »

Healthcare Hotline: understanding prostate cancer
... Urologist Dr. Steven Lynch and radiation oncologist Dr. Jeffrey Lee with Utah Cancer Specialists and Intermountain Healthcare will answer inquiry phone ... Source: The Deseret News »

New Model May Simplify High-Dose Radiosurgery Planning
... Radiation oncologists at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard ... Source: Science Daily »

Seattle Genetics to Host Conference Call and Webcast on September 13, 2010 to Discuss Top-line Data from Lintuzumab (SGN-33) Phase IIb Clinical Trial
... and Drug Administration. Brentuximab vedotin is being developed in collaboration with Millennium: The Takeda Oncology Company. In addition, Seattle Genetics has five other clinical-stage programs: lintuzumab (SGN-33), dacetuzumab (SGN-40), ... Source: Business Wire »

UA connects breast and uterine cancer
... her she was developing an aggressive cancer of the uterus. For years Janine's gynecologic oncologist had observed that patients with aggressive uterine cancer also had breast cancer. So she ... Source: KVOA »

Prostate Cancer Patients Go to School (PRN)
... overuse of surgery in is likely due to that almost total absence of medical oncology input when men are diagnosed. (Unlike other common cancers such as breast, colon or ... Source: AlphaTrade Finance »

Removing Fallopian tubes cuts ovarian cancer risk
... warning: stop leaving the tubes in, it is where ovarian cancer begins," said gynaecologic oncologist Sarah Finlayson from Vancouver General Hospital. She said the discovery that ovarian cancer actually ... Source: Channelnewsasia »

Genetic Testing Helps Cancer Victims Fight Disease
... with breast cancer are positive for the BRCA1," said Dr. Edward Wos, Medcenter One oncology. Cancer is so common that counselors must closely study family histories to determine the ... Source: KFYR TV »

J&J Prostate Cancer Drug Boosts Survival
... benefit derived from abiraterone. That data will come at the European Society for Medical Oncology (ESMO) meeting, being held Oct. 8-12. J&J said it is evaluating its approval filing ... Source: The Street »

Questioning Chemo
... comes to cancer treatment. Would it surprise you to know that the use of oncological chemotherapy in the U.S. has a shocking 2.1% statistical benefit?. That means that that ... Source: Associated Content »

Dana Farber earns grant from "Stand up to Cancer"
... Farber were in the 13 selected nationwide,” said Dr. Loren Walensky, Professor of Pediatric Oncology. Walensky said the funding will help to get results much faster, which is desperately ... Source: WHDH »

Prostate Cancer Awareness Month: Top Expert Debunks 4 Myths
... survival rate is roughly 91 percent. While early treatment is still widely preferred, many oncologists argue that patients receive prostate cancer treatment when active surveillance would be a prudent ... Source: KGUN TV-9 (ABC - Tucson) »

FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
... commercialization of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of For more information about AstraZeneca ... Source: KGUN TV-9 (ABC - Tucson) »

Removing Fallopians cuts ovarian cancer risk: study
... warning: stop leaving the tubes in, it is where ovarian cancer begins," said gynecologic oncologist Sarah Finlayson from Vancouver General Hospital. She said the discovery that ovarian cancer actually ... Source: France 24 »

Stand Up to Cancer Airs Nationally Friday at 8 p.m.
... be available to improve the well-being and help prolong the lives of cancer fighters. Oncologist Sushil Mehrotra of Ohio Valley Medical Center said that is why fundraising is so ... Source: WOWK-TV »

Swiss private equity firm Nextech closes oncology fund on €26m.
... > > > Fund Swiss private equity firm Nextech closes oncology fund on ¬26m. Swiss private equity firm Nextech Invest has closed its latest fund ... Source: Global Private Equity News and Research »

Ziopharm Oncology to Present at the Rodman & Renshaw Annual Global Investment Conference NYC (BIZ)
is a biopharmaceutical company that is seeking to develop and commercialize a diverse, portfolio of cancer drugs. Our principal focus is on the development of ... Source: AlphaTrade Finance »

Ziopharm Oncology to Present at the Rodman & Renshaw Annual Global Investment Conference NYC
... ZIOPHARM Oncology, Inc. is a biopharmaceutical company that is seeking to develop and commercialize a diverse, ... Source: Business Wire »

To Reach, Perchance to Kill the Cancer: A Soliloquy From Epeius Nanotechnologies Opposes That 'Sea of Troubles'
... field of targeted genetic medicine, reports the publication of a landmark paper in clinical oncology. Following up on its advanced U.S. Phase I/II clinical trials of Rexin-G in chemo-resistant ... Source: Pharmalive.com/ »

: Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Barcelona Revolutionary radiotherapy treatment device among highlights on Varian booth at annual meeting of Eur
... highlights on Varian booth at annual meeting of European Society for Therapeutic Radiology and Oncology Sep 10, 2010 (M2 PRESSWIRE via COMTEX News Network) -- Barcelona, Spain, aEUR" Varian ... Source: Quote.com »

: Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Barcelona Revolutionary radiotherapy treatment device among highlights on Varian
... highlights on Varian booth at annual meeting of European Society for Therapeutic Radiology and Oncology Sep 10, 2010 (M2 PRESSWIRE via COMTEX News Network) -- Barcelona, Spain, aEUR" Varian ... Source: Quote.com »

Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010,
... highlights on Varian booth at annual meeting of European Society for Therapeutic Radiology and Oncology is spotlighting its new TrueBeam(TM) medical linear accelerator for fast, powerful and efficient cancer ... Source: Interest Alert »

IntrinsiQ CEO Examines Oncology Myths at 2010 ICORE Summit
... plans, employers and government agencies nationwide. IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each ... Source: Business Wire »

Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Bar
... fast, powerful and efficient cancer treatments at the European Society for Therapeutic Radiology and Oncology exhibition in Barcelona next week. A fully-featured TrueBeam system will be the centerpiece of ... Source: News Blaze »

Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Barcelona
... fast, powerful and efficient cancer treatments at the European Society for Therapeutic Radiology and Oncology exhibition in next week. A fully-featured TrueBeam system will be the centerpiece of Varian's ... Source: Street Insider »

Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Barcelona (PRN)
... fast, powerful and efficient cancer treatments at the European Society for Therapeutic Radiology and Oncology next week. A fully-featured TrueBeam system will be the centerpiece of Varian's booth at ... Source: AlphaTrade Finance »

Specialist Business Unit of the University of Nottingham Spins-Out to Form New R&D Oncology Company
... NOTTINGHAM, UK, 9th September 2010 - Preclinical Oncology Services Limited (PRECOS), a leading pre-clinical research and development service with a specific focus ... Source: PharmiWeb.com »

Study Of Investigational Agent Abiraterone Acetate For Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre-Determined Criteria
... Ortho Biotech Oncology Research & Development, a unit of Cougar Biotechnology, Inc., announced that it has unblinded ... Source: Medical News Today »

Porsche Cars North America and Porsche AG of Stuttgart, Germany to Support the Quail Porsche Race Ca
... J. Addario Lung Cancer Foundation and Dr. David Jablons, Director of the UCSF Thoracic Oncology Program are honored to announce today that Porsche will be a major collaborator in ... Source: Interest Alert »

Porsche Cars North America and Porsche AG of Stuttgart, Germany to Support the Quail Porsche Race Car Classic
... Bonnie J. Addario Lung Cancer Foundation and Dr. , Director of the UCSF Thoracic Oncology Program are honored to announce today that Porsche will be a major collaborator in ... Source: Street Insider »

Abiraterone Acetate Meets Criteria in Cancer Study
... Cancer Unblinded After Meeting Pre-Determined Criteria LOS ANGELES, CA, September 9, 2010 -Ortho Biotech Oncology Research & Development, a unit of Cougar Biotechnology, Inc., today announced that it has ... Source: The Financial Mail »

Molecular Insight Receives Ninth Extension of Waiver Agreement With Bond Holders
... a biopharmaceutical company discovering and developing targeted therapeutic and imaging radiopharmaceuticals for use in oncology, today announced that the Company has received a ninth extension of its waiver agreement ... Source: PR-USA.net »

Nottingham City Hospital Chooses Quality, Throughput and Flexibility With TomoTherapy® Radiation The
... playing in a publicly funded health service, Julie Mead, Director and Clinical Advisor from Oncology Systems Limited, states: "The oncology team at Nottingham put all equipment vendors through a ... Source: PR-USA.net »

Hwang named manager at South Nassau Communities Hospital
... Hwang served as senior radiation therapist at Hackensack University Medical Center. "South Nassaus radiation oncology program continues to grow rapidly to meet the needs of the patients and the ... Source: North Jersey Media Group »

What is the precedent for using cell culture assay tests?
... So yes, there is precedent for using cell culture assays. The June issue of Oncology News International (June 2010, V 19, No 6) quotes a Duke University study of ... Source: Medical News Today »

Saint Francis officials tour site of heart, cancer center
... facilities are scattered between its Cancer Institute in Doctors' Park and the Cape Medical Oncology practice on the west side of the Saint Francis campus. When the new facility ... Source: Semissourian.com »

Promising Treatment for Metastatic Melanoma 'Fast Tracked' by FDA
... cancer." Results of this study were originally presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in June 2010, and published online by the ... Source: Science Daily »

Aethlon Medical Announces Data Against Metastatic Melanoma
... to 68%, while stage IV survival is approximately 18%. "Our goal is to provide oncologists with a device that will improve effectiveness of melanoma cancer therapies without adding drug ... Source: Rt Magazine »

$3M Grant To Virtua To Aid Women Vets ' Courier Post
... members on obstetric and gynecologic care; diagnostic screening for breast health and bone health; oncologic care for gynecology and breast treatment needs; and mental health resources, including for victims ... Source: John Adler Official Page »

Onyx to sell cancer treatment in Japan
... have rights to develop and commercialize the compounds carfilzomib and ONX 0912 for all oncology indications in Japan. Onyx retains rights in other countries in Asia as well as ... Source: The Oakland Tribune »

Ed Randall's Fans For The Cure Charity Announces Medical Advisory Board Addressing Prostate Cancer Awareness, Early Detection and Support
... Euroendocrine Research Laboratory at the St. Luke's-Roosevelt Hospital Center Dr. Paul Gliedman, Radiation Oncologist, St. Luke's-Roosevelt Hospital Center Dr. William Catalona, Professor, Northwestern University Feinberg School of ... Source: Business Wire »

Allos Therapeutics Announces FOLOTYN® Data Presentation at the 35th ESMO Congress
... cell lung cancer (NSCLC) will be presented at the 35 European Society of Medical Oncology (ESMO) Congress Milan, Italy from October 8-12, 2010. This is the first time ... Source: Business Wire »

Euthanasia hearings not linked to cost-cutting: MNA
... legalized in Quebec, 1,000 patients might die every year without giving their consent. Another oncologist, Dr. Caroline Girouard from Montreal's Sacr-Coeur hospital, told the committee that there is a ... Source: CBC »

First lady targets women's cancers
... cervical cancer in sub-Saharan Africa. The head of the University of Pretoria's gynaecology and oncology unit, Professor Greta Dreyer, said that more than two-thirds of South African women diagnosed ... Source: Sunday Times »

Show the Love to Your Prostate!
... my prostate was loaded with the big "C." "This thing was a bomb," my oncologist later told me. "You would have been dead within a couple years and wouldn't ... Source: Associated Content »

Tengion Adds The Johns Hopkins Hospital as an Additional Clinical Trial Site For Its Phase I Neo-Urinary Conduit'
... allows for the participation of , M.D., Bernard L. Schwartz Distinguished Professor of Urologic Oncology as a sub-investigator in the study. Dr. Schoenberg, a leader in urologic oncology, ... Source: KGUN TV-9 (ABC - Tucson) »

Study of Investigational Agent Abiraterone Acetate for Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre-D
... LOS ANGELES, Sept. 9 /PRNewswire/ -- Ortho Biotech Oncology Research & Development, a unit of Cougar Biotechnology, Inc., today announced that it has ... Source: News Blaze »

Study of Investigational Agent Abiraterone Acetate for Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre-Determined Criteria
... /PRNewswire/ -- Ortho Biotech Oncology Research & Development, a unit of Cougar Biotechnology, Inc., today announced that it has ... Source: Street Insider »

Myrexis Reports Fiscal Year 2010 Results
... and changed name to Myrexis, Inc. from Myriad Pharmaceuticals, Inc. -- Prioritized potential first-in-class/best-in-class oncology pipeline and suspended HIV product candidates -- Presented Azixa Phase 2a data at the ... Source: Interest Alert »

Pharmaceutical Industry Veteran Dr. Craig Eagle Appointed as an Independent Member to Regenicin Board of Directors
... Dr. Eagle currently serves as Vice President of Strategic Alliances and Partnerships for the Oncology business unit at Pfizer Inc. Dr. Eagle joins Amgen Co-Founder Dr. Joseph Rubinfeld as ... Source: Pharmalive.com/ »

CRH to offer radiation oncology therapy soon
... feature a new TomoTherapy machine, a high-tech medical device used to scan and treat oncologists will staff the new facility, which is expected to open in January. Construction on ... Source: StarExponent.com »

IntrinsiQ CEO Examines Oncology Myths at 2010 ICORE Summit (BIZ)
... include health plans, employers and government agencies nationwide. is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each ... Source: AlphaTrade Finance »

IntrinsiQ CEO Examines Oncology Myths at 2010 ICORE Summit
... plans, employers and government agencies nationwide. IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each ... Source: News Blaze »

Multi-disciplinary team awarded grant to develop interdisciplinary oncology palliative care education program
A multi-disciplinary team representing the schools of Medicine, Nursing and Social Work at the University of Louisville, as well as clinical pastoral education programs ... Source: News-Medical.net »

Specialist Business Unit of the University of Nottingham Spins-Out to Form New R&D Oncology Company
... UK in 2004, having evolved from the research expertise of the Division of Pre-clinical Oncology (formerly Academic Unit of Cancer Studies). This unit has had successful collaborations with pharmaceutical ... Source: Newswire Today »

Interdisciplinary Oncology Palliative Care Education Program
... Institutes of Health that will fund the development, implementation and evaluation of an interdisciplinary oncology palliative care education program. Work related to the project will begin immediately. "Almost every ... Source: Medical News Today »

SWOG Names Five Cancer Researchers As Outstanding Young Investigators
... The Southwest Oncology Group, or SWOG, one of the nation's largest clinical trials networks, has selected five ... Source: Medical News Today »

US Oncology selects PatientPoint's self-service solutions to enhance patient experience
PatientPoint, a provider of multi-channel self-service applications for the healthcare industry, today announced that US company supporting more than 1,300 affiliated physicians ... Source: News-Medical.net »

Sanofi Aventis : Phase 3 Trial of Aflibercept in Second-Line Met...
... to benefit patients with this difficult-to-treat disease," said Tal Zaks, Head of Development, Global Oncology Division, sanofi-aventis. About the VELOUR Study The main objective of the VELOUR (Aflibercept Versus ... Source: InvestEgate »

Clarient Presentation Time Change at the Baird 2010 Health Care Conference (PRN)
... translate cancer discovery and research into better patient care. 's principal customers include pathologists, oncologists, hospitals, and biopharmaceutical companies. The rise of individualized medicine as the new direction in ... Source: AlphaTrade Finance »

Clarient Presentation Time Change at the Baird 2010 Health Care Conference
... Care Conference ), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the biopharmaceutical industry, today announced that the Company's presentation time at the Baird ... Source: PR Newswire »

Marshall Edwards Reaches Agreement In Principle To Acquire Intellectual Property Portfolio From Novogen
... Portfolio From Novogen San Diego, CA /PRNewswire-FirstCall/ - Marshall Edwards, Inc. (Nasdaq: ), an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today that it ... Source: Pharmaceutical Online »

Raoul Ramirez Joins IntrinsiQ Tendler as Vice President
... a BA and an MBA from the Monterrey Institute of Technology. Unrivaled Expertise & Oncology Market Complexity Fuels Growth IntrinsiQ Tendler runs two of the most respected omnibuses in ... Source: PharmiWeb.com »

Prostate cancer treatments can vary
... get second and third opinions about what's going on. Dr. Henry Yampolsky, a radiation oncologist with The Center for Radiation Therapy of Beverly Hills, recommends patients see both a ... Source: San Bernardino Sun »

Colon Cancer Outcomes Unaffected By Multivitamin Use
... a print edition. Kimmie Ng, MD, MPH, the paper's first author and a gastrointestinal oncologist at Dana-Farber, said that despite conflicting evidence on the efficacy of multivitamins to reduce ... Source: Medical News Today »

Elekta Customers See Their Ideas Brought to Life at ESTRO 29 (PRN)
... will demonstrate its continued leadership role in the technological advancement of radiation oncology at the 2010 meeting of the European Society for Therapeutic Radiology and Oncology 's ... Source: AlphaTrade Finance »

Elekta Customers See Their Ideas Brought to Life at ESTRO 29
... -- Elekta will demonstrate its continued leadership role in the technological advancement of radiation oncology at the 2010 meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO) ... Source: PR Newswire »

Chemotherapy-induced Nausea and Vomiting (CINV): No Longer an Inevitable Side Effect of Chemotherapy for Head & Neck Cancers
... side effect can drastically interfere with treatment. At a recent annual meeting of the Oncology Nursing Society, more than half of oncology nurses surveyed reported that they had interrupted ... Source: CancerConsultants.com »

A-Life Medical promotes president to CEO
... XSense is the test f ... Clarient, a technology and services resource for pathologists, oncologists and the pharmaceutical industry, has said that data from a new study suggested that ... Source: Pharmaceutical Business Review »

Star Power: Part 2
... 2010. Here are No. 11 through 20. Mark Perman, MD, has been a radiation oncologist for more than 20 years in Florida, Maryland, and Pennsylvania and now serves as ... Source: rt-image.com »

Phase 3 Trial of Aflibercept in Second-Line Metastatic Colorectal Cancer to Continue as Planned at Recommendation of Independent Data Monitoring Committee
... potential to benefit patients with this difficult-to-treat disease," said , Head of Development, Global Oncology Division, sanofi-aventis. The main objective of the VELOUR (Aflibercept Versus Placebo in Combination with ... Source: KGUN TV-9 (ABC - Tucson) »

Multivitamin doesn't affect colon cancer
... find. The study, published online ahead of print issue of the Journal of Clinical Oncology, finds multivitamin use did not appear to have any beneficial effect on patients' outcomes ... Source: United Press International (UPI) »

Two Genes Linked to Chemotherapy Resistant Ovarian Cancer
... deadly form of ovarian cancer. According to Nickolas Papadopoulos, Ph.D., an associate professor of oncology and director of Translational Genetics at the Ludwig Center for Cancer Genetics & Therapeutics ... Source: Emaxhealth »

Two Lakeland Doctors Featured In Televised Cancer Special
... Wednesday, September 8, 2010 at 11:40 p.m. Two Lakeland doctors, Kris Guerrier, a radiation oncologist, and Richard Boothby, a gynecologic oncologist, will be featured in a television segment during ... Source: The Ledger »

TGI Healthworks Presents the First Plant Medicine Expo & Healthcare...
... Abrams, Professor of Clinical Medicine at the University of California San Francisco, Chief of Hematology/Oncology at San Francisco General Hospital and Director of Integrative Oncology Research at the UCSF ... Source: PR Web »

Gene links ovarian cancers to endometriosis
... a little more aggressively to remove that risk." Dr. Andrew Berchuck, director of gynecologic oncology at Duke University Medical Center in Durham, N.C., called the research "a major scientific ... Source: Metro Toronto »

Swedish Expands its Scientific Research Program
... abroad. In addition to participating in major, federally funded programs (such as the Southwest Oncology Group and the Center for Perinatal Studies), Swedish physicians are involved in research studies ... Source: Street Insider »

Dr. Marina Jacobsen Adds New Dimension to Ob/Gyn Practice
... tumor been tested for estrogen and progesterone receptors. She had not met with an oncologist or any other doctor, other than the breast surgeon. Jacobson stepped in to help, ... Source: ParamusPost.com »

Colette Baumann Krol
... was, "I'm not dying of cancer. I'm living with cancer." After her death, her oncologist wrote a note to the Krol and Baumann families. "Colette was one of the ... Source: Durango Herald »

What is a CA-125 Test
... on a wide scale. However, CA-125 tests are a valuable and useful tool for oncologists to use in monitoring women who have already been diagnosed with ovarian, fallopian tube, ... Source: Associated Content »

Healthy fast-food restaurant honored
... explained how the restaurant came about. As a physician, said Myers, who had an oncology practice in Yuma for several years, he saw the impact of a person's diet ... Source: Yumasun »

Tracking system reduces risks from prostate cancer radiation treatments
... U.S., 10 of which are in Southern California. Dr. Howard Sandler, chairman of radiation oncology Dr. Howard Sandler uses the Calypso system which is a GPS for the body ... Source: Daily Breeze »

B.C. study a 'eureka moment' in fight against ovarian cancer
... litigations would “have an immediate impact on saving lives,” said Dianne Miller, a gynecologic oncologist with the Ovarian Cancer Research Program of the B.C. Cancer Agency. That is because, ... Source: The Globe and Mail »

Emergent's Trubion buyout clears regulatory hurdle
... aiming to diversify its pipeline of drugs in development by providing potential treatments in oncology and autoimmunity. Under the agreement, each Trubion share will be converted into the right ... Source: WWSB ABC »

DiaTech Oncology Files Patents for Drug Discovery
... DiaTech Oncology has announced the filing of a patent for Drug Discovery that will provide a ... Source: PR-USA.net »

Raoul Ramirez Joins IntrinsiQ Tendler as Vice President Pharmaceutical Market Research Veteran Will Meet Strong, Rising Demand for Research Firm's Unique Insights
... a BA and an MBA from the Monterrey Institute of Technology. Unrivaled Expertise & Oncology Market Complexity Fuels Growth IntrinsiQ Tendler runs two of the most respected omnibuses in ... Source: Quote.com »

US Oncology Selects Self-Service Solutions from PatientPoint
... US Oncology Selects Self-Service Solutions from PatientPoint National Oncology Services Provider Chooses Patient Portal Technology to ... Source: Business Wire »

Curing Cancer
... full-bore supportive care that children do to keep them from dying of complications, says oncologist James Downing of St. Jude. The life-or-death importance of that approach shows up starkly ... Source: Newsweek »

DIAGNOCURE ONCOLOGY LABORATORIES TO PRESENT AT RODMAN & RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE ON SEPTEMBER 15, 2010
... and this Station make no warranties or representations in connection therewith. /PRNewswire/ - DiagnoCure Oncology Laboratories, the U.S. subsidiary of DiagnoCure, Inc. (TSX: CUR), announced that , President of ... Source: WTHR »

DIAGNOCURE ONCOLOGY LABORATORIES TO PRESENT AT RODMAN & RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE
... DIAGNOCURE ONCOLOGY LABORATORIES TO PRESENT AT RODMAN & RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE ON SEPTEMBER 15, ... Source: Interest Alert »

Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Com
... Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft(TM) Platform Champions Biotechnology Announces Agreement With Cephalon for the ... Source: Interest Alert »

From the Pacific to the Atlantic, 42 cyclists are participating In the Sears National Kids Cancer Ride To Raise Money for Kids, Families
... survival rate in the future. "Sears is fully committed to the cause of pediatric oncology. Through the involvement of our associates and the vast network of Sears locations across ... Source: Canadian Business Magazine »

From the Pacific to the Atlantic, 42 cyclists depart White Rock In the Sears National Kids Cancer Ride To Raise Money for Kids, Families
... survival rate in the future. Sears is fully committed to the cause of pediatric oncology. Through the involvement of our associates and the vast network of Sears locations across ... Source: Canadian Business Magazine »

Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predicti
... BALTIMORE, Sept. 8 /PRNewswire/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and ... Source: News Blaze »

Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft'
... Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft Platform /PRNewswire/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: ... Source: PR Newswire »

From the Pacific to the Atlantic, 42 cyclists are participating In the Sears National Kids Cancer Ride To Raise Money for Kids, Families (CNW)
... the survival rate in the future. is fully committed to the cause of pediatric oncology. Through the involvement of our associates and the vast network of locations across the ... Source: AlphaTrade Finance »

Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft¿ Platform (PRN)
... (OTC Bulletin Board: CSBR), an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and ... Source: AlphaTrade Finance »

DIAGNOCURE ONCOLOGY LABORATORIES TO PRESENT AT RODMAN & RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE ON SEPTEMBER 15, 2010 (PRN)
(TSX: CUR) is a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services that increase clinician and patient confidence in making ... Source: AlphaTrade Finance »

Cell Point's imaging agent ready to join cancer fight
... reducing treatment costs by billions. “It’s going to be a major tool in the oncologists’ arsenal to treat cancer,” Colip said. “Any agent that can potentially go up to ... Source: South Florida Business journal »

Onyx Pharmaceuticals Announces Carfilzomib Development and Commercialization Agreement with Ono Phar
... the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in Japan. Onyx retains commercialization rights in other countries in the Asia Pacific ... Source: Interest Alert »

Multivitamin has no effect on colon cancer outcomes
... have a detrimental effect. Dr. Kimmie Ng, the paper's first author and a gastrointestinal oncologist at Dana-Farber, said that there has been conflicting evidence on the efficacy of multivitamins ... Source: Thaindian News »

Onyx strikes cancer drug deal in Japan
... disease. Ono has exclusive rights to develop and commercialze carfilzomib and ONX-0912 for all oncology indications in Japan. Onyx retains rights in other countries in the Asia-Pacific region and ... Source: Bizjournals »

Onyx Pharmaceuticals Announces Carfilzomib Development and Commercialization Agreement with Ono Pharmaceutical for Japan (PRN)
... the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in . Onyx retains commercialization rights in other countries in the region, as ... Source: AlphaTrade Finance »

TRANSGENE : Jennerex and Transgene Enter into an Exclusive Partnership for the Development and Commercialization of JX-594 for t
... for JX-594. Transgene is an ideal partner for this product given their expertise in oncology and in the development of virus-based immunotherapeutic products. We look forward to working together ... Source: www.euroinvestor.co.uk »

Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
... JX-594. Transgene is an ideal partner for this product given their expertise in oncology and in the development of virus-based immunotherapeutic products. We look forward to working together ... Source: Street Insider »

Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers (CNW)
... partner for JX-594. is an ideal partner for this product given their expertise in oncology and in the development of virus-based immunotherapeutic products. We look forward to working together ... Source: AlphaTrade Finance »

DiaTech Oncology files patent for Drug Discovery to validate cancer treatment
... to receive an individualized report measuring sensitivity of selected chemo drugs and assisting the Oncologists in selection of the personalized treatment most likely to succeed. "We are pleased with ... Source: News-Medical.net »

Blast Crisisx: Data on blast crisisx reported by researchers at University of Milan, Department of Clinical Medicine
... Crisisx, Bone Marrow Diseases, Hematologic Diseases, Hematology, Hemic and Lymphatic Diseases, Leukemia, Myeloproliferative Disorders, Oncology. This article was prepared by NewsRx editors from staff and other reports. Copyright 2010, ... Source: NewsRx »

IntraOp Medical Corporation Announces Purchase Of Two Next Generation Mobetrons By UCSF
... adult and pediatric cancer patients," said Mack Roach, MD, chair of the UCSF Radiation Oncology Department. IntraOp's Mobetron is a mobile, self-shielded, technology that delivers radiation directly to a ... Source: Medical Design Online »

Multivitamin Use Doesn't Impact Colon Cancer Outcomes, Study Finds
... a print edition. Kimmie Ng, MD, MPH, the paper's first author and a gastrointestinal oncologist at Dana-Farber, said that despite conflicting evidence on the efficacy of multivitamins to reduce ... Source: Science Daily »

To Reach, Perchance to Kill the Cancer: A Soliloquy From Epeius Nanotechnologies Opposes That 'Sea of Troubles' (PRN)
... field of targeted genetic medicine, reports the publication of a landmark paper in clinical oncology. Following up on its advanced U.S. Phase I/II clinical trials of Rexin-G in chemo-resistant ... Source: AlphaTrade Finance »

Magic Mushrooms may help cancer patients
... obtaining subjects, Griffiths said. Because the drug has "such a tarnished history many oncologists are reluctant to refer volunteers," he said. All three discouraged cancer patients from using ... Source: HULIQ »

Multivitamin use doesn't impact colon cancer outcomes: study
... detrimental effect. The findings were reported online on Tuesday in the Journal of Clinical Oncology and later will be published in a print edition. Kimmie Ng, the paper's first ... Source: Peoples Daily »

Cancer educates a med student
... a demanding 12-week surgery rotation. The line at the metal detector near the county's oncology clinic snaked out the door. Lilienstein, who'd arrived straight from morning rounds in his ... Source: Los Angeles Times »

Multivitamin Use Doesn't Impact Colon Cancer Outcomes
... have a detrimental effect. The findings are reported online in the Journal of Clinical Oncology and later will be published in a print edition. Kimmie Ng, MD, MPH, the ... Source: RedOrbit »

Study looks at CT scans in pregnancy
... baby, no problems to date," he said. The researchers received funding from the Pediatric Oncology Group of Ontario. In a perspective piece also published by PLoS Medicine, Eduardo Franco ... Source: Metro Toronto »

Childhood brain tumour really 4 cancers: study
... findings were published Tuesday in the advance online edition of the Journal of Clinical Oncology. Better understanding of medulloblastoma could lead to a fine-tuning of treatments, the researchers say. ... Source: Metro Toronto »

Rosetta Genomics Reports Second Quarter 2010 Financial Results
... and medical communities. This was particularly evident at this years American Society for Clinical Oncology Annual Meeting where biomarkers and companion diagnostics were a key topic of discussion. Because ... Source: Business Wire »

Bristol-Myers Pays Up for ZymoGenetics
... topical hemostat to control non-arterial bleeding, and a number of early clinical and pre-clinical oncology and immunoscience programs. Written by Michael Baron in New York. >To contact the writer ... Source: The Street »

Genetic testing in oncology
... Source: Drug Topics Daily News »

What We Can Learn From 'Curable Cancers'
... full-bore supportive care that children do to keep them from dying of complications, says oncologist James Downing of St. Jude. The life-or-death importance of that approach shows up starkly ... Source: Newsweek »

Targeting tumors: Research has led to lifesaving breast cancer treatments
... That's when I knew the treatment wasn't just a fluke." Mehta, who works in hematology/oncology at UC Irvine Medical Center, published her findings and played a pivotal role in ... Source: PhysOrg »

Pharmaceutical Industry Veteran Dr. Craig Eagle Appointed as an Independent Member to Regenicin Boar
... Dr. Eagle currently serves as Vice President of Strategic Alliances and Partnerships for the Oncology business unit at Pfizer Inc. Dr. Eagle joins Amgen Co-Founder Dr. Joseph Rubinfeld as ... Source: Interest Alert »

US Oncology Selected to Help Association of Northern California Oncologists With Payer Provider Part
... US Oncology Selected to Help Association of Northern California Oncologists With Payer Provider Partnership Strategy US ... Source: Interest Alert »

US Oncology Selected to Help Association of Northern California Oncologists With Payer Provider Partnership Strategy
... Innovent Oncology is a choice to help community oncologists in Northern California negotiate payer provider partnerships ... Source: Street Insider »

Pharmaceutical Industry Veteran Dr. Craig Eagle Appointed as an Independent Member
... Dr. Eagle currently serves as Vice President of Strategic Alliances and Partnerships for the Oncology business unit at Pfizer Inc. Dr. Eagle joins Amgen Co-Founder Dr. Joseph Rubinfeld as ... Source: Antara »

Brentwood lab DiaTech Oncology filed for patent on cancer fighting method
... treating individual cancer patients the ability to predict what chemotherapy can be effective. Currently, Oncologists prescribe chemotherapy treatment based on empirical research collected and evaluated on specific cancers. The ... Source: Bizjournals »

Pharmaceutical Industry Veteran Dr. Craig Eagle Appointed as an Independent Member to Regenicin Board of Directors (CNW)
... Sydney, Australia and received his general internist training at in Sydney. He completed his hemato-oncology and laboratory hematology training at in Sydney. He was granted Fellowship in the (FRCPA). ... Source: AlphaTrade Finance »

Pharmaceutical Industry Veteran Dr. Craig Eagle Appointed as an Independent Member to Regenicin Board of Directors (PRN)
... Dr. Eagle currently serves as Vice President of Strategic Alliances and Partnerships for the Oncology business unit at Dr. Eagle brings a wealth of pharmaceutical industry experience to help ... Source: AlphaTrade Finance »

DiaTech Oncology Files Patents for Drug Discovery
... NASHVILLE, Tenn., Sept. 7 /PRNewswire/ -- DiaTech Oncology has announced the filing of a patent for Drug Discovery that will provide a ... Source: News Blaze »

CytRx Initiates Phase 2 Clinical Trial with Bafetinib in Advanced Prostate Cancer
... in patients with advanced-stage cancers now underway (Nasdaq:CYTR), a biopharmaceutical company specializing in oncology, today announced initiation of the reatment (PROACT) Phase 2 proof-of-concept clinical trial to evaluate ... Source: Business Wire »

Pharmaceutical Industry Veteran Dr. Craig Eagle Appointed as an Independent Member to Regenicin Board of Directors
... Dr. Eagle currently serves as Vice President of Strategic Alliances and Partnerships for the Oncology business unit at Pfizer Inc. Dr. Eagle joins Amgen Co-Founder Dr. as the second ... Source: PR Newswire »

Cancer patient credits radiation technology
... Robert Rak sits at Sonoran Desert Medical Oncology in Yuma, Ariz. on Aug. 18. Rak, 71, was diagnosed with prostate cancer in ... Source: Your West Valley »

Spectrum Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
... company with fully integrated commercial and drug development operations with a primary focus in oncology, today reported that an overview of the Companys business strategy will be given at ... Source: Street Insider »

Clarient to Present at Two Investor Conferences in September (PRN)
... translate cancer discovery and research into better patient care. 's principal customers include pathologists, oncologists, hospitals, and biopharmaceutical companies. The rise of individualized medicine as the new direction in ... Source: AlphaTrade Finance »

Clarient to Present at Two Investor Conferences in September
... translate cancer discovery and research into better patient care. Clarient's principal customers include pathologists, oncologists, hospitals, and biopharmaceutical companies. The rise of individualized medicine as the new direction in ... Source: Street Insider »

Colorado Integrative Cancer Care Expands
... of Aurora. CICC was created in response to the increasing patient demand for integrative oncology - healing-oriented medicine that takes account for the whole person (body, mind and spirit), ... Source: PR-USA.net »

Hospital to host sleep disorders seminar
... Anthony's welcomes new cancer specialist Dr. Lin Chen, a board-certified internist and board-eligible medical oncologist and hematologist, recently joined the staff of St. Anthony's Medical Center. Chen has joined ... Source: Suburban Journals »

Axelar AB publishes first AXL1717 data on phase I/II cancer study
... article on the ongoing phase I/II study with AXL1717 has been published in Acta Oncologica. The article, including clinical data from a limited group of AXL1717-treated patients, by Drs. ... Source: News-Medical.net »

Metformin May Protect Against Lung Cancer
... Research, and professor and chair in the department of thoracic head and neck medical oncology at the University of Texas M. D. Anderson Cancer Center on Wednesday, Sept. 1, ... Source: PR Web »

Jefferson County
... Anthony's welcomes new cancer specialist Dr. Lin Chen, a board-certified internist and board-eligible medical oncologist and hematologist, recently joined the staff of St. Anthony's Medical Center. Chen has joined ... Source: Suburban Journals »

Chewing your way to an early death
... proliferation of cancer cases. According to Nadeem Mohammed Saeed, head of the state-funded National Oncology Centre (NOC) in the capital Sanaa, about 30 percent of the cancer patients he ... Source: Irinnews »

First AXL1717 Clinical Data From Ongoing Phase I/II Study in Cancer Patients has Been Published (PRN)
... on the ongoing phase I/II cancer study with AXL1717 has been published in Acta Oncologica. The article, including clinical data from a limited group of AXL1717-treated patients, by Drs. ... Source: AlphaTrade Finance »

TGI Healthworks Presents the First Plant Medicine Expo & Healthcare Provider Conference
... Abrams, Professor of Clinical Medicine at the University of California San Francisco, Chief of Hematology/Oncology at San Francisco General Hospital and Director of Integrative Oncology Research at the UCSF ... Source: Street Insider »

New
... first radiotherapy treatment centre yesterday. The machines will be housed in Clatterbridge Centre for Oncology's satellite radiotherapy facility at the Walton Centre, in Aintree. It is the first time ... Source: Liverpool Daily Post »

Breast Cancer: Research from Immutep S.A. reveals new findings on breast cancer
... Country:France, Biological Factors, Breast Cancer, Breast Carcinoma, CD Antigens, CD8 Antigens, Cycloparaffins, Differentiation, Hydrocarbons, Oncology, Organic Chemicals, Paclitaxel, T Lymphocyte Antigens, Taxoids, Terpenes, Women's Health. This article was prepared ... Source: NewsRx »

Human Papillomavirus: Researchers from SAIC-Frederick, Inc. describe findings in human papillomavirus
... Viruses, Human papillomavirus, Intercellular Signaling Peptides and Proteins, Macrophages, Mononuclear Phagocyte System, Myeloid Cells, Oncology, Papillomavirus Infections, Phagocytes, Tumor Virus Infections, Viral, Virology. This article was prepared by NewsRx ... Source: NewsRx »

Prostate Cancer: Reports from United BioSource Corporation describe recent advances in prostate cancer
... M.E. Stokes, United BioSource Corporation, Dorval, Quebec, Canada. Keywords: City:Quebec, Country:Canada, Health Policy, Medicare, Oncology, Prostate Cancer, Prostatic Neoplasms. This article was prepared by NewsRx editors from staff and ... Source: NewsRx »

DNA Research: Study results from F.J. Rodriguez-Jimenez and colleagues in the area of DNA research published
... Spain. Keywords: City:Valencia, Country:Spain, Colon Cancer, Colon Carcinoma, DNA Damage, DNA Research, Deoxyribonucleic Acid, Oncology, Proteomics. This article was prepared by NewsRx editors from staff and other reports. Copyright ... Source: NewsRx »

Leiomyosarcoma: Studies from University of Arkansas, Department of Pathology yield new information about leiomyosarcoma
... Pathology, Little Rock, Arkansas USA. Keywords: City:Little Rock, State:Arkansas, Country:United States, Cancer, Leiomyosarcoma, Necrosis, Oncology, Urology. This article was prepared by NewsRx editors from staff and other reports. Copyright ... Source: NewsRx »

Psilocybin helps cancer patients
... obtaining subjects, Griffiths said. Because the drug has "such a tarnished history ... many oncologists are reluctant to refer volunteers," he said. All three discouraged cancer patients from using ... Source: Omaha World-Herald »

'Magic mushrooms' ingredient helps cancer patients, report says
... obtaining subjects, Griffiths said. Because the drug has "such a tarnished history & many oncologists are reluctant to refer volunteers," he said. All three discouraged cancer patients from using ... Source: Los Angeles Times »

Cancer educates a med student
... a demanding 12-week surgery rotation. The line at the metal detector near the county's oncology clinic snaked out the door. Lilienstein, who'd arrived straight from morning rounds in his ... Source: Los Angeles Times »

Anderson family, friends raise funds for oncology patients
Copyright © 2010 Geo. J. Foster Company. Site Design: ... Source: Citizen.com »

PennyStockBets.com: The Safest Bet in Town! (OTCBB: IMUC)
... June the Company presented the results at the prestigious 2010 American Society of Clinical Oncology Annual Meeting in Chicago, which was very well received by participating neurosurgeons and neuro-oncologists. ... Source: Quote.com »

Bayer looks to vibrant ops in Malaysia
... were several key areas in the country in which the company could expand, including oncology and contraception. On the National Pharmaceutical Control Bureau's assurance that its stringent regulations had ... Source: Business Times Malaysia »

Anderson family, friends raise funds for oncology patients
Copyright © 2010 Geo. J. Foster Company. Site Design: ... Source: Foster's Daily Democrat »

Clinical trials
... trial at West Texas Cancer Center. The cancer center is part of the U.S. Oncology network, a national service with 500 sites that has helped develop 42 FDA-approved cancer ... Source: Odessa American »

Thu 9/9: I Can Cope: Understanding Treatment Options and Their Side Effects
... and their loved ones. This one will be given by Dr. Darren Klish, radiation oncologist; Dr. Ronald Stephens, medical oncologist; Karen Finkbiner, oncology pharmacist; Jodi Carlson, clinical research coordinator; ... Source: Lawrence Journal-World »

TGA Australia approves Shilpa Medicare oncology manufacturing facility
The new facility will enable collaboration very early in development process Economics and Technology Minister visits global leader's headquarters in southern Germany. Vetter's ... Source: Pharmaceutical Business Review »

Palliative care shows promise
... were happier, more mobile, suffered less pain and lived longer than those patients receiving oncology treatments alone. Palliative care is medical treatment that concentrates on reducing symptoms, rather than ... Source: Inside Bay Area »

First Radiation Oncologist Hired For BC Cancer Agency Centre For The North And Appointed To The Northern Medical Program
... Dr. Robert Olson, a radiation oncologist, is the first physician to be hired for the BC Cancer Agency Centre for ... Source: Medical News Today »

Algeta ASA : Algeta's financial calendar 2011
... Oslo, Norway, 6 September 2011 - Algeta ASA (OSE: ALGETA), the focused oncology company, announces its financial calendar for 2011 4(th) Quarter Results 2010: ... Source: InvestEgate »

Acupuncture eases side effects and symptoms of some cancers
... symptom management. In a study in February 2010 issue of the Journal of Clinical Oncology, 50 women with hormone-receptor positive breast cancer were assigned into one of two groups. ... Source: Thaindian News »

Chemotherapy-induced Nausea and Vomiting (CINV): No Longer an Inevitable Side Effect of Chemotherapy for Gastric Cancer
... side effect can drastically interfere with treatment. At a recent annual meeting of the Oncology Nursing Society, more than half of oncology nurses surveyed reported that they had interrupted ... Source: CancerConsultants.com »

New Model May Simplify High-Dose Radiosurgery Planning
... treat brain and , or for high-dose brachytherapy for prostate and other . Radiation oncologists at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard ... Source: Medical News Today »

Yuma cancer patient credits radiation technology
... I can lay down for a little catnap and I'm fine." Calypso enables radiation oncology clinicians to keep the target in Rak's case, the prostate in the ... Source: Stamford Advocate »

Top nurse believes in information, honesty, and hope
... choice of departments in which to work as a beginning nurse, Yow picked the oncology unit which was then at Moses Cone Memorial Hospital in Greensboro and is ... Source: Asheboro Courier-Tribune »

Celsion Receives SBIR Grant To Expand Its Technology Platform
... its proprietary heat-activated liposomal technology in combination with carboplatin, an approved and frequently used oncology drug for treatment of a wide range of cancers. The grant is valued at ... Source: Pharmaceutical Online »

Proline-Directed Protein Kinases: Researchers at Amgen, Inc., Department of Hematology publish new data on proline-directed protein kinases
... Cell Proliferation, Enzymes and Coenzymes, Intracellular Signaling Peptides and Proteins, Mitogen Activated Protein Kinases, Oncology, Phosphotransferases (Alcohol Group Acceptor), Proline Directed Protein Kinases, Proline-Directed Protein Kinases, Protein Serine Threonine ... Source: NewsRx »

Biomarkers: Research data from Johnson & Johnson update understanding of biomarkers
... Researchers detail in 'Personalized medicine in oncology: tailoring the right drug to the right patient,' new data in biomarkers. According to ... Source: NewsRx »

Faces and Places: Ronald McDonald House hires development director
... was an event specialist for the United Way of Central Georgia. She was an oncology social worker at The Medical Center of Central Georgia and received training from Memorial ... Source: macondaily.com »

Sanofi Comes Out With Genzyme Bid
... operate as a stand-alone unit, and the remainder of Genzyme's businessescardiology, biosurgery, hematology, and oncologywould be integrated into Sanofi's larger and more experienced marketing infrastructure. ... Source: Chemical & Engineering News »

Two Cleveland doctors among 187 doctors disciplined by medical board
... CT scan that showed a potential problem. The patient was not referred to an oncologist until a year later, at which time the patient was diagnosed with lung cancer. ... Source: Houston Community Newspapers Online »

The Cowboy Who Never Gave Up
... and dividing. So they also see the effects of that therapy, " Sanford Pediatric Oncologist Dr. Charlie Peters said. Still, this pediatric oncologist says 50 years ago doctors couldn't ... Source: Keloland News »

Docs learn about cancer cure via implants
... brachytherapy is also an effective alternative to aggressive surgical removal of cancer." Sr radiation oncologist, Dr Nisar , explained, "High Dose Rate Brachytherapy treatment has become much more effective ... Source: The Times of India »

Cancer survivor rates improving
... years, a conference in Dublin heard at the weekend. Dr Séamus O'Reilly, consultant medical oncologist at Cork University Hospital who chaired the Innovation in Cancer Care conference at the ... Source: The Irish Times »

Skin cancer threat looms
... already got skin cancer but are yet to be diagnosed," said Subir Ganguly, senior oncologist. Prithvijit Mitra ... Source: The Times of India »

Duke researcher awarded St. Baldrick's grant
... to specialize in pediatric cancer research, by spending a summer working in a pediatric oncology research lab. Goldstein is in her first year of medical school at the UNC ... Source: Durham Herald-Sun »

Woman's strike chemo hell
... in fear that the cancer cells now have the opportunity to multiply. A specialist oncologist who spoke to Beeld on condition of anonymity said the interruption of chemotherapy at ... Source: News24 »

Laura E. Mirian, Ph.D., Inducted into Cambridge Who's Who
... Humanistic and Transpersonal Psychology from Saybrook University. She earned her Master's Degree in Gynecologic Oncology Nursing, and her Bachelor of Science in Nursing, with a minor in Psychology, from ... Source: PR-CANADA.net »

Conn.'s Camp Rising Sun inspires kids touched by cancer (video)
... Heffernan became a counselor a decade ago, when a friend who is a pediatric oncology nurse asked him to come on board. Now he’s a co-director and one of ... Source: New Haven Register »

YEMEN: Chewing your way to an early death
... proliferation of cancer cases. According to Nadeem Mohammed Saeed, head of the state-funded National Oncology Centre (NOC) in the capital Sanaa, about 30 percent of the cancer patients he ... Source: Reuters AlertNet »

Rose garden at oncology center a tribute for all to enjoy
... peaceful spot of joy for cancer patients going in and out of the Ravenel Oncology Center at Memorial Hospital. During their retirement, the Heatons really developed a passion for ... Source: Martinsville Bulletin »

Chewing your way to an early death
... proliferation of cancer cases. According to Nadeem Mohammed Saeed, head of the state-funded National Oncology Centre (NOC) in the capital Sanaa, about 30 percent of the cancer patients he ... Source: Irinnews »

Camp Rising Sun inspires kids touched by cancer (video)
... Heffernan became a counselor a decade ago, when a friend who is a pediatric oncology nurse asked him to come on board. Now he’s a co-director and one of ... Source: New Haven Register »

NADPH Oxidoreductases NADH: Researchers from New York Medical College describe findings in NADPH oxidoreductases NADH
... Carcinoma, Cell Cycle Proteins, Cell Proliferation, Cyclin D1, Enzymes, NADPH Oxidoreductases NADH, Neoplasm Proteins, Oncology, Peptides, Proto Oncogene Proteins, Quinone Reductases, Treatment, Women's Health. This article was prepared by ... Source: NewsRx »

Lung Cancer: Research from Fourth Military Medical University reveals new findings on lung cancer
... Taiwan. Keywords: Country:People's Republic of China, Apoptosis, Cancer Gene Therapy, Lung Cancer, Lung Neoplasms, Oncology. This article was prepared by NewsRx editors from staff and other reports. Copyright 2010, ... Source: NewsRx »

When oncology becomes hope-ology
... it different in healthcare, and especially in patients with cancer? The fact is, in oncology, we are not just delivering cold, hard anti-cancer therapy, but hope as well. I ... Source: The Star Online »

Kuykendall - Miller Engagement
... from the University of Central Oklahoma in 2008. She is employed by Oklahoma Radiation Oncology. Andrew is a 2004 Latta High School graduate. He recently retired from professional baseball ... Source: News-star.com »

Megliola: A day Herzlich will never forget
... Check it out. The visit to the orthopedist led to the visit to the oncologist which led to the big C. If Herzlich, young and vigorous one day, cancer-stricken ... Source: Metro West Daily News »

Neurosurgery: World's largest neurosurgical society launches the specialty's first comprehensive global journal
... He is the Edwin M. Todd, Trent H. Wells, Professor of Neurosurgical Surgery, Radiation Oncology, Biology and Physics at the Keck School of Medicine at the University of Southern ... Source: NewsRx »

Sasha Clifton, Geoffrey Oxnard
... the owner of a catering company in Cambridge. The bridegroom, 33, is a medical oncology third-year fellow at in New York. He graduated from Harvard and received a medical ... Source: The New York Times »

Annual Megan Savage Memorial Run planned Sept. 25 in Upland
... enduring cancer treatments. It has an adopt-a-family component, too, which provides assistance to pediatric oncology families during the holidays. And it works with families at three Inland Valley hospitals ... Source: Daily Bulletin »

For acupuncture, proof in the placebo
... way we do with drugs," said Dr. Eleanor M. Walker, director of breast radiation oncology at the Henry Ford Health System. "The thing that can't be argued in my ... Source: China Daily »

'I'm giving cancer the chop!': Mother uses techniques honed in karate classes to help fight rare form of the disease
... And normal - which is the most important thing.' Linda is not alone. Consultant oncologist Professor Robert Thomas, of Addenbrooke's Hospital, Cambridge, and author of Lifestyle After Cancer, believes ... Source: Daily Mail »

Leukemia takes Neshaminy senior off football field
... Dapkey's family by his side in the intensive care unit, Dr. Spencer Sullivan, an oncology fellow at CHOP, revealed the diagnosis to him: acute lymphoblastic leukemia (ALL). Dapkey's first ... Source: Philly »

Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Brea
... US once approved. Archimedes Pharma is an international specialty pharmaceutical company focused on the oncology, pain, neurology, and critical care sectors. Archimedes Pharma is marketing an expanding portfolio of ... Source: PR-CANADA.net »

Oncolytics Biotech(R) Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by th
... Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Gynecologic Oncology Group (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus ... Source: PR-CANADA.net »

Varian Medical Systems Management to Present at Baird's 2010 Health Care Conference
... and corporate communications. The presentation will focus on the company's growth opportunities in radiation oncology, X-ray imaging, proton therapy and security and inspection. Varian Medical Systems, Inc., of Palo ... Source: PR-CANADA.net »

The United States Therapeutic Apheresis Market to Reach US$120 Million...
... (GVHD). is the second largest segment, followed by In terms of end-use, hematology and oncology is the single-largest market for therapeutic apheresis. Rheumatology represents the fastest growing end-use market ... Source: PR Web »

Cancer Center to be the First in Europe to Install a CyberKnife VSI System, the Latest Generation of
... in France . The addition of the CyberKnife System to the already well-equipped Radiation Oncology department, - which features five treatment accelerators, one dedicated scanner and one brachytherapy suite, ... Source: PR-CANADA.net »

CURE Magazine Named a Finalist in PM360's 2010 Trailblazer Awards
... for the newly diagnosed. Led by editor-in-chief Debu Tripathy, MD, a nationally recognized breast oncologist, McClure, and cancer survivor and editor-at-large, Kathy LaTour, CURE covers all tumor types and ... Source: PR-USA.net »

Mesothelioma - 10 Different Ways For Treating Mesothelioma
... the age as well as state of health of the patient. It is the oncologist who specializes in the disease who will decide on the line of treatment. The ... Source: American Chronicle »

Generex Oncology Corp hires Dr George E Peoples as consultant
... Generex Oncology Corp hires Dr George E Peoples as consultant Drug delivery systems company Generex Biotechnology ... Source: Therapeutics Daily »

Nationwide Prostate Screenings to Detect Cancer and Help Save Lives
... benefits of prostate cancer screenings," said Dr. E. David Crawford, Head of the Urologic Oncology Department at the University of Colorado Health Sciences Center, and Founder/Chairman of the PCEC. ... Source: PR-USA.net »

Forecasting: Patient Flow Modeling Comes Of Age - Pre-Summit Workshop October 5th Boston
... potential is affected by movement between disease states. The technique is used frequently in oncology, , RA, and other markets with lines of therapy dynamics. E4P: How do you ... Source: Medical News Today »

Laser Tattoo Removal Training Course Offered by New Look Laser College
... nurse practitioner with the ability to treat patients in a variety of fields from oncology to allergy to cosmetic laser procedures. Her undergraduate program from University of California at ... Source: Street Insider »

Special day for Herzlich
... with an orthopedist led to an MRI, which led to an appointment with an oncologist. On a mid-May day, Herzlich was told he had Ewing's sarcoma, a rare form ... Source: Metro West Daily News »

MSKCC develops new prediction tool to calculate risk for DCIS recurrence after breast-conserving surgery
... after surgery. "For the first time, using readily available information, a patient and her oncologist can estimate her individualized risk, and then use this tool to help in the ... Source: News-Medical.net »

Multiple Sclerosis: Studies from G. Matarese and co-researchers yield new data on multiple sclerosis
... sclerosis. For more information, contact G. Matarese, Laboratorio di Immunologia, Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), Via S Pansini 5, 80131 Napoli, Italy. Keywords: ... Source: NewsRx »

Venous Thromboembolism: New venous thromboembolism study findings have been reported by scientists at University of Virginia, Division of Gynecologic Oncology
... and pathology reviewed. All patients had surgical staging and/or cytoreductive surgery by a Gynecologic Oncologist at the MGH. All patients received appropriate peri-and post-operative and/or sequential compression devices. VTE ... Source: NewsRx »

Bone Marrow: Data on bone marrow reported by researchers at Kobe Pharmaceutical University
... Epithelial Cells, Receptors, Immune System, Immunotherapy, Interleukin 16 Receptors, Membrane Proteins, Mononuclear Phagocyte System, Oncology, T Lymphocyte Antigens, Treatment. This article was prepared by NewsRx editors from staff and ... Source: NewsRx »

TNS therapy improves depression condition: Study
... infants, comparing the behavior of the siblings of children ... CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for ... Researchers at Ben-Gurion University ... Source: News-Medical.net »

Michael Douglas 'optimistic' about Stage 4 throat cancer diagnosis
... Dr. Kevin Cullen, director of the University of Maryland Greenebaum Cancer Center and an oncologist who specializes in head and neck cancer. 'Typically cancers of the tongue we treat ... Source: Palm Beach Post »

Man taking part in cancer fundraiser in memory of his wife
... Margaret Hospital in Toronto on occasion. "I think we sometimes forget what a great oncology department we have (at St. Catharines General Hospital)," Osmond said. "But that said, Lesley ... Source: St. Catharines Standard »

Craig County mother to shave head on national TV during Stand Up to Cancer
... through with her, on a recent check-up for Levi. During our interview, Levi's pediatric oncologist, , came in with some good news. Levi's latest , who still feels concern ... Source: WSLS »

Generex Oncology Corp hires Dr George E Peoples as consultant
... for the Advancement of Military Medicine. Currently, Dr Peoples is the chief of Surgical Oncology at Brooke Army Medical Center in Houston, TX, professor of Surgery and the director ... Source: M2 »

Fellows to join Great River Hematology and Oncology
... Fellows to join Great River Hematology and Oncology WEST BURLINGTON - A new oncologist/hematologist soon will begin practicing at Great River Medical ... Source: Burlington Hawk Eye »

First doctor hired for cancer centre
... Dr. Robert Olson, a radiation oncologist, is the first physician to be hired for the BC Cancer Agency Centre for ... Source: BCLocalNews.com »

Learn how to develop a comprehensive Oncology strategy from pre-launch to the end of a patient's cancer treatment at 1st annual Oncology Japan 2010
... Finally, the hottest topic in pharma gets the platform for discussion in Oncology Japan. With 1 in 2 Japanese people diagnose with cancer and 1 in 3 ... Source: PharmiWeb.com »

"To Your Good Health Radio" welcomes author, Dr. Block to discuss his...
... Latest Book "Life Over Cancer" Dr. Block is an internationally recognized expert in integrative oncology. He combines cutting-edge conventional treatment with individualized and scientifically-based complementary and nutraceutical therapies. Dr. ... Source: PR Web »

Blood Publication Shows MLN4924 Preclinical Activity in Lymphoma
... new molecule, by combining MLN4924 and an NAE substrate called NEDD8. Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets a first-in-class proteasome inhibitor, ... Source: Therapeutics Daily »

BioWatch: Emergent wins more federal backing for anthrax vaccine
... its proprietary heat-activated liposomal technology in combination with carboplatin, an approved and frequently used oncology drug. Neuralstem has applied to the FDA for permission to launch a phase 1 ... Source: Gazette.Net »

Radiation Oncology Services of America, Inc. to Work With Washington University on Quality Assurance
... Radiation Oncology Services of America, Inc. (ROSA), a subsidiary of Ambulatory Services of America, Inc. (ASA), ... Source: PR-USA.net »

The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Ad
... The ASCO Post captured initial reactions to the Oncologic Drugs Advisory Committee (ODAC) recommendation that the breast cancer indication for bevacizumab (Avastin) be ... Source: PR-USA.net »

Campaign on out-of-hours cancer care
... Cancer Foundation has agreed to fund an awareness campaign to reduce the number of oncology emergencies across the North West. Symptoms which would be considered relatively minor in healthy ... Source: Preston Today »

doctors
... younger women are becoming more susceptible to the disease, say doctors. Amit Bhargav, consultant oncologist at the Max Healthcare hospital in the capital, said that in his career, the ... Source: Top News »

The United States Therapeutic Apheresis Market to Reach US$120 Million by 2015, According to New Report by Global Industry Analysts, Inc.
... (GVHD). is the second largest segment, followed by In terms of end-use, hematology and oncology is the single-largest market for therapeutic apheresis. Rheumatology represents the fastest growing end-use market ... Source: Street Insider »

Study: Preventive Cancer Surgeries Save Lives
... Ashton said. "It's a blood test. You can get it at your gynecologist, your oncologist (cancer specialist), genetic specialists do it. It is expensive. But if you are at ... Source: Ktva.com »

St. Peregrine Cancer Shrine director to speak at 'facing cancer with faith' event
... Community conference. Dr. Chris Kellogg, a Corpus Christi parishioner, candidate for the deaconate and oncologist, will address Diagnosis, Now What? while Franciscan Brother Mark Maximillian will be among a ... Source: The Catholic Sun »

Diabetes drug may have cancer uses
... liver's glucose output and increasing the sugar's use by muscle tissue. Scott Lippman, an oncologist at the M.D. Anderson Cancer Center in Houston, estimates more than 40 million metformin ... Source: United Press International (UPI) »

Spero Pain Relief Therapy LLC Announces Opening of Pain Relief Clinic in St. George, Utah (MRW)
... Treatment medical device technology is a non-invasive medical device for the treatment of high-intensity oncologic and neuropathic pain, including pain resistant to traditional painkillers which often have bad side ... Source: AlphaTrade Finance »

Celsion Receives SBIR Grant To Expand Its Technology Platform
... its proprietary heat-activated liposomal technology in combination with carboplatin, an approved and frequently used oncology drug for treatment of a wide range of cancers. The grant is valued ... Source: KGUN TV-9 (ABC - Tucson) »

Spero Pain Relief Therapy LLC Announces Opening of Pain Relief Clinic in St. George, Utah
... wait for pain relief." Dr. Chalmers continued, "At the recent American Society of Clinical Oncology, or ASCO, a clinical study was presented on the Calmare system's effectiveness with chronic ... Source: Interest Alert »

Clare Holland memorials come home
... annual nursing scholarship to be awarded to a student with a special interest in oncology, palliative care or community nursing. The third was to plant a double lilac tree ... Source: Canberra Times »

New Model May Simplify High-Dose Radiosurgery Planning
... Radiation oncologists at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard ... Source: ScienceDaily Magazine »

Strong health investment in Tairawhiti DHB area
... "Building a $900,000 community health facility for people with chronic conditions "Refurbishment of an oncology room in the children's ward "The three year programme to improve school dental services ... Source: Scoop »

Losing the census will impact Canadian's health
... Prime Minister, Dr. Patti Groome, (Canada Research Chair in Cancer Care Evaluation, Department of Oncology at Queens University) stated that Epidemiologists and other population researchers know that the groups ... Source: Digital Journal »

Study challenges value of oxygen therapy in end-of-life care
... the practice is not based on rigorous scientific investigation," says Dr. Amy Abernethy, an oncologist and palliative care expert in the Duke Comprehensive Cancer Center and the lead author ... Source: Eurek Alert »

CAMC purchases land for $40 million cancer center at old ballpark
... Authority for approval. The hospital is soliciting suggestions for the future cancer center from oncologists (doctors who specialize in cancer treatment), nurses, patients, families and community leaders. "It's a ... Source: The Charleston Gazette »

Fears grow for Portiuncula oncology services
... staff and patients at Ballinasloe’s Portiuncula Hospital await a decision on the future of oncology services at the hospital, unions are gearing up to launch a public protest and ... Source: Advertiser.ie »

Fellows to join Great River Hematology and Oncology headlin
... Fellows to join Great River Hematology and Oncology WEST BURLINGTON - A new oncologist/hematologist soon will begin practicing at Great River Medical ... Source: Burlington Hawk Eye »

Innovent Oncology teams with Milliman to develop oncology risk models
... THE WOODLANDS, TX – Innovent Oncology, a division of US Oncology, has engaged the actuarial and consulting firm Milliman to ... Source: Healthcare Finance News »

Generex Oncology Announces Consultancy of Dr. George E. Peoples, MD (GNW)
... Dr. Peoples is presently the Chief of Surgical Oncology at in Houston, TX, a Professor of Surgery and the Director & Principal Investigator ... Source: AlphaTrade Finance »

Generex Oncology Announces Consultancy of Dr. George E. Peoples, MD
... the Advancement of Military Medicine ( Dr. Peoples is presently the Chief of Surgical Oncology at Brooke Army Medical Center in Houston, TX, a Professor of Surgery and the ... Source: Street Insider »

Oncolytics Biotech Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic Oncology Group and Sponsored by the National Cancer Institute
... Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic Oncology Group and Sponsored by the National Cancer Institute TORONTO, Sept. 2 /PRNewswire-FirstCall/ -- Oncolytics ... Source: Pharmalive.com/ »

Oncolytics Biotech(R) Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic Oncolog
... 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Gynecologic Oncology Group (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus ... Source: News Blaze »

Oncolytics Biotech(R) Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic Oncology Group and Sponsored by the National Cancer Institute
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ) announced today that the Gynecologic Oncology Group (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus ... Source: Street Insider »

Oncolytics Biotech(R) Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic Oncology Group and Sponsored by the National Cancer Institute (PRN)
("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with ... Source: AlphaTrade Finance »

Oncolytics Biotech(R) Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic Oncology Group and Sponsored by the National Cancer Institute (CNW)
"Ovarian cancer is typically diagnosed at the later stages, because earlier stage disease usually has no obvious symptoms," said Dr. David E. Cohn. "On this ... Source: AlphaTrade Finance »

Diabetes drug metformin found to reduce cancer risk, reseachers say
... all other things are equal, early evidence that metformin might have benefit on the oncology side may play a role in decision making," said Dr. Michael Pollak, a medical ... Source: Belleville.com »

Melanie Beattie Appeal raises cash for two chemo cars for Clatterbridge Oncology Centre
... Melanie Beattie Appeal raises cash for two chemo cars for Clatterbridge Oncology Centre FUNDRAISERS from Aughton have seen the fruits of their labours delivered to help ... Source: Southport Visitor »

"To Your Good Health Radio" welcomes author, Dr. Block to discuss his groundbreaking book "Life Over Cancer" on Thursday, September 2nd at 1pm ET.
... Friedman welcomes Dr. Keith Block, referred to by many as the father of integrative oncology, live to the show Thursday, September 2nd, 1pm ET (Vocus) September 2, 2010 -- ... Source: Street Insider »

"To Your Good Health Radio" welcomes author, Dr. Block to discuss his...
... Latest Book "Life Over Cancer" Dr. Block is an internationally recognized expert in integrative oncology. He combines cutting-edge conventional treatment with individualized and scientifically-based complementary and nutraceutical therapies. Dr. ... Source: PR Web »

Studies: Diabetes drug metformin shows promise as cancer fighter
... all other things are equal, early evidence that metformin might have benefit on the oncology side may play a role in decision making," said Dr. Michael Pollak, a medical ... Source: Arizona Daily Star »

Genetic markers could predict prostate cancer in younger men
... genetic markers, says study author Dr. Kathleen Cooney, Frances and Victor Ginsberg professor of Hematology/Oncology and division chief of hematology/oncology at the U-M Medical School. Researchers looked for 14 ... Source: St Louis American »

Radiation Oncology Services of America, Inc. to Work With Washington University on Quality Assurance Initiative
... Radiation Oncology Services of America, Inc. to Work With Washington University on Quality Assurance Initiative Information ... Source: KGUN TV-9 (ABC - Tucson) »

The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer
... Station make no warranties or representations in connection therewith. captured initial reactions to the Oncologic Drugs Advisory Committee (ODAC) recommendation that the breast cancer indication for bevacizumab (Avastin) be ... Source: KGUN TV-9 (ABC - Tucson) »

Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice
... a while," said editor-in-chief Dr. Scott Lippman, chair of thoracic head and neck medical oncology at the University of Texas M.D. Anderson Cancer Center in Houston, at a Wednesday ... Source: Health Finder »

Open House at Gulf Coast Cancer Treatment Center Introduces Elekta Synergy(R) to Community
... -- Gulf Coast Cancer Treatment Center, the area's only American College of Radiology-accredited radiation oncology center, introduces the Elekta Synergy system. The new technology will be showcased at the ... Source: Interest Alert »

HealthCare Global to Establish Cancer Centre in Ghana
... largest Cancer Care Network, on Monday called for the need to empower and improve Oncology Centres and Cancer management in Africa. Speaking at a Press Conference in Accra yesterday, ... Source: Open Press »

Clinical Oncology: Reports summarize clinical oncology research from M.C. Coroi and co-authors
performed in County Hospital of Oradea between 2000-2007,' is newly published data in Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et ... Source: NewsRx »

Cancer in remission after state-of-the-art radiation
... using the Calypso System. The state-of-the-art radiation technology is used at Sonoran Desert Medical Oncology, a cancer treatment center in Yuma. The machine is one of about 40 in ... Source: Yumasun »

Microsoft Excel-based algorithm predicts cancer prognosis
... Research aims to provide a high-quality forum for basic, clinical and translational work in oncology. ) is an STM (Science, Technology and Medicine) publisher which has pioneered the open ... Source: Eurek Alert »

Open House at Gulf Coast Cancer Treatment Center Introduces Elekta Synergy® to Community
... -- Gulf Coast Cancer Treatment Center, the area's only American College of Radiology-accredited radiation oncology center, introduces the Elekta Synergy system. The new technology will be showcased at ... Source: KGUN TV-9 (ABC - Tucson) »

This week's events 9/2/10
... Pharmacist -- Sponsored by Claudia Mayer Cancer Resource Center. Featuring Anne Delisa, a clinical oncology pharmacist. Fri., Sept. 3, noon-3 p.m., 10710 Charter Drive, Suite G050, Columbia. 410-740-5858. Health ... Source: The View From Ellicott City »

New test seen as big advance in diagnosing TB
... it can reduce rates of colorectal tumors in humans. Dr. Michael Pollak, a medical oncologist at McGill University in Montreal, who surveyed recent metformin research in an article in ... Source: The Seattle Times »

Analysis: Genzyme units attract interest but what about Sanofi?
... is moving ahead with plans announced in May to sell off its reproductive and oncology genetic testing business, which generated 2009 sales of $371 million, and its diagnostics business, ... Source: Reuters »

Analysis - Genzyme units attract interest but what about Sanofi?
... is moving ahead with plans announced in May to sell off its reproductive and oncology genetic testing business, which generated 2009 sales of $371 million (240 million pounds), and ... Source: Reuters »

Alere Inc. Declares Dividend on its Series B Convertible Perpetual Preferred Stock
... services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Alere is headquartered in ... Source: Stockwatch »

New Approach To Treating Lung Cancer Patients
... A study just released in the Journal of Thoracic Oncology shows it is possible to screen lung cancer patients for a sensitivity to certain ... Source: WCCO »

Diabetes drug can reduce risk of cancer, researchers find
... the side may play a role in decision-making," said Dr. Michael Pollak, a medical oncologist at McGill University in Montreal who surveyed recent metformin research in an article in ... Source: Los Angeles Times »

EmpowHER Offers FREE Resources and Support to Women Living With Ovarian Cancer
... initial tests indicate the possibility of ovarian cancer, referral to a specialist, a gyn oncologist, is appropriate care," he adds. For women dealing with ovarian cancer, EmpowHER has created ... Source: Market Wire »

Open House at Gulf Coast Cancer Treatment Center Introduces Elekta Synergy® to Community
... -- Gulf Coast Cancer Treatment Center, the area's only American College of Radiology-accredited radiation oncology center, introduces the Elekta Synergy system. The new technology will be showcased at the ... Source: PR Newswire »

The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Ad
... Cancer COLD SPRING HARBOR, N.Y., Sept. 1 /PRNewswire/ -- captured initial reactions to the Oncologic Drugs Advisory Committee (ODAC) recommendation that the breast cancer indication for bevacizumab (Avastin) be ... Source: Interest Alert »

Radiation Oncology Services of America, Inc. to Work With Washington University on Quality Assurance
... Radiation Oncology Services of America, Inc. to Work With Washington University on Quality Assurance Initiative Radiation ... Source: Interest Alert »

Radiation Oncology Services of America, Inc. to Work With Washington University on Quality Assurance Initiative
... Radiation Oncology Services of America, Inc. to Work With Washington University on Quality Assurance Initiative /PRNewswire/ ... Source: PR Newswire »

The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer
... captured initial reactions to the Oncologic Drugs Advisory Committee (ODAC) recommendation that the breast cancer indication for bevacizumab (Avastin) be ... Source: Street Insider »

Cancer Center to be the First in Europe to Install a CyberKnife VSI System, the Latest Generation of the CyberKnife System
... region in . The addition of the CyberKnife System to the already well-equipped Radiation Oncology department, - which features five treatment accelerators, one dedicated scanner and one brachytherapy suite, ... Source: PR Newswire »

Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
... US once approved. Archimedes Pharma is an international specialty pharmaceutical company focused on the oncology, pain, neurology, and critical care sectors. Archimedes Pharma is marketing an expanding portfolio of ... Source: News Blaze »

Chuck Bennett: Canadians invade Troy for fundraiser
... in Windsor, Glamfunkshion raised $85,000 for a program called Transition to Betterness (T2B) Pediatric Oncology Backpack Program which will launch in September. Each child in the oncology program will ... Source: Detnews »

Chemotherapy-induced Nausea and Vomiting (CINV): No Longer an Inevitable Side Effect of Chemotherapy for Esophageal Cancer
... side effect can drastically interfere with treatment. At a recent annual meeting of the Oncology Nursing Society, more than half of oncology nurses surveyed reported that they had interrupted ... Source: CancerConsultants.com »

As breast cancer spreads in India, awareness is key (Feature)
... lump was increasing did she tell her husband. The following day they consulted an oncologist and got a shock. Sunaina was diagnosed with breast cancer. The 38-year-old woman was ... Source: Thaindian News »

Conveyance of charity
... his business suit for a bike as he endeavours to raise $20,000 for the Oncology Children's Foundation. Accompanied by Sydney Swans fundraisers Ryan O'Keefe and Jared Crouch, Mr Denny ... Source: WhereILive »

As breast cancer spreads in India, awareness is key
... lump was increasing did she tell her husband. The following day they consulted an oncologist and got a shock. Sunaina was diagnosed with breast cancer. The 38-year-old woman was ... Source: Mangalorean.Com »

Reportlinker Adds Threats to Avastin - Targeting the VEGF Pathway
... culminating in sales of ) in 2009. Not only is Avastin now Roche's top-selling oncology product, ahead of both MabThera/Rituxan (rituximab) and Herceptin (trastuzumab), but its sales exceed those ... Source: KGUN TV-9 (ABC - Tucson) »

Moderate Drinking May Boost Risk of Breast Cancer's Return
... findings will need to be confirmed by other studies. Dr. Paula Klein a medical oncologist and breast cancer specialist at the Beth Israel Comprehensive Cancer Center in New York ... Source: Medline plus »

Ipsen's Half-year 2010 Results
... 2010 results validate Ipsen's positioning with a double digit Specialist Care sales growth in oncology, neurology and endocrinology and a sustained intrinsic operating profitability, up 20.2%. In a difficult ... Source: Therapeutics Daily »

Swiss Breast Cancer Patient Becomes First In World To Receive Treatment Using Gated RapidArc From Varian Medical Systems
... treatment delivery by compensating for tumor motion. The treatment took place at the Istituto Oncologico della Svizzera Italiana (IOSI) radiation oncology unit in Bellinzona, a public comprehensive cancer center ... Source: Medical Design Online »

Preventive Cancer Surgeries Save Lives
... medicine at the Northwestern University Feinberg School of Medicine in addition to being an oncologist at Northwestern Memorial Hospital. "Primary care physicians, gynecologists and women need to be more ... Source: Medical Breaktroughs »

Cipla Medpro lifts drug market share
... for Cipla over the next few years would be OTC drugs, anti-diabetic treatments and oncology medications. Cipla Medpro's shares leapt 10.5 percent to R6.19 yesterday. ... Source: Independent Online »

Canada Grants GW Pharm's Sativex Full Approval for MS Spasticity
... on the development of new cannabinoid drugs as therapeutic candidates for CNS disorders and oncology indications. ... Source: Genetic Engineering News »

New prisons are a poor investment
... just, effective, and humane criminal justice system. &italics;Dr. James P. Bond is a retired oncologist and a former professor of hematology and oncology at the University of Pennsylvania. As ... Source: Pocono Record Online »

Penile Cancer: Research on penile cancer reported by scientists at University of Padua
... in For additional information, contact V. Ficarra, University of Padua Monoblocco Ospedaliero, Dept. of Oncological and Surgical Sciences, Urology Clinic, Via Giustiniani 2, Padua, Italy. Keywords: City:Padua, Country:Italy, Hemic ... Source: NewsRx »

Phelophepa
... cervical cancer, breast examinations and PSA testing for prostate cancer. In 2009 Roche funded oncology training for three nursing professionals who are now responsible for educating patients on the ... Source: BoiValley CH »

Bar Harbor BioTechnology uses genetic tools for disease research
... CEO Robert Phelps: “We are developing diagnostic tests for a variety of diseases, in oncology, metabolic disease like diabetes, and auto-immune diseases like Lupus. The tests can tell a ... Source: Mass High Tech »

Ovary removal proves beneficial for cancer-prone women
... live longer if they get their ovaries taken out, says Virginia Kaklamani, a medical oncologist at Northwestern University School of Medicine in Chicago. gene encodes a protein that protects ... Source: ScienceNews.org »

Edith Rosen Strauss organization holds donor lunch
... Sylvia Gammerman and Paula Scherr, ERS donor co-chairs; Dr. Teresa York, director of pediatric oncology at the University of Md. Hospital; Dr. Joseph Wiley, chief of pediatric oncology at ... Source: Crofton Crier »

Relieving the burden at a difficult time
... as shower chairs and demountable beds for the home nursing of cancer patients. The oncology ward at the Cowra District Hospital also receives assistance from the Group. There are ... Source: Cowra Guardian »

Council to talk with GWAHS before cancer campaigner invited
... to improve other things, he said. More specialists were a must, particularly a resident oncologist who could give patients quicker access to a treatment program, he said. ... Source: The Daily Liberal »

Sringeri Sharada Peetham to set up cancer hospital in Bangalore
... of the hospital is its committed R&D wing, which will especially focus on community oncology, preventive oncology, and clinical trials. Essentially being set up with an altruistic motive, the ... Source: Mangalorean.Com »




Zip